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1. SUMMARY  
Pyrrolidine dithiocarbamate (PDTC), a known inhibitor of NF-κB-activation, has anti-
oxidative as well as antiviral activities. PDTC is effective against several virus families, 
indicating that its antiviral mechanism targets host rather than viral functions. To 
investigate its mode of action, we use baker’s yeast as a simple eukaryotic model system 
and two types of genome-wide analysis. First, expression profiling using whole-genome 
DNA microarrays identifies more than 200 genes differentially regulated upon PDTC 
exposure. Interestingly, the Aft1-dependent iron regulon is a main target of PDTC, 
indicating a lack of iron availability. Additionally, the PDTC-caused zinc influx triggers a 
strong regulation of zinc transporters due to cytoplasmic zinc excess. Second, phenotypic 
screening the EUROSCARF collection of non-essential deletion mutants for PDTC 
hypersensitivity identifies numerous mutants implicated in vacuolar maintenance, 
acidification, as well as in transport, trafficking, mitochondrial organization and 
translation. Notably, the screening data indicate significant overlaps of genes whose 
deletions cause PDTC-sensitivity and those mediating zinc, as well as alkaline pH 
tolerance. Strikingly, PDTC inhibits the proteolytic activation of the alkaline pH-responsive 
transcription factor Rim101 in a zinc-dependent manner. Hence, our data show that 
PDTC-induced cytoplasmic zinc excess triggers vacuolar detoxification, which in turn 
disturbs iron homeostasis and activates the iron-dependent regulator Aft1. Consequently, 
PDTC links intracellular disturbance of iron and zinc homeostasis to other cellular 
processes, including vacuolar and vesicular transport, as well as pH regulation. Our work 
reveals for the first time a complex cross-talk between yeast ion homeostasis and the 
underlying genetic regulatory networks. 
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2. ZUSAMMENFASSUNG 
Pyrrolidine dithiocarbamate (PDTC), ein bekannter Inhibitor der NF-κB-Aktivierung, zeigt 
sowohl anti-oxidative als auch antivirale Aktivität. Da PDTC gegen verschiedene 
Virusfamilien wirksam ist, sind vermutlich eher Wirtsfunktionen Ziele des antiviralen 
Mechanismus. Um seine Wirkungsweise zu analysieren verwenden wir Bäckerhefe als 
einfaches eukaryontisches Modellsystem und  zweierlei Strategien genomweiter Analyse. 
Genomweite Microarray Expressionsprofile identifizieren mehr als 200 Gene, die 
aufgrund von PDTC Zugabe differentiell reguliert werden. Interessanterweise ist das Aft1-
abhängige Eisenregulon ein Hauptangriffspunkt von PDTC, was auf Eisenmangel deutet. 
Überdies verursachen der PDTC-induzierte Zinkeinstrom und der damit einhergehende 
cytoplasmatische Zinküberschuss eine starke Regulierung der zellulären Zinktransporter. 
Das phänotypische Screening  der EUROSCARF Deletionssammlung zeigt, dass vor allem 
Mutanten in vakuolären Funktionen wie der Ansäuerung der Vakuole, aber auch jene mit 
Funktionen in Transportprozessen, mitochondrialer Organisation und Translation, sensitiv 
auf PDTC reagieren. Insbesondere gibt es erhebliche Überschneidungen von 
Genfunktionen, deren Deletion PDTC-Sensitivität hervorruft, mit jenen, die Resistenz bei 
Zinküberschuss oder alkalischem pH vermitteln. Bemerkenswerterweise inhibiert PDTC 
die proteolytische Aktivierung des Transkriptionsfaktors Rim101, die normalerweise als 
Antwort auf alkalischen pH erfolgt, in zinkabhängiger Weise.  Folglich zeigen unsere 
Daten, dass PDTC cytoplasmatischen Zinkeinstrom induziert, was zur Speicherung des 
überschüssigen Zinks in der Vakuole führt. Dadurch kommt es zu einer Störung der Eisen-
Zink-Homöostase, die wiederum den eisenabhängigen Regulator Aft1 aktiviert. Daher 
stellt PDTC durch die intrazelluläre Störung des Eisen-Zink-Gleichgewichts eine 
Verbindung zu anderen zellulären Prozessen wie vakuolären und vesikulären 
Transportprozessen und pH-Regulierung her. Unsere Arbeit zeigt erstmals eine komplexe 
Co-Regulation von intrazellulärer Ionenhomöostase und den zugrunde liegenden 
regulatorischen genetischen Netzwerken in Hefe auf. 
ZUSAMMENFASSUNG 
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3. INTRODUCTION 
From garlic to red wine – trials to fight the common cold 
Runny or stuffy nose, scratchy throat, sneezing all day long, cough, and headache – 
everyone knows the symptoms of a common cold. Human Rhinoviruses (HRVs), belonging 
to the family of Picornaviridae, are the most frequent cause of mild upper respiratory 
illnesses. Although neither life-threatening and with symptoms usually lasting for less 
than a week, the common cold is one of the leading causes for people staying at home 
from school or work. Even though normally self-limited, rhinoviruses are implicated in 
induction of serious disease in elderly people and in people suffering from asthma and 
chronic lung disease. Millions of lost work days and physician visits build up to an 
enormous social and economic burden annually (for review see (Dreschers et al., 2007)).  
The common cold is caused by numerous virus types that are associated with 
heterogeneous pathogenic symptoms. HRVs make up about 50% of upper respiratory 
infections. Additionally, coronavirus, influenzavirus, respiratory syncytial virus, 
parainfluenza virus and adenovirus have been related to the common cold. These agents 
account for minor proportions of the common cold syndrome and even cause lower 
respiratory illnesses and symptoms more typical for these viruses (Heikkinen and 
Jarvinen, 2003).  
Beside some household remedies and symptomatic treatment, there are no antiviral 
drugs or marketed therapies preventing or curing the common cold available yet. First of 
all, the multitude of viruses causing common cold symptoms, accounts for the lack of a 
universal treatment. Due to the central role of HRVs in causing the common cold, 
potential antiviral drugs targeting HRVs are expected to be the most successful treatment 
(De Palma et al., 2008). However, rhinoviruses, with their high diversity, exhibit a 
tremendous immunological resistance and variability.  A total of 99 serotypes, and the 
fact that the main virus-host interaction site is barely accessible for antibodies, make 
vaccine development impracticable (McKinlay, 2001; Dreschers et al., 2007). In search for 
an anti-rhinoviral therapy, many substances exhibited promising activity in cell culture, 
but failed to reach the market. Moreover, dependent on the short duration and mildness 
of the common cold, the safety-profile of an anti-rhinoviral drug has to be superior to 
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gain a perfectly balanced risk-to-benefit ratio (McKinlay, 2001; Dreschers et al., 2007). 
Thus, screening for new antiviral substances is a main aim to fight the common cold.  
The viral life cycle 
To specifically target virus multiplication, one has to study the viral life cycle (Lin et al., 
2009). In the case of HRVs, the virus particle is internalized upon receptor binding. 
Receptor-mediated endocytosis results in uncoating and delivery of the viral RNA genome 
into the cytosol where translation takes place. The coding region of the viral genome 
covers one functional open reading frame which directs the expression of a polyprotein 
precursor of all the viral proteins. The central coding part of the genome can be divided 
into three regions P1, P2, and P3. P1 encodes the capsid proteins VP1 to VP4, P2 and P3 
encode the non-structural proteins involved in co-translational cleavage of the 
polyprotein (viral proteases 2A and 3C), inhibition of host cell functions (proteases 2A, 3C, 
and L), determination of host range (2B, 2C) and replication of the viral RNA (2C, 3AB, Vpg 
and RNA polymerase 3D) (Fig. 1). Importantly, a viral protease cleaves the eukaryotic 
translation initiation factor 4G (eIF4G) leading to a shut-off of cap-dependent translation 
only allowing IRES-dependent translation of viral RNA. Finally, new viral particles, 
consisting of a newly synthesized RNA genome, non-structural proteins and capsid 
proteins, are assembled and then released by cell lysis (for review see (Whitton et al., 
2005; Lin et al., 2009)).  
 
Figure 1: A diagrammatic representation of the Picornavirus genome, the polyprotein, its organization and the main 
function of the encoded proteins is shown. The three cleavage intermediates together with the 12 main resulting 
polypeptides are presented. Additionally, the key functions of the polypeptides are indicated. IRES, internal ribosome 
entry site; UTR, untranslated region; Vpg, viral protein genome-linked; (Whitton et al., 2005). 
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Potential anti-rhinoviral approaches 
Numerous studies of potential treatments and therapies against the common cold are 
available. They include red wine (Takkouche et al., 2002), capsid blockers and protease 
inhibitors (De Palma et al., 2008), and even the effect of garlic (Lissiman et al., 2009) on 
the infection course. Potential ways to prevent virus infections and inhibit virus 
multiplication are to block virus entry, to inhibit uncoating, replication or polyprotein 
processing, assembly and virus release (Lin et al., 2009).  
A historical old strategy of anti-rhinoviral therapy targets the viral capsid. So called WIN 
compounds bind to viruses and inhibit a conformational change in the capsid, thereby 
preventing RNA release (Otto et al., 1985). In clinical trials, these substances failed due to 
pharmacokinetic problems, such as the applicable drug concentration range showed little 
efficacy. The most promising candidate of the capsid binding substances, Pleconaril, is 
considered as prove that capsidblockers can reduce severity and duration of common 
cold symptoms (Hayden et al., 2003). However, in 2001, Pleconaril was not approved by 
the US Food and Drug Administration (FDA) for oral drug formulation for common colds 
because of its unconvincing safety profile. However, ViroPharma re-licensed Pleconaril to 
Schering-Plough, who completed a phase II trial in 2007 
(http://www.clinicaltrials.gov/ct/gui/show/NCT00394914).   
Beside capsid blockers, several compounds have been tested as protease 2A and 3C 
inhibitors (e.g. homophthalimides, rupintrivir, compound 1, keto-glutamine analogues). 
As viral replication inhibitor, guanidine hydrochloride was extensively studied. However, 
so far most of the substances failed to reduce and shorten the common cold symptoms in 
clinical trials (for review see (De Palma et al., 2008)). Notably, preventing transmission by 
smear infections using hand-disinfection provides an option to decrease the onset of the 
illness.  
Zinc supplementation has often been suggested to reduce virus multiplication, thereby 
gaining more and more popularity as over-the-counter alternative therapy. Many studies 
on the effect of zinc supplied as lozenges, nasal sprays or oral therapy were performed. 
Some of them exert positive effects, whereas others found no inhibitory effect (for review 
see (Caruso et al., 2007)). Overall controversial studies on the role of zinc in rhinovirus 
infections failed to convincingly prove clinical benefits.  
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As rhinovirus infections are often accompanied by oxidative stress in the host cell, several 
antioxidants were tested as potential antivirals. However, vitamin C, Trolox, 2-
mercaptoethanol, and N-acetyl-L-cysteine failed to inhibit rhinovirus infection. Strikingly, 
pyrrolidine dithiocarbamate, a compound generally used as NF-κB inhibitor (Schreck et 
al., 1992), was identified to inhibit virus replication (Gaudernak et al., 2002).  
 
Figure 2: Structure of pyrrolidine dithiocarbamate (PDTC). 
Pyrrolidine dithiocarbamate, a multifunctional compound 
Pyrrolidine dithiocarbamate (PDTC), a low-molecular weight thiol compound, is a 
multifunctional drug exerting various effects in biological systems (Fig.2). For instance, it 
is a potent inhibitor of the nuclear factor kappa B (NF-κB) activation (Schreck et al., 1992). 
It can exert pro-apoptotic and anti-apoptotic effects, dependent on the cellular system 
(Erl et al., 2000; Morais et al., 2006). Furthermore, PDTC shows inhibitory effects on 
protein degradation (Hayakawa et al., 2003; Kim et al., 2004), and induces transcription of 
the manganese superoxide dismutase and the heme oxygenase HO-1 (Borrello and 
Demple, 1997; Hartsfield et al., 1998).  
Interestingly, PDTC displays antiviral activity against picornaviruses, including human 
rhinovirus, poliovirus and coxsackievirus (Gaudernak et al., 2002; Lanke et al., 2007), as 
well as on influenza virus, the latter being orthomyxoviruses with a very different life 
cycle (Uchide et al., 2002). PDTC prevents polyprotein processing and reduces virus titers 
mainly by causing zinc influx into host cells (Krenn et al., 2005). This observation is 
consistent with the suggested modulation of metal ion availability as a prerequisite of NF-
κB activation (Kim et al., 2003). PDTC binds free or protein-bound metal ions, thereby 
forming lipophilic dithiocarbamate-metal complexes. These complexes transport zinc and 
copper from the extracellular medium into cells (Krenn et al., 2005).  
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As PDTC inhibits multiplication of different virus families (Uchide et al., 2002; Lanke et al., 
2007), and no resistant strains have been observed to date, it has been speculated that 
the antiviral mechanism of PDTC might target host cell gene functions rather than viral 
functions. To gain insight into the cellular mechanisms and control programs affected by 
PDTC, we decided to use the yeast Saccharomyces cerevisiae as a simple eukaryotic 
model organism.  
Yeast as a model system 
The budding yeast Saccharomyces cerevisiae is a versatile model organism invaluable for 
the unraveling of many fundamental biological processes including drug target 
identification by providing genome-wide chemogenomic approaches (Giaever, 2003; 
Parsons et al., 2004). The availability of the whole-genome sequence and the ease, with 
which yeast can be genetically manipulated provide profound research strategies. Yeast is 
particularly suitable for large-scale screening techniques. Many experimental approaches 
have been developed in this model organism, from gene deletion collections, gene- 
tagging collections, whole-genome DNA or protein arrays, up to yeast-two-hybrid 
systems. Furthermore, high-throughput data have been generated by transcriptomics, 
metabolomics, and proteomics (Vizeacoumar et al., 2009). All these data have been 
collected in databases building an immense information resource. Moreover, due to the 
high evolutionary conservation of essential cellular processes up to humans (Foury, 1997), 
phenotypic screening approaches in yeast have become advantageous for drug 
development and pharmacokinetic studies (Bharucha and Kumar, 2007).  
Using chemical genetics for drug target identification 
A key challenge is to identify interactions of small molecules with the genome and to 
understand the subsequent modulation of pathways and protein functions. This has 
become feasible with the availability of whole genome sequences. The field of chemical 
genetics and chemogenomics aims to identify drug targets by using cell-based or 
microorganism-based screening of bioactive compounds (Jacoby, 2006). Thus, chemical 
genetics entails to inhibit gene functions in an organism or cellular context by using small-
molecule xenobiotics, thus exploring the mode of action of these bioactive compounds. 
The underlying idea is that a compound inhibiting a certain gene product phenocopies the 
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corresponding deletion of this gene. Thus, lack of a gene in combination with a sublethal 
dose of a drug can have a synthetic effect such as reduced fitness, thereby allowing the 
identification of genes or pathways that otherwise mediate tolerance to the drug. In 
contrast to classical “forward or reverse” genetics with gene mutations or deletions, the 
inhibitory effect of a drug on a certain gene function is conditional as drug 
supplementation, dose-dependency or removal of the drug can readily be adjusted (for 
review see (Stockwell, 2000)). 
 
In principle, a drug can affect the growth, cell division and survival of a yeast cell in 
different ways. For instance, it can directly inhibit a protein that is crucial for a certain 
pathway or process (Stockwell, 2000). This direct inhibition should mimic the phenotype 
of the deletion of the corresponding gene.  Furthermore, the transcription level of 
virtually every yeast gene can be altered and the changing drug sensitivities can easily be 
monitored. Consequently, the transcriptional changes of a drug-induced gene inhibition 
versus a gene deletion can be compared and allow for conclusions on drug action 
(Giaever et al., 2004).  
Genome-wide functional screening techniques 
In the course of the Gene Deletion Project an as much as possible complete set of single 
gene deletion strains was generated. The main goal was to assign a function to every 
open reading frame (ORF). Based on the acquired whole-genome sequence of S. 
cerevisiae (Goffeau et al., 1996), every potential ORF was deleted from start to stop 
codon. Deletion strains were analyzed for growth defects under various conditions 
(Winzeler et al., 1999). In 2002, Giaever et al published a functional profiling of the S. 
cerevisiae genome using a bar-coded gene deletion set. The deletion strains were 
screened on several stress conditions and their relative fitness compared to the wild type 
was quantified. Thereby, genes contributing to buffer a certain stress condition were 
identified (Giaever et al., 2002).  In total, four deletion collections are available so far: 
haploids of both mating types, homozygous diploids for non-essential genes and 
heterozygous diploids comprising of non-essential and essential ORFs (http://www-
sequence.stanford.edu/group/yeast_deletion_project/).  
INTRODUCTION 
  19    
The yeast knock-out collection has been widely used for phenotypic screenings, to 
investigate the effect of various stress conditions and the mode of action of drugs, their 
targets and the corresponding target pathways (Parsons et al., 2004; Tucker and Fields, 
2004; Bharucha and Kumar, 2007; Ericson et al., 2008). The principle of screening is fairly 
simple, since loss of a defined gene alters the growth abilities of a mutant strain under 
certain conditions when compared to its wild type. In other words, genes whose deletions 
render cells hypersensitive to a certain drug, are required to counteract drug-induced 
effects. In this way, genes or pathways affected by the drug are identified, thereby 
deciphering the mechanisms of action of the drug. Compounds that render a similar set of 
deletion mutants sensitive, might act in the same pathway. By collecting and comparing 
screening data sets, compound-specific profiles and chemical-genetic interactions can be 
generated (Giaever et al., 2004). 
Transcriptional profiling of stress responses 
Likewise, microarray profiling using whole-genome DNA microarrays can yield conclusive 
insights into the mode of action of a drug or the genetic networks modulated by 
comparing untreated to drug-exposed cells (Hughes et al., 2000). Due to rapidly changing 
environmental conditions, yeast has developed several mechanisms for adapting to 
drastic changes, including fluctuations in nutrition availability, temperature, osmolarity, 
radiation or drug treatment.  Every cell establishes a distinct transcription profile 
dependent on the external conditions. For example, microarray profiling for a set of 
different stresses and environmental conditions identified an extensive transcriptional 
network underlying cellular stress responses (Gasch et al., 2000), but also enables the 
discovery of direct as well as off-targets of bioactive compounds (Parsons et al., 2006; 
Ericson et al., 2008). Genes, whose transcription levels change upon various stresses, are 
involved in the so called ‘environmental stress response’ (Gasch et al., 2000; Gasch and 
Werner-Washburne, 2002). This general stress response encompasses remodeling 
processes at all cellular stages and compartments. Thereby, physiological processes can 
be transiently arrested until cells have adjusted to the new conditions. Additionally, cells 
may specifically adapt to a specific stress condition. For instance, lack of a certain nutrient 
would cause induction of specific transporters, mediating import of this nutrient. In 
parallel, the cell would shut-down or silence exactly those non-essential mechanisms 
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consuming this nutrient. Consequently, a cell has to simultaneously control uptake, 
silencing and reconstruction of its intracellular homeostasis (for review see (Gasch and 
Werner-Washburne, 2002)).  
Fine tuning of essential but dangerous metal ions  
Cells constantly adapt to changes in their environment. For example, they accurately 
control uptake of essential nutrients or ions. Maintenance of the cellular ion homeostasis 
plays a crucial role for survival, as well as adaptation, since many ions are sometimes 
essential but as well toxic at higher concentrations. Therefore, cells have to strike a 
balance between uptake, usage and storage in intracellular compartments to avoid cell 
damage (Radisky and Kaplan, 1999). This toxicity is mainly based on the versatility of the 
transition metals, since they can produce free radicals in redox reactions. For uptake of 
transition metals, yeast has both a high affinity uptake system and low affinity 
transporters. High affinity transporters are specific for certain ions and regulated 
according to requirements for this specific ion. In contrast, low affinity transporters are 
less responsive to metal needs and can transport different ions. By establishing a dual 
layer uptake system, cells ensure adequate ion acquisition under conditions of either 
metal depletion or excess (Johnson et al., 1985; Hentze et al., 2004; Jin et al., 2008; Eide, 
2009). 
Pumping iron  
Iron is essential to almost all known organisms, since it is important for oxygen exchange 
and oxidizing processes. With its high affinity for oxygen, iron is involved in many cellular 
redox reactions, as well as being incorporated in heme, thereby acting as electron 
transporter. The ability of electron transport can cause production of harmful superoxide 
anion and hydroxyl radicals in the presence of oxygen. Thus, cells have to coordinate free 
intracellular iron either by strictly regulating iron uptake or by intracellular iron storage 
through proper sequestration (Kaplan and Kaplan, 2009).  
In yeast, intracellular iron concentrations are mainly regulated by plasma membrane iron 
transport systems. Yeast has both high affinity and low affinity transport systems, as well 
as cell wall mannoproteins that bind siderophore-bound iron. The high affinity transport 
system is composed of a ferroxidase (Fet3) (Askwith et al., 1994) and a transmembrane 
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permease (Ftr1) (Stearman et al., 1996). The theory is that Fet3 oxidizes Fe(II) to Fe(III), 
which is in turn transported across the membrane by the permease Ftr1. Fet3/Ftr1-
dependent iron transport requires oxygen. Under anaerobic conditions, Fet4 and Smf1, 
the low affinity transporters with broad transition metal specificity, import iron into the 
cells (Dix et al., 1994; Supek et al., 1996). Additionally, the ARN family of transporters 
specifically recognizes and imports siderophore-bound iron chelates (Yun et al., 2000). In 
any case, reduction of ferric to ferrous iron happens at the cell surface through the heme- 
containing metalloreductases Fre1 and Fre2 (for review see (Radisky and Kaplan, 1999; 
Kaplan and Kaplan, 2009). 
Under iron-replete conditions, the low-affinity transporters Fet4 and Smf1 import most of 
the required iron into cells. Iron is incorporated in heme and iron sulfur clusters, whereas 
excess iron is stored in the vacuole, from where it can be recovered if necessary. In 
contrast, under iron-limiting conditions, the low affinity transporters are not sufficient to 
provide suitable iron levels. Therefore, cells have to remodel enzymatic activities and 
metabolic pathways and activate the high affinity iron uptake machinery (Hausmann et 
al., 2008).  
Iron depletion causes transcriptional activation of a small set of about 20 genes, referred 
to as the iron regulon (Fig.3B, (Rutherford et al., 2003; Courel et al., 2005; Philpott and 
Protchenko, 2008)), which is regulated by the transcription factors Aft1 (Yamaguchi-Iwai 
et al., 1995) and Aft2 (Blaiseau et al., 2001). Low iron is sensed by the Aft1 transcription 
factor, which shuttles between the cytoplasm and the nucleus depending on the cellular 
iron availability (Yamaguchi-Iwai et al., 2002). Aft2 is an Aft1 paralogue, which can bind to 
promoter elements of iron transport genes. However, its deletion does not cause any 
effects on iron transporters, whereas deletion of AFT1 renders cells hypersensitive to iron 
depletion. 
Low-iron conditions are not directly sensed by Aft1. Instead, they are transmitted by 
signals coming from the mitochondrial iron sulfur cluster (ISC) biosynthesis (Hausmann et 
al., 2008). Due to a lack of iron, the synthesis of ISC decreases, resulting in transcriptional 
activation of iron transport genes independent of cytosolic iron levels (Chen et al., 2004). 
However, maturation of Fe-S clusters in the nucleus or mitochondria is not required for 
low-iron sensing by Aft1/Aft2 (Rutherford et al., 2005). So far, the model for low iron 
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sensing in yeast suggests that under iron depletion the decreased ISC levels are 
interpreted by a cytosolic complex of glutaredoxins Grx3 and Grx4 and the two cytosolic 
proteins Fra1 and Fra2, resulting in the nuclear translocation of Aft1 (Fig.3A, (Ojeda et al., 
2006; Pujol-Carrion et al., 2006; Kumanovics et al., 2008)).  
A 
 
B 
 
Figure 3: Low-iron sensing in yeast. A. Model for the regulation of low-iron sensing in yeast (Kumanovics et al., 2008). B. 
Regulation of iron transport machinery under iron-limiting conditions, modified from (Rutherford and Bird, 2004).  
Transcriptional activation of the iron regulon by Aft1/Aft2 causes responses by several 
metabolic processes.  First, iron transporters at the plasma membrane are induced, 
ensuring the import of iron into cells. Second, intracellular iron stores are rapidly 
mobilized. Third, non-essential processes consuming iron are repressed to establish an 
iron-saving metabolism. For example, cells switch from biotin synthesis to biotin import, 
thereby saving iron that would be incorporated into the biotin synthase, which is an ISC-
containing enzyme. Furthermore, genes involved in amino acid, nitrogen and tricarboxylic 
acid metabolism, as well as respiratory pathways change under iron-deplete conditions. 
Consequently, cells shift their metabolism from an iron-dependent to a parallel iron-
independent mode (Shakoury-Elizeh et al., 2004).  
Zinc uptake in yeast 
Zinc is an essential element for the cell, which, in contrast to iron or copper, is not redox-
reactive. It is an important cofactor binding to proteins to establish their structure, 
conformational change and activity (MacPherson et al., 2006). A prominent example for 
the importance of zinc in terms of protein conformation and function is the group of zinc-
finger transcription factors (Krishna et al., 2003). Although zinc is often referred to as a 
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trace element, cells actually carry high zinc concentrations. The so called ‘zinc quota’ 
refers to the total zinc content of a cell required to maintain its optimum growth (107 
atoms /cell),(Outten and O'Halloran, 2001). Zinc is mainly bound by proteins because free 
zinc is highly toxic to cells. The main zinc binding proteins are Cu/Zn superoxide dismutase 
Sod1, the alcohol dehydrogenase Adh1 and the ribosome (Eide, 2006). Beside these high-
affinity zinc binding proteins, zinc also binds to other proteins, as well as to DNA or small 
cellular compounds such as glutathione. Furthermore, excess zinc is stored in organelles 
such as the mitochondria, endoplasmic reticulum and the vacuole (Simm et al., 2007).  
Similar to the iron uptake systems, there are several zinc transporters regulating zinc 
homeostasis in yeast. Yeast expresses low-affinity and high-affinity zinc importers at the 
plasma membrane, as well as zinc transporters in the vacuolar membrane (Fig.4). 
Interestingly, no plasma membrane zinc exporters have been reported yet.  First, the high 
affinity zinc transporter Zrt1 is expressed due to zinc limitation and specifically imports 
zinc into the cytoplasm (Zhao and Eide, 1996a). Under zinc-replete conditions, this 
transporter is endocytosed and degraded (Gitan and Eide, 2000). Second, the low-affinity 
transporter Zrt2 is active when zinc is abundant (Zhao and Eide, 1996b). Third, due to the 
fact that there is no zinc exporter, the main site for zinc storage and detoxification is the 
vacuole. Zrt3 is expressed under zinc shortage conditions to replenish cytoplasmic zinc. In 
contrast, Zrc1 and Cot1, vacuolar zinc transporters, import zinc into the vacuole for zinc 
sequestration (MacDiarmid et al., 2000). Expression of zinc transporters is regulated by 
the transcription factor Zap1. During zinc deficiency, Zap1 transcriptionally activates the 
plasma membrane zinc transporters, as well as Zrt3 to mobilize zinc stored in the vacuole. 
Zap1 induces its own transcription under zinc-limiting conditions. Furthermore, if zinc 
levels are replete, Zap1 activity is repressed (Zhao and Eide, 1997). 
Wild type yeast cells can grow on media containing millimolar ranges of zinc.  As 
mentioned before, in yeast, no zinc export system has been identified yet. Therefore, the 
vacuole is the main site for zinc detoxification and sequestration in yeast. Mutants 
defective in vacuolar biogenesis or acidification have been shown to be zinc-
hypersensitive (Ramsay and Gadd, 1997). Therefore, a functional V-ATPase is required to 
import zinc into the vacuole. Most likely, the established proton gradient across the 
vacuolar membrane drives zinc import into the vacuole. Depending on the cellular zinc 
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status, vacuolar zinc levels can reach up to 100mM zinc (i.e., 7x108 zinc atoms per cell in 
the vacuole) (Simm et al., 2007). Such enormous storage capacities provide even 
following yeast generations with sufficient zinc under changing nutrient conditions. 
 
Figure 4: Scheme of proteins regulating zinc homeostasis in yeast, including plasma membrane and vacuolar zinc 
transporters, zincosomes as well as the zinc-responsive transcription factor Zap1 (Eide, 2006). 
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4. AIMS 
This study aimed to decipher the mode of action of the antiviral drug PDTC, as well as 
potential target genes for PDTC. As PDTC shows antifungal activity, we applied a chemical 
genetic approach using the yeast Saccharomyces cerevisiae as simple eukaryotic model 
organism by combing transcriptional profiling and genome-wide phenotypic screenings. 
Target genes identified in yeast may help to ascertain structural and sequence 
homologues in mammalian genomes. 
 To analyze the transcriptional response and the kinetics of yeast cells to sublethal 
concentrations of PDTC, we performed whole-genome DNA microarray-based expression 
profiling. The microarray data sets were analyzed by extensive bioinformatics and verified 
by Northern blotting and immunoblotting. Clustering and Gene Ontology enrichment 
identified the functional categories and pathways involved in the transcriptional response 
to PDTC. Since expression profiling misses genes whose mRNA levels do not change upon 
drug treatment, the transcriptomics were complemented by a functional genomic screen.  
The EUROSCARF yeast deletion strain collection, representing haploid viable single 
deletions representing some 4800 yeast genes, were subjected to robotic screening to 
identify genes mediating PDTC resistance. By systematically screening the entire yeast 
gene deletion collection, it is possible to identify all non-essential yeast genes that can 
modulate PDTC susceptibility.  
Finally, genes and pathways identified by transcriptomics or phenotypic screening were 
further investigated by biochemical, genetic, physiological and proteomic studies.  
Taken together, the eukaryotic model system baker’s yeast and its genetic tractability 
were exploited to pursue several approaches to identify cellular targets of the antiviral 
drug PDTC, but also to study the mechanisms of its toxicity and resistance. 
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5. MATERIALS AND METHODS 
Chemicals and reagents 
Pyrrolidine dithiocarbamate (PDTC) was purchased from Alexis Biochemicals, Lausen, 
Switzerland, dissolved in H2O and a 500mM stock solution was stored at -20°C. 
Media and growth conditions 
All media and buffers were prepared according to Karl Kuchler standard laboratory 
protocols.  
Yeast media and growth 
Rich medium (YPD) and synthetic medium (SC) were prepared essentially as described 
elsewhere (Kaiser, 1994). All media were autoclaved, heat sensitive substances were 
sterile-filtered and added to the media afterwards. For solid media, 250 ml of 4% agar 
were added to 250 ml of 2x medium. All yeast strains were routinely grown at 30°C unless 
otherwise indicated. For growth inhibition tests, exponentially growing cells were 
adjusted to OD600 of 0.2, serially diluted to 2x10
-4 and equal volumes were spotted onto 
YPD plates containing different substances and concentrations. S. pombe was grown on 
YES medium as described in (Moreno et al., 1991). For viability assays, cells were grown in 
liquid medium supplemented with PDTC and/or metal ions for 24h. Afterwards, cells were 
plated onto YPD plates and colony-forming units were determined after 48h incubation. 
Stressed cells were normalized to untreated wild type cells. 
Rich medium (YPD) 
50ml of 20% sterile glucose was added to 450ml 1x YPD to prepare liquid medium with a 
final concentration of 2% glucose. YPD plates contained glucose at a final concentration of 
2% and 2% agar.  
1x YPD  2x YPD 
Yeast extract   10g/l   20g/l 
Peptone   20g/l   20g/l 
Glucose (w/v)  2%   4%  
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Minimal medium  
Minimal medium (MM) was prepared with 2x YNB without amino acids and glucose was 
added at a final concentration of 2%. MM solid media contained 2% glucose and 2% agar. 
1x MM 
Bacto-YNB w/o aa 6.7g/l 
Glucose (w/v) 2% 
Drop-out media 
SC medium (500ml) was prepared with 2xSC medium and 250ml sterile H2O and glucose 
were added to a final concentration of 2%. 5ml of the required amino acids from 100x 
stocks were added. SC solid media contained 2% glucose and 2% agar. 
2x SC 
Bacto-YNB w/o aa and (NH4)2SO4 3.4g/l 
Ammonium sulfate 10.0g/l 
Amino acid mix 2.86g/l 
YES medium (Fission yeast medium) 
5g/l yeast extract 
30g/l glucose 
supplements: 225mg/ml adenine, histidine, leucine, uracil, and lysine hydrochloride. 
Sterile stock solutions: 
Glucose: 20%, Agar: 4% 
100x URA: 4g/l L-uracil in H2O 
100x HIS: 6g/l L-histidine in H2O 
100x LEU: 26g/l L -leucine in H2O 
100x TRP: 8g/l L-tryptophane in H2O (filter-sterilized, 4°C) 
Amino acid mix (per 29g): 
0.4g L-arginine 0.6g L-tyrosine 
0.6g L-isoleucin 8.0g L-serine 
1.0g L-phenylalanine 2.0g L-glutamic acid 
2.0g L-aspartic acid 3.0g L-valine 
3.0g L-methionine 3.6g L-lysine 
4.0g L-threonine 0.8g adenine 
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Sporulation media 
250ml    2x 
KAc    5g 
Bacto-Yeast extract  0.5g 
glucose   0.25g 
Bacto agar   10g 
E. coli media 
For LB solid media, 2% agar was added to 2x LB. For selective media, e.g. LB-amp plates, 
100µg/ml ampicillin (100mg/ml stock, H2O) were added. 
 
1x LB   2x LB   SOC 
Tryptone   10g/l   20g/l   20g/l 
Yeast extract  5g/l   10g/l   5g/l 
NaCl    10g/l   20g/l   10mM 
KCl       -                     -  2.5mM 
MgCl2        -                     -  20mM 
Bacterial strains 
DH5α F-, λ-, endA1, hsdR17(rk-, mk+), supE44, thi-1, recA, gyrA96,relA1, Φ80lacZΔM15 
(Hanahan, 1983) 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 araD139 
Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG Invitrogen 
Mating of yeast strains 
To generate a sod1∆ sod2∆ double deletion strain, we mated the BY4742 sod1∆ and the 
BY4741 sod2∆ strains, followed by selecting the diploids. Afterwards cells were forced to 
undergo sporulation, followed by tetrad dissection. For tetrad dissection, cells were 
resuspended in water and treated with 1µl zymolyase (20mg/ml) for 5 minutes at RT to 
remove the cell wall. Spores were physically separated with the needle of the 
micromanipulator (Singer MSM) and placed one by one on a YPD plate.  
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Yeast strains used in this study 
Name Genotype Reference 
BY4741 MATa; his3∆1; leu2∆0; met15∆0; ura3∆0 (Brachmann et al., 1998) 
BY4742 MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 (Brachmann et al., 1998) 
BY4743 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 
met15Δ0/MET15 ura3Δ0/ura3Δ0 
(Brachmann et al., 1998) 
EUROSCARF yeast 
deletion collection 
http://web.uni-
frankfurt.de/fb15/mikro/euroscarf/index.html 
  
W303-1A MATa, leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-
11,15 
by Rodney Rothstein and 
Stephan Bartsch 
AMP1600 MATa RIMl-531::TRP1, rme1∆5::LEU2, lME2-5-
lacZ::URA3, ura3, leu2::hisG, trp1::hisG, lys2, ho::LYS2 
(Li and Mitchell, 1997) 
AMP1603 MATa RIMI-HA2 rim13-1 arg6, rme1∆5::LEU2, lME2-5-
lacZ::URA3, ura3, leu2::hisG, trp1::hisG, lys2, ho::LYS2 
(Li and Mitchell, 1997) 
AMP1604 MATa RIMI-HA2 arg6, rme1∆5::LEU2, lME2-5-
lacZ::URA3, ura3, leu2::hisG, trp1::hisG, lys2, ho::LYS2  
(Li and Mitchell, 1997) 
AMP1605 MATa rim1∆12 arg6, rme1∆5::LEU2, lME2-5-
lacZ::URA3, ura3, leu2::hisG, trp1::hisG, lys2, ho::LYS2  
(Li and Mitchell, 1997) 
AMP1606 MATa arg6 his3, rme1∆5::LEU2, lME2-5-lacZ::URA3, 
ura3, leu2::hisG, trp1::hisG, lys2, ho::LYS2 
(Li and Mitchell, 1997) 
DY1457 MATα, ura3-52, leu2-3, trp2-1, his3-11, can1-100(oc), 
ade6 
(Chen et al., 2004) 
OCY355  MATα, ura3-52, leu2-3, trp2-1, his3-11, can1-100(oc), 
ade2, ho::FET3LacZ  
(Kumanovics et al., 2008) 
ATCC2001  C. glabrata wild type strain available at www.atcc.org   
Sc5314  C. albicans wild type strain  (Gillum et al., 1984) 
K11217 S. pombe wild type strain Kindly provided by K. 
Nasmyth 
YCG31 Isogenic to W303-1A, ARN4-Cit::LEU2 Kindly provided by C. Gregori 
YCG31∆r Isogenic to YCG31, rim101∆::kanMX4 Kindly provided by C. Gregori 
YCG31∆a Isogenic to YCG31, aft1∆::kanMX4 Kindly provided by C. Gregori 
YCG14 Isogenic to W303-1A, STL1-Cit::TRP1 Kindly provided by C. Gregori 
YCG12 Isogenic to W303-1A, MLP1-Cit::URA3 Kindly provided by C. Gregori 
YCG12∆s Isogenic to YCG12, slt2∆::kanMX4  Kindly provided by C. Gregori 
YNLSS12 Isogenic to BY4741, sod1∆:: kanMX4, sod2∆:: kanMX4 This study 
Table 1: Yeast strains used in this study. 
General methods of molecular biology 
Standard methods like agarose gelelectrophoresis , determination of DNA concentration 
and PCR, as well as general cloning techniques including restriction analysis, 
dephosphorylation and ligation were performed as described in (Sambrook, 2001). For 
purification and elution of DNA fragments from agarose gels, the Peqlab gel extraction kit 
was used according to the manufacturer’s recommendations. For restriction digestions 
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and dephosphorylation, Fermentas enzymes were used according to the manufacturer’s 
recommendations.  
 
For plasmid preparation, the STET minipreparation protocol adapted from Holmes and 
Quigley was used (Holmes and Quigley, 1981). 2ml of bacterial overnight culture were 
harvested by centrifugation at 6000rpm for 3 min in a table-top centrifuge. The pellet was 
resuspended in 500µl of STET buffer and 20µl of lysozyme (20mg/ml) were added. After 
inverting the tube several times, it was incubated on ice for 5 minutes. For lysis, the 
sample was incubated on 95°C for 70 seconds and immediately put on ice afterwards. 
After centrifugation for 10 minutes at 13000 rpm, the white pellet was removed and 
500µl of isopropanol were added. The mixture was centrifuged at 13000rpm for 15 
minutes, the pellet was washed with 70% ethanol and resuspended in 100µl of TE buffer. 
Finally, RNaseA was added to a final concentration of 50µg/ml (Karl Kuchler standard 
laboratory protocol).  
STET-buffer (100ml): 8g Saccharose 
0.5ml Triton X-100 
10ml 0.5M EDTA 
5ml 1M Tris/HCl pH 8.0 
0.45µm filter-sterilize (Millipore) 
Isolation of RNA from yeast  
Total yeast RNA was isolated by the hot phenol method (Sambrook, 2001). 50ml of a 
yeast culture were harvested at 3000rpm, for 5min, at 4°C and washed with ice-cold 
water. The pellet was resuspended in 400μl of 50mM sodium acetate (pH 5.3) plus 10mM 
EDTA (pH 8). 40µl of 10% SDS and 400µl of acid phenol (pH 4.3) were added and the 
sample was incubated at 65°C for 15 minutes followed by rapid chilling on ice. The sample 
was centrifuged at 13000 rpm for 5 minutes at RT and the aqueous phase was used for 
PCI extraction, followed by two times chloroform extraction. For RNA precipitation, 1/10 
volume of 3M sodium acetate (pH 5.3) and 2.5 volumes of ice cold 100% ethanol were 
added to the sample. After centrifugation (15min, 4°C, 13000rpm), the pellet was washed 
with 70% ethanol, dried at 55°C and resuspended in 100μl of TE buffer. RNA 
concentration was measured at 260nm in TE, pH 7, (Karl Kuchler standard laboratory 
protocol).  
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Northern Blot Analysis 
About 20µg of total RNA were separated on a 1.4% agarose gel and transferred to nylon 
membranes (Amersham Biosciences). Methylene blue staining was used as control for 
equal RNA loading.  Northern blots were pre-hybridized for 3h at 65°C. PCR-amplified 
probes were radiolabeled by incorporation of [-32P]dCTP using a MegaPrime labeling kit 
(Amersham Biosciences). The radiolabeled probes were added to the prehybridization 
solution after purification on a NICK column (Amersham Biosciences). Membranes were 
washed at 65 °C three times in 2x SSC, 1% SDS, and three times in 1x SSC, 1% SDS, and 
then exposed to x-ray films at -80 °C, (Karl Kuchler standard laboratory protocol).  
 
Pre-hybridization solution:  2ml 50x Denhardt reagent 
    1ml 20x SSC 
    500µl 20% SDS 
    6.5ml sterile water 
    40µl ssDNA (10mg/ml) 
50x Denhardt Reagent: 1% (w/v) Ficoll 400 
1% (w/v) Polyvinylpyrrolidone 
1% (w/v) Bovine Serum Albumine 
DNA Microarray Experiments 
Microarrays (Yeast 6.4K Arrays) were ordered from the Microarray Centre, University 
Health Network, Toronto (www.microarrays.ca). 50ml cultures of BY4741 or aft1∆ were 
grown in YPD to an OD600 of about 0.4. PDTC was supplemented, untreated control cells 
and PDTC treated cells were harvested after 1, 3 and 5 hours, washed with ice-cold water 
and frozen immediately. Total RNA was prepared by the hot phenol method and 20µg 
were used for cDNA synthesis using 200 units of Superscript II reverse transcriptase 
(Invitrogen) with either Cy3-dCTP or Cy5-dCTP. Labeled cDNAs were pooled, and RNA was 
hydrolyzed for 20 min in 50mM NaOH at 65 °C, followed by neutralization with acetic acid 
and probe clean-up with CyScribe GFX purifiaction kit (Amersham Biosciences). 
Hybridization to whole genome cDNA microarrays was done in DigEasyHyb (Roche 
Applied Science) solution at 37°C overnight with 70µg of salmon sperm DNA/ml as a 
carrier. Microarrays were washed three times in 1x SSC, 0.1% SDS at 50 °C, followed by a 
1-min wash in 1x SSC at room temperature. Glass slides were spun dry for 5 min at 
500rpm in a tabletop centrifuge, scanned on an Axon 4000B scanner (Molecular Devices). 
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All microarray experiments were carried out with three independent RNA preparations 
and at least one technical replicate using dye-swaps. Microarray data sets are MIAME-
compliant. 
Computational analysis of microarray data and screening results 
Gridding and spot identification on microarrays were performed using the Gene Pix Pro 
4.1 software (Axon). For preprocessing, the background was subtracted and subsequently 
normalized, using the print-tip loess method of the limma Bioconductor/R package 
(Wettenhall and Smyth, 2004). To identify differentially expressed genes, a linear model 
and empirical Bayesian-moderated F-statistics were used with cut-off values of 0.001 for 
the adjusted p-value and a 2-fold expression change, as well as A-values ≥7 (Smyth, 2004). 
Genes identified either on the microarrays or in the functional screening were grouped by 
gene ontology enrichment according to the predicted biological process using the GO 
Termfinder program provided by the Saccharomyces Gene Database 
(www.yeastgenome.org). Clustering of differentially expressed genes was performed 
using the MEV software using the linkage method and Euclidean distance (Saeed et al., 
2003; Saeed et al., 2006).  
Preparation of yeast cell extracts and immunoblotting 
For immunoblotting, total cell-free protein extracts were prepared by the trichloroacetic 
acid (TCA) method. About 5 OD600 equivalents of cells were harvested. The pellet was 
resuspended in 1ml ice-cold water and supplemented with 150μl YEX lysis buffer. After 10 
minutes incubation on ice, proteins were precipitated by adding 150μl of 50% TCA. 
Samples were centrifuged at 13000 rpm and the pellet was resuspended in sample buffer.  
YEX lysis buffer: 1.85M NaOH 
7.5% β-mercaptoethanol 
Protein sample buffer:  40mM Tris–HCl pH 6.8 
8M urea 
5% sodium dodecyl sulfate (SDS) 
0.1mM EDTA 
0.1g/l bromophenol blue 
1% β-mercaptoethanol 
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SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Cell lysates equivalent to 0.5 OD600 units were resolved by SDS–polyacrylamide gel 
electrophoresis gels and blotted onto nitrocellulose membranes.  
7.5% running gel: 4.5% stacking gel: 
5ml H2O   6ml H2O 
2.5ml 1.5 M Tris pH 8.8 2.5ml 0.5M Tris pH 6.8 
2.5ml acrylamide (30%) 1.5ml acrylamide (30%) 
50µl SDS (20%) 50µl SDS (20%) 
10µl TEMED   10µl TEMED 
100µl APS (10%)  100µl APS (10%) 
 
Protein running buffer: 1.5g Tris 
7.2g glycine 
 4.0g SDS 
 
To investigate PDTC-dependent changes in Rim101 processing and CoxIV protein levels, 
we performed immunoblotting using the monoclonal mouse anti-HA 12CA5 (Roche) and 
the mouse anti-CoxIV antisera (kindly provided by Andreas Hartig), respectively. 
Polyclonal anti-Swi6 antibodies (kindly provided by Kim Nasmyth) were used to verify 
equal loading. 
Proteins were transferred to a nitrocellulose membrane by blotting for 1h at 25V in a 
Trans-Blot semidry transfer cell (Biorad), followed by blocking of unspecific binding with 
Blotto (TBS-T, 5% milk powder) shaking for 1h at RT. The primary antibodies, usually 
diluted 1:1000 or according to the manufacturer’s recommendations, were incubated 
over night shaking at 4°C. The membrane was washed 3 times with 1x TBS-T followed by 
incubation with the secondary antibody conjugated to horse radish peroxidase (HRP) 
(1:7500) for 45 minutes. The membrane was washed again 3 times with 1xTBS-T, then 
equilibrated with Super Signal West Pico Chemiluminescent Substrate (Pierce, VWR) and 
exposed to CL-Xposure films (Pierce) (Karl Kuchler standard laboratory protocol). 
Anode buffer 1:  0.3M Tris 
 20% methanol (v/v) 
Anode buffer 2: 25mM Tris 
 20% methanol (v/v) 
Cathode buffer: 25mM Tris 
 40mM 6-amino-n-hexanoic acid 
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If desired, blots can be stripped by shaking 15min in 50ml stripping buffer in a 50°C water 
bath and reused again for detection with another antibody  
 
Stripping buffer:  100mM ß-mercaptoethanol 
   2% SDS 
   62.5mM Tris/HCl pH 6.7 
Beta-galactosidase assays 
Cells containing a genomically integrated FET3-LacZ reporter construct (OCY355) were 
grown in YPD medium to an OD600 of about 0.6. Cultures (50ml) were harvested after 
incubation with 100µM PDTC or being left untreated for 3 hours. Cells were resuspended 
in 250µl of breaking buffer plus protease inhibitor. Glass beads were added and crude cell 
extracts were prepared using a Fast Prep (FastPrep (2 × 15′′, speed 5, Thermo Savant). The 
extract was clarified by centrifugation at 4°C 13000rpm for 15 minutes. Protein 
concentration of the extracts was determined using Coomassie Plus (Bradford) Protein 
Assay (Pierce) according to the manufacturer’s recommendations.  
Enzyme measurements were carried out by adding 10-100µl of cell extract to 0.9ml of Z-
buffer and adjusting the volume to 1ml with breaking buffer. After incubating the mixture 
at 28°C for 5 minutes, the reaction was initiated by adding 200µl ONPG solution and 
further incubation at 28°C. The exact time was measured until the mixture turned to a 
pale yellow color. The reaction was terminated by adding 0.5ml of Na2CO3 stock solution. 
Finally optical density at 420nm was measured and normalized. The specific activity of the 
extract was expressed according to the formula: 
 
                  OD420 x 1.7         
 0.0045 x protein (mg/ml) x extract volume (ml) x time (minutes) 
OD420 is the optical density of the product o-nitrophenol, at 420nm. The factor 0.0045 is 
the OD of 1nmol/ml solution of o-nitrophenol. The factor 1.7 corrects for the reaction 
volume. Specific activity is expressed as nmoles/minute/mg protein (Kaiser, 1994).  
 
Breaking buffer:  100mM TrisCl pH8 
 1mM dithiothreitol (DTT) 
 20% Glycerol 
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Z-buffer:  16.1g Na2HPO4*7H2O 
 5.5g NaH2PO4*4H2O 
 0.75g KCl 
 distilled water to adjust to a final volume of 1l  
ONPG stock solution:  4mg/ml in Z-buffer 
 
Fluorescent detection of zinc influx into yeast cells 
About 2x 108 cells of a pdr5∆ pdr12∆ double deletion strain (laboratory strain collection) 
were loaded with 30µM mag-fura-2 (Molecular Probes, Invitrogen) for 30 minutes in 
1xTBS; cells were washed three times and finally resuspended in 10ml TBS. Experiments 
were performed with constant agitation in 3ml silica cuvettes containing 2ml aliquots of 
cell suspensions. Intracellular zinc accumulation was monitored in real-time kinetics over 
a 500 second-period using a spectrofluorimeter LS-55 (Perkin-Elmer) by continually 
alternating the excitation wavelengths of 340 and 380nm in 20ms intervals and recording 
the emission at 509nm. Moreover, 10µM ZnSO4, 10µM CaCl2 or 10µM CuSO4, and 100µM 
PDTC and 50µM EDTA were added to cell suspensions at indicated time points. 
Phenotypic screening of the EUROSCARF deletion collection 
For large scale phenotypic profiling, the 4800 haploid viable single gene deletion strains of 
the EUROSCARF deletion collection (http://web.uni-frankfurt.de/fb15/mikro/euroscarf/) 
were grown on YPD plates in 96-well format. For transferring strains to PDTC-containing 
plates and control YPD plates, we used the RoToR HDA robot (Singer Ltd., Roadwater, 
UK). Growth was inspected after 2 days incubating at 30°C. After incubation, plates were 
scanned with an HPScanjet G3010, using the Adobe Photoshop CS3 software. All strains 
displaying PDTC-sensitivity strains identified in the first screening were manually re-
spotted for confirmation. Therefore, equal volumes of serial dilutions of exponentially 
growing cells ranging from an OD600 of 0.2 to 2x10
-4 were spotted onto PDTC-plates and 
control plates. 
Detection of reactive oxygen species 
For detection of accumulated reactive oxygen species after incubation with PDTC, we 
stained yeast cells with H2DCF-DA, dihydroethidium (DHE) and dihydrorhodamine (DHR). 
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Dyes were ordered from Invitrogen Molecular Probes, Oregon. Yeast cells were stressed 
for 15-30 minutes with PDTC or H2O2 as control, washed with 1xPBS and resuspended in 
PBS. Dyes were added and samples were incubated at 30°C for 10 minutes and directly 
used for FACS analysis. Chemiluminescence was measured using a FACS Calibur, PD 
Biosciences. 
Dyes were used to a final concentration of: 
DHR:   5µg/ml 
H2DCF-DA:   10µg/ml 
DHE:   2µM 
Analyis of PDTC response using promoter-tagged reporter strains  
Promoter-tagged reporter strains were inoculated in YPD pH 4 and grown over night at 
30°C, shaking. Cultures were diluted to an OD600~0.2 in YPD pH 4, 6.5, and 9, respectively. 
After three hours cells were stressed or left untreated for two hours, washed with 1xPBS 
and resuspended in 1xPBS to a final concentration of 1x106 cells/ml). Fluorescence was 
detected using a FACS Calibur, PD Biosciences or pictures were taken using the Olympus 
Cell R Live Cell Imaging Unit.  
The promoter tagged-reporter strains for the Rim101 pathway (ARN4-Cit wild type, ARN4-
Cit rim101∆, ARN4-Cit aft1∆) carried a genomically integrated ARN4-citrine construct (1kb 
of the ARN4 promoter, citrine, 500bp of the ARN4 terminator). Additionally, we used 
reporter strains for the PKC-pathway (MLP1-Cit wild type, MLP1-Cit slt2∆), as well as the 
HOG-pathway (STL1-Cit wild type). All reporter strains were kindly provided by Christa 
Gregori.   
Vacuolar staining with fluorescent dyes 
For carboxy-DCFDA vacuolar staining, yeast cells were grown to an OD600 of 0.8 before 
adding PDTC. After 2 hours incubation at 30°C with shaking, the fluorescent dye was 
added and cells were incubated at room temperature for another 15 minutes. Cells were 
washed with 50mM natrium citrate buffer, pH 7.5, 2% glucose, resuspended in buffer and 
kept on ice for microscopy. For vacuolar staining with FM4-64, cells were stained with 
FM4-64 for 15 minutes at 30°C, washed and resuspended in rich medium. Cells were 
either stressed or left untreated for the indicated time points, washed, resuspended in 
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PBS and used for microscopy. The cells were examined using an Olympus Cell-R Live 
Imaging Unit.  
Carboxy-DCFDA (Invitrogen, Molecular Probes, C369) in DMSO, 10mM stock, stored at -
80°C. 
FM4-64 (Invitrogen, Molecular Probes, T3166) in DMSO, 3.2µM stock, stored at RT. 
Buffers and solutions 
TAE (50x stock solution):  2M Tris/HCl pH8 
1M acetic acid 
    50mM EDTA 
Electrophoresis buffer: 1xTAE 
DNA Loading buffer:  1.2ml 10xTAE 
0.6ml 5% bromphenol blue 
0.6ml 5% xylene cyanol 
4.8ml 100% glycerol 
4.8ml H2O 
1M DTT dissolved in 0.01M NaOAc pH 5.2 
PBS, pH 7.4 87.7g NaCl 
2.6g NaH2PO4 
22.5g Na2HPO4 
1000x Ampicillin 120mg/ml 
G418 in H20, 200mg/ml 1000x stock 
20x SSC (1l) 876.5g NaCl 
441g NaCitrat  
pH 7.0 
TE 100mM Tris-HCl pH7.5 
10mM EDTA pH 8.0 
10x TBS 1.44M NaCl 
0.5% Tween 20 
250mM Tris-HCl pH 7.5  
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6. RESULTS 
PDTC shows antifungal activity 
The effect of PDTC on growth of Saccharomyces cerevisiae, Candida albicans, Candida 
glabrata and Schizosaccharomyces pombe was analyzed by growth inhibition assays on 
agar plates (Fig.5). Serial dilutions of yeast cultures were spotted onto PDTC-
supplemented plates. Cell growth was inhibited in a dose-dependent manner in both non-
pathogenic and pathogenic yeast species, although not to the same degree. Namely, S. 
cerevisiae, C. albicans and S. pombe were sensitive at 30µM PDTC, whereas C. glabrata 
was more resistant to PDTC, growing up to a concentration of 75µM. However, it is 
known that C. glabrata shows increased tolerance to a variety of compounds including 
antifungals such as azoles (Pfaller and Diekema, 2004).  
 
Figure 5: Spot assays of various yeast species to show PDTC-sensitivity. Cells were spotted in serial dilutions ranging 
from OD600 0.2 to 2x 10
-4 onto PDTC containing plates and grown at 30°C for 2 days. S. pombe requires YES medium and 
was therefore spotted onto a gradient plate ranging from 0 to 50µM PDTC (OD600 of 0.2). 
In addition, we performed growth curves and viability assays with S. cerevisiae wild type 
cells to investigate the PDTC tolerance in liquid culture. Cells were grown in rich medium 
supplemented with increasing concentrations of PDTC, monitoring OD600 over time 
(Fig.6A). The growth curves showed a dose-dependent growth inhibition. At low 
concentrations (25µM), PDTC-treated cells responded with an elongated lag-phase and a 
delayed period to reach the stationary phase. At higher concentrations (100µM), PDTC 
caused complete growth inhibition. For testing viability, we treated cells with 100 to 
325µM PDTC for 24h in liquid culture, determined colony forming units on YPD plates and 
set them relative to unstressed cells (Fig.6B). Remarkably, we found that PDTC lead to 
growth inhibition rather than killing of cells. The antifungal activity suggested using yeast 
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as a model system by exploiting well-established large-scale screening techniques to 
identify putative PDTC target genes.   
A 
 
B 
 
Figure 6: PDTC caused dose-dependent growth inhibition in yeast. A. Cells were grown in YPD medium supplemented 
with increasing concentrations of PDTC, monitoring OD600 over time. B. Viability assays. Cells were grown in liquid YPD 
medium with different concentrations of PDTC. After 24 hours of PDTC treatment, cells were plated on YPD plates. CFU 
was determined and normalized to untreated cells. 
To characterize the genes involved in PDTC response, we screened by two types of 
genome-wide analysis. First, transcriptional changes were measured by whole-genome 
DNA microarrays. Second, we functionally screened the EUROSCARF yeast gene deletion 
collection. 
Expression profiling in response to PDTC treatment 
To examine the regulatory effects and kinetics of PDTC exposure on the yeast 
transcriptome, we performed whole-genome DNA microarray analysis. Therefore, wild 
type yeast cells were grown to the mid-logarithmic growth phase in rich medium, and 
treated with PDTC for 1, 3 or 5 hours. Transcript data of three independent biological and 
one technical replicate were generated comparing PDTC-treated versus untreated cells. 
Microarray results were statistically evaluated considering changes more than two-fold as 
significant and confirmed at RNA level by Northern blot analysis. 
The PDTC transcriptome consisted of more than 200 differentially expressed genes, 
indicating a major transcriptional shift in yeast. Gene ontology (GO) enrichment of the 
microarray data using the Saccharomyces Gene Database GO Termfinder revealed that 
the main functional categories comprised of the iron regulon, aerobic respiration and 
general metabolic changes (Table 2). 
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Categories Gene names N° of 
Genes 
Iron regulon 
Aft1/Aft2 targets 
FTH1, SIT1, FTR1, ARN1, ARN2, CTR2, FRE1, CCS1, FET3, ENB1, FIT1, 
FIT2, FIT3, YLR126C, ISU2, ISU1, FTR1 
17 
Carboxylic acid 
metabolic process 
CYS3, GCV3, SHM1, CHA1, SFA1, GLT1, GCV1, ARO3, HOM3, MET6, 
LPD1, ARO9, POT1, ELO1, FBA1, FAS1, ILV5, ILV2, GCV2, LEU4,  LYS9, 
LEU9, HIS3, GDH1, CAR1, GLN1, SHM2, URA1, GTT1, URA4 
30 
Purine biosynthetic 
process 
ADE1, ADE8, ADE5,7, ADE13, ADE17, ADE3, ADE12 7 
Stress response to 
drug / toxin 
AAD3, RPN4, UBC5, YCF1,  SNF1,  AAD6, AAD16, YML131W,  DDR48, 
HOR7, LAP3, GRE2, TIR2, OYE3, HSP31, SFP1, OYE2 
17 
Response to 
oxidative stress 
YDL124W, CTA1, TRR1, YPR1, GRX2, TRX2, STB5, SOD1, CCP1, TRX1, 
AHP1, ZWF1, ATX1, GLR1,  PEP4 
15 
Hexose transport HXT10, HXT4, HXT5, HXT8, GAL2, HXT11, HXT12 7 
Respiration & citric 
acid cycle 
COX6, COX5A, COX9, COX13, IDH1, ACO1, RIB3, POR1, QCR7 9 
Heme HEM13, YHB1, YCP4 3 
Transport STP22, TRS23, INH1, VHT1, TOM6, HNM1, MUP1, TPO1, DIC1, SFH5 11 
Ergosterol 
biosynthesis 
ERG3, ERG1, ERG27, ERG11 4 
Telomere 
maintenance 
YGL039W, NMD2, CST6, HCR1, LST7, SWD1, PNC1 7 
Transcription/ 
translation 
MRP8, EFB1, GCD2, RLI1, GAT1, ERB1, UTP23, SSZ1, RLP7, TUF1 10 
DNA replication/ 
repair 
RNR2, RNR4, DON1, WTM1, YPL033C, NNF1, RFA2, SIM1 8 
Oxidoreductase 
activity 
ADH7, YDR541C, DLD3, YGL157W, ADH6, YNL134C 6 
Other PHO5, PHO11, PHO86, IRC7, IZH1, FRM2, MFA1, EMI2, AGA2, KOG1, 
BAR1, BNR1, MSG5, LAP4, AIM46, RIB4, SLA1, EHD3, FLO9, NDE1, 
SNC2, PAC11, TEC1, PEX5, UGP1, RMD6, AIM18, PMI40, SCW4, CWP1, 
SRP40, EMI1, VHS1, YRO2, PRE8, MRH1, APT2, TIP1, LRG1, CNS1, 
WWM1, RPN6, DPH5, FRQ1, FMP43 
45 
Unknown YAL065C, YMR173W-A, YCR102C, YJL217W, YER156C, YGR146C, 
YDR476C, YOR285W, YKL088W, YDR154C, YKL030W, YPL067C, 
YKL066W, YLL044W, YDR271C, YBR053C, YJL068C, YFR024C, 
YHR213W, YAR073W, YKL171W, YEL033W, YDR119W, YLR460C, 
YNL208W, YCR074C 
26 
Table 2: Functional categories of differentially expressed genes during PDTC treatment. Genes that were at least 2-fold 
(p-value ≤ 0.05) differentially expressed on our microarrays were categorized using the Saccharomyces Gene Database 
Gene Ontology termfinder (www.yeastgenome.org). 
PDTC induced an immense stress response in yeast by changing expression levels of 
hundreds of genes. To identify the regulatory associations of the differentially expressed 
genes, we clustered the genes with YEASTRACT (Teixeira et al., 2006).  Thereby, 
differentially expressed genes identified through microarrays were grouped according to 
their transcription factors or potential regulators. Supporting the findings of the GO 
enrichment, the main transcription factors required for general and oxidative stress 
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response genes as well as proteasome and multidrug resistance genes were activated 
(Table 3). These included the transcriptional regulators Yap1, Msn2/4, Rpn4 and Sfp1 
correlating with the activation of general stress response genes, as well as with repression 
of ribosomal genes (i.e. protein synthesis) under various conditions (Gasch et al., 2000; 
Wu et al., 2008). 
Some 60 % of the genes are regulated by the Yap1 transcription factor (Table 3), which is 
required for oxidative stress tolerance (Lee et al., 1999). Furthermore, the stress-
responsive transcription factors Msn2 and Msn4, which are the main regulators of the 
environmental stress response program (Gorner et al., 1998), were also found. 
Additionally, we found Pdr1, a transcription factor regulating multidrug resistance genes 
regulating about 28% of the PDTC-induced genes (Balzi et al., 1987). Moreover, Rpn4, 
stimulating the expression of proteasome genes, and Gcn4, which is involved in amino 
acid biosynthesis, were also activated by PDTC (Xie and Varshavsky, 2001). Interestingly, 
the clustering specifically identified the iron-responsive transcription factor Aft1 
(Yamaguchi-Iwai et al., 1995) as one of the major responders.  
The highest induced genes at least at one time point were FIT1, HSP31, YNL134C, GRE2, 
FIT2, YLR460C and FIT3. HSP31 encodes a stress responsive protein probably acting as a 
chaperone. Gre2 is a metalloreductase involved in the high osmolarity glycerol (HOG)-
pathway. YNL134C encodes a putative protein of unknown function that is induced upon 
DNA damage. YLR460C belongs to the quinone oxidoreductase family. Both, YNL134C and 
YLR460C are members of the medium-chain dehydrogenase/reductase (MDR) family. 
Many enzymes of the MDR family play roles in detoxification and environmental stress 
response coping with osmotic and oxidative stress. FIT1, FIT2 and FIT3 are cell wall 
mannoproteins involved in retention of siderophore-bound iron in the cell wall. Hence, 
among the 7 most induced genes, we identified three Aft1-regulated genes. 
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Transcription 
factor 
% ORF 
Yap1 60.3 EFB1, CYS3, ADE1, PHO11, IMD1, SLA1, YBR053C, YRO2, TIP1, PHO5, CNS1, FTH1, SHM1, YCL026C-A, YCP4, YCR102c, ADH7, AAD3, RPN4, RPN6, YDL124w, SFA1, GLT1, GCV1, MRH1, ARO3, EHD3, VBA4, YCF1, YDR154c, CTA1, 
DON1, TRR1, YPR1, FRQ1, ADE8, RIB3, GRX2, EMI2, HSP31, FIT1, DLD3, RMD6, PMI40, MET6, YER156c, GAT1, AAD6, 
AAD16, IRC7, PNC1, HNM1, MUP1, VHT1, YGR146c, ERG1, RNR4, ADE3, TRX2, YHB1, ARN1, ERG11, COX6, HXT4, 
HXT5, ARO9, CTR2, STB5, OYE2, KOG1, FMP22, FMP34, SIM1, HXT12, GTT1, RNR2, SOD1, YKL030w, FBA1, YKL066w, 
CWP1, LAP4, MRP8, FAS1, URA1, CCP1, SRP40, TPO1, TRX1, ERG3, SHM2, AHP1, DPH5, FRE1, ACO1, ILV5, SFP1, 
URA4, YLR460c, PRE8, YML131w, CCS1, ERB1, FET3, ADE17, DDR48, YMR173w-a, GCV2, HOR7, ADH6, LEU4, YNL134c, 
YNL208w, ADE12, LAP3, ZWF1, RFA2, RIB4, GRE2, HXT11, LEU9, ISU2, WTM1, YOR285w, GDH1, FIT3, YPL067c, GLR1, 
CAR1, PEP4, OYE3, GLN1 
Sfp1 47.0 EFB1, GCV3, FLO9, IMD1, SLA1, YBR053c, CNS1, STP22, YCL026c-a, YCR102c, RPN4, RPN6, LRG1, GCV1, MRH1, HEM13, RLI1, VBA4, YCF1, YDR154c, TRS23, TRR1, YPR1, FRQ1, MFA1, PAC11, IZH1, HSP31, FIT1, SIT1, DLD3, PMI40, 
HOM3, FTR1, YER156c, HXT10, AAD16, AGA2, YGL039w, YGL157w, VHT1, YGR146c, ERG1, ADE3, YHB1, ARN1, ERG11, 
SSZ1, HXT4, CTR2, STB5, OYE2, YHR213w, BAR1, POT1, HXT12, RNR2, YJL068c, ELO1, NNF1, CWP1, FAS1, URA1, 
SRP40, ERG3, SHM2, GAL2, ERG27, AHP1, HCR1, ACO1, ILV5, SFP1, YLR460c, YML131w, ERB1, FET3, ILV2, ADE17, 
YMR173w-a, GCV2, HOR7, ADH6, RLP7, MSG5, LEU4, YNL134c, LAP3, ZWF1, RFA2, LYS9, RIB4, GRE2, ENB1, UTP23, 
LEU9, HIS3, ISU2, FIT2, YPL067c, CAR1, OYE3, GLN1 
Msn2 34.2 EFB1, PHO11, SLA1, YBR053c, PHO5, RPN4, YDL124w, MRH1, YDR154c, CTA1, TRR1, APT2, EMI1, GRX2, EMI2, HSP31, MET6, FTR1, GAT1, AAD16, PNC1, HNM1, YGL157w, ADE5,7, MUP1, LST7, VHT1, ERG1, TRX2, YHB1, HXT4, HXT5, 
ARO9, CTR2, SIM1, POT1, GTT1, ACO2, REE1, SOD1, UGP1, FBA1, CWP1, LAP4, MRP8, CCP1, ERG3, AHP1, YLR126c, 
FRE1, ILV5, YML131w, ERB1, FET3, DDR48, YMR173w-a, HOR7, RLP7, IDH1, COX5a, YNL134c, LAP3, ATX1, RIB4, GRE2, 
UTP23, LEU9, HIS3, ISU2, WTM1, YOR285w, GDH1, FIT2, PEP4, OYE3 
Ste12 34.2 EFB1, FLO9, ADE1, PHO11, YBR053c, YRO2, TIP1, TEC1, YCL026c-a, CHA1, YCR102c, SFA1, GLT1, LRG1, EHD3, HEM13, RLI1, APT2, MFA1, HSP31, RMD6, MET6, FTR1, LPD1, GAT1, IRC7, AGA2, PNC1, YGL039w, YGR146c, RNR4, 
YHB1, FMP43, SCW4, ARN1, ERG11, HXT4, HXT5, ARO9, OYE2, BAR1, CST6, SIM1, BNR1, POT1, HXT12, GTT1, SFH5, 
ELO1, ACO2, HXT8, CWP1, LAP4, TPO1, TRX1, GAL2, AHP1, ACO1, DIC1, URA4, YLR460c, CCS1, ERB1, ILV2, NDE1, 
DDR48, HOR7, MSG5, POR1, YNL208w, LYS9, TIR2, SNC2, GDH1, ISU1 
Sok2 30.1 EFB1, FLO9, YBR053c, YRO2, TIP1, TEC1, CHA1, AAD3, YDL124w, SFA1, HEM13, APT2, IZH1, EMI2, HSP31, SIT1, DLD3, FTR1, AAD16, IRC7, AGA2, PNC1, YGL157w, YGR146c, RNR4, YHB1, SCW4, ERG11, HXT4, HXT5, OYE2, SIM1, HXT12, 
GTT1, RNR2, HXT8, CWP1, LAP4, FAS1, SRP40, TPO1, ERG3, SHM2, ACO1, ILV5, YLR460c, YML131w, NDE1, DDR48, 
HOR7, LEU4, ZWF1, LYS9, GRE2, HXT11, ENB1, TIR2, TUF1, WTM1, SNC2, GDH1, FIT3, YPL067c, ISU1, PEP4, OYE3 
Met4 28.8 CYS3, GCV3, FLO9, IMD1, YBR053c, YRO2, SHM1, YCP4, AAD3, RPN4, INH1, GCV1, HEM13, UBC5, YCF1, YDR154c, YDR476c, RIB3, GRX2, QCR7, HSP31, SIT1, DLD3, MET6, HXT10, GAT1, AAD6, AAD16, YFR024c-a, PNC1, ADE5,7, MUP1, 
LST7, VHT1, ADE3, ARO9, BNR1, RNR2, PHO86, ACO2, REE1, SOD1, UGP1, MRP8, URA1, CCP1, TRX1, SHM2, SFP1, 
PRE8, YML131w, ERB1, NDE1, GCV2, MSG5, YNL208w, ADE12, LAP3, LYS9, HXT11, WTM1, FIT2, OYE3 
Rpn4 28.8 GCV3, IMD1, YBR053c, YRO2, TIP1, PHO5, STP22, YCL026c-a, CHA1, YCP4, YCR102c, RPN4, RPN6, GCV1, MRH1, TRR1, FRQ1, FIT1, MTC7, DLD3, PMI40, HOM3, MET6, AAD6, AAD16, PNC1, YGL039w, TRX2, YHB1, FMP43, SCW4, ARN1, 
ARN2, HXT4, HXT5, ARO9, GTT1, UGP1, CWP1, LAP4, FAS1, URA1, ERG3, FRE1, DIC1, YLR460c, PRE8, YML131w, FET3, 
ILV2, ADE17, NDE1, GCV2, HOR7, IDH1, POR1, ENB1, TIR2, YOR285w, FIT2, FIT3, PEP4, GLN1 
Pdr1 27.9 EFB1, YAL065c, PHO11, YBR053c, YRO2, TEC1, PHO5, YCL026c-a, ADH7, RPN4, YDL124w, TRR1, YPR1, IZH1, EMI2, HSP31, FIT1, SIT1, DLD3, HOM3, FTR1, AAD16, PNC1, YGL039w, YGL157w, YGR146c, FMP43, SCW4, HXT4, OYE2, 
HXT12, GTT1, YKL030w, UGP1, CWP1, FAS1, URA1, TPO1, ERG27, AHP1, ACO1, DIC1, ILV5, YML131w, FET3, NDE1, 
HOR7, ADH6, YNL134c, ZWF1, ATX1, LYS9, GRE2, HXT11, ENB1, HIS3, SNC2, FIT2, ISU1, PEP4, GLN1 
Aft1 25.6 FLO9, YRO2, FTH1, YCP4, ADH7, AAD3, RPN4, YDL124w, YDR154c, YDR271c, HSP31, FIT1, YDR541c, SIT1, FTR1, YER156c, PNC1, COX13, VHT1, YGR146c, YHB1, FMP43, ARN1, ARN2, HXT4, HXT5, FMP22, GTT1, ELO1, SOD1, UGP1, 
LAP4, TPO1, ERG3, GAL2, AHP1, HCR1, FRE1, YML131w, FET3, NDE1, DDR48, GCV2, HOR7, IDH1, ZWF1, ATX1, HXT11, 
ENB1, TUF1, ISU2, FIT2, FIT3, ISU1, PEP4, OYE3 
Gcn4 24.7 CYS3, GCV3, ADE1, PHO11, YRO2, PHO5, YCL026c-a, CHA1, COX9, GLT1, GCV1, ARO3, PEX5, ADE8, RIB3, EMI1, GRX2, HOM3, LPD1, GAT1, IRC7, PNC1, ADE5,7, VHT1, ADE3, YHB1, HXT5, ARO9, FMP34, ACO2, SOD1, NNF1, FBA1, CWP1, 
LAP4, ILV5, ADE13, ILV2, ADE17, DDR48, GCV2, IDH1, LEU4, ADE12, LAP3, ZWF1, LYS9, LEU9, HIS3, WTM1, GDH1, 
CAR1, ISU1, GLN1 
Pdr3 24.2 EFB1, YAL065c, PHO11, SLA1, YRO2, PHO5, YCL026c-a, YCR102c, RPN4, YDL124w, MRH1, TRR1, IZH1, EMI2, HSP31, DLD3, HOM3, FTR1, AAD6, AAD16, PNC1, YGL039w, YGL157w, TRX2, YHB1, FMP43, SSZ1, HXT4, UGP1, LAP4, URA1, 
SRP40, TPO1, ERG27, DPH5, ACO1, YLR460c, ERB1, HOR7, YNL134c, GRE2, HXT11, ENB1, UTP23, TIR2, HIS3, ISU2, 
SNC2, FIT2, CAR1, ISU1, PEP4, OYE3 
Cin5 20.5 GCV3, FLO9, ADE1, YBR053c, YRO2, YCR102c, SFA1, GLT1, MRH1, APT2, HSP31, RNR4, TRX2, ARN1, COX6, STB5, OYE2, SIM1, HXT12, GTT1, LAP4, MRP8, FAS1, CCP1, SHM2, GAL2, AHP1, YLR126c, FRE1, ACO1, ADE13, YLR460c, 
YML131w, CCS1, ADE17, DDR48, YMR173w-a, GCV2, ZWF1, GRE2, HXT11, WTM1, YOR285w, FIT2, GLN1 
Table 3: PDTC responsive genes grouped by transcription factor (TF) involved in their regulation. Microarray data sets 
were clustered using YEASTRACT (Teixeira et al., 2006). 
PDTC activates the iron regulon 
Strikingly, among the highest induced genes, we identified several genes of the high-
affinity iron uptake system (FET3, ARN4) as well as low-affinity iron-transporters (FET4) 
and cell wall mannoproteins (FIT1, FIT2, FIT3) required for iron retention of siderophore-
bound iron. Interestingly, this set of the highest induced genes is referred to as the iron 
regulon which is activated under iron-limiting conditions. The iron regulon is mainly 
controlled by the transcription factors Aft1/ Aft2 (activator of ferrous transport 1/2) 
(Rutherford et al., 2003). Aft1 mediates the response to the cellular iron status by 
trafficking into the nucleus upon iron deprivation and staying in the cytoplasm under iron-
replete conditions. Nuclear shuttling of the Aft1 transcription factor induces a well-
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regulated transcriptional remodeling program involving many cellular processes 
(Yamaguchi-Iwai et al., 2002). The primary response comprises of the up-regulation of the 
iron uptake machinery and the import of iron. In the second phase, intracellular iron 
storage is mobilized. Finally, the cells modulate and adapt their metabolic iron usage to 
the limitation switching to less iron-consuming pathways, shutting down non-essential 
pathways while preserving essential ones. Pathways regulated in response to iron 
changes are the biotin, glutamate and purine biosynthetic pathways, as well as the TCA 
cycle. Furthermore, genes involved in heme biosynthesis and in the respiratory chain are 
down-regulated (Hausmann et al, 2008). Recently, it has been shown that under low-iron 
conditions genes involved in biotin synthesis, glutamate metabolism and heme assembly 
are downregulated mediated through coordinated targeted mRNA degradation by 
Cth1/Cth2 (Tis11). By binding to certain mRNAs, Tis11 causes rapid degradation of these 
mRNAs, thereby reducing their expression level. These second wave targets complete the 
known multistage remodeling during iron deprivation (Table 4).  
Upregulation of iron uptake genes Genes either down-regulated or involved in 
downregulation of iron-consuming pathways 
ARN1, FIT2, FIT3, ARN2, FET3, FIT1, FTR1, ARN4, 
ARN3, FRE1, FTH1, ATX1, CTR2, CCS1, ENB1, 
YLR126C, ISU2, ISU1 
TIS11, HMX1, LEU1, COR1, RIP1, COX6, CYC1, HEM15, 
CCP1, HEM13, COX9, RLI1, RNR4, BIO2, RNR2, ISA1, 
SDH2, COX8, COX5A, COX13, ACO1 
Table 4: List of genes differentially regulated in response to PDTC after 1, 3 or 5h treatment and iron deprivation. We 
compared our microarray data set to published data on iron deprivation (Puig et al., 2005), overlapping genes are 
shown in bold.  
The PDTC transcriptome compares to the transcriptional profile during iron deprivation 
Hence, we compared the transcriptional profile of PDTC to published data on iron 
deprivation. Indeed, we found a significant overlap (p-values ≤ 0.005) between profiles 
reflecting iron deprivation or deletion of the iron sulfur complex (ISC) machinery and 
other stress conditions activating Aft1 (Fig.7). Consistent with the known cellular 
remodeling upon iron limitation, on the one hand, PDTC induced genes of the high-
affinity and low-affinity iron import machineries, as well as sterol and fatty synthesis 
genes. On the other hand, genes of iron-consuming pathways were down-regulated. 
Many of these genes were known Tis11 target genes, indicating a secondary response 
after PDTC-induced activation of Aft1. Thus, PDTC triggered both the primary and 
secondary wave response genes involved in iron-dependent cellular remodeling (Table.4). 
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Figure 7: Venn diagrams of 
genes differentially 
expressed genes under iron-
limited conditions and upon 
PDTC treatment (p-values ≤ 
0.005). 
 
PDTC causes strong induction of Aft1-target genes 
To confirm the induction of the iron regulon in response to PDTC, we performed Northern 
analysis. As shown in Fig.8A, PDTC strongly induced the expression of TIS11, GRE2 and 
FIT3 when compared to untreated cells. The most upregulated genes (e.g. FIT1, FIT2) have 
several Aft1 binding sites in their promoter regions, explaining their enormous 
upregulation seen by microarray analysis and Northern blots (Fig.8B, (Yamaguchi-Iwai et 
al., 1996)). 
A 
 
B 
 
 
 
 
Figure 8: A. Northern blot analysis investigating induction of PDTC-induced genes. Cells were treated for 1 to 6h with 
PDTC. Untreated and PDTC-treated cultures were harvested and total RNA was isolated and transferred to a PVDF 
membrane. Radiolabeled probes were hybridized and the membrane was exposed to X-ray films. B. Cluster of Aft1 
target genes in the subtelomeric region of chromosome XV. 
The effect of PDTC on the iron regulon is Aft1-dependent 
To investigate whether the increase in the expression levels of these genes is Aft1-
dependent, we compared the transcript levels of wild type cells and those lacking the 
AFT1 gene (Fig.9A). Activation of the iron regulon (FIT2, FIT3) upon PDTC exposure was 
fully Aft1-dependent, whereas GRE2, encoding a metalloreductase involved in the HOG 
pathway, served as control for Aft1-independent induction. Thus, in addition to the iron 
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regulon, other genes were differentially expressed, indicating additional regulatory 
mechanisms independent of Aft1. Furthermore, PDTC strongly induced the FET3 
promoter encoding the multicopper ferroxidase of the high-affinity iron uptake system as 
shown by a FET3-lacZ reporter assay (Fig.9B).  
A 
 
B 
 
Figure 9: A. Northern blot analysis comparing gene expression in wild type and aft1∆ cells in the presence of PDTC. B. 
PDTC induced activation of the FET3-promoter. Cells containing an integrated lacZ-FET3 reporter construct were grown 
to the logarithmic phase in YPD and treated with PDTC for 2 hours. Cells were harvested, crude extracts were prepared 
and β-galactosidase activity was determined. 
PDTC causes down-regulation of the cytochrome c oxidase 
Under iron-limited conditions, yeast cells switch to less-iron consuming pathways by post-
transcriptional down-regulation of certain genes. Tis11 (Cth2) is a key player down-
regulating genes related to respiration and citric acid cycle (Fig.10A, (Vergara and Thiele, 
2008)). In cellular respiration, the cytochrome c oxidase (COX), a multisubunit enzyme 
and known target of Tis11, catalyzes the terminal step in the respiratory electron 
transport chain. Since several genes encoding subunits of the cytochrome c oxidase were 
downregulated during PDTC response, we confirmed downregulation of COXIV by 
immunoblotting using an anti COXIV antibody (Fig.10B).  
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Figure 10: A. Schematic presentation of coordinated mRNA degradation by Cth2 in respone to iron deficiency to 
prioritize less-iron consuming pathways (Vergara and Thiele, 2008). B. PDTC caused down-regulation of COXIV. Cells 
were harvested at the indicated time points. 0.5 OD600 equivalents of TCA extracts were loaded per lane. Proteins were 
detected using an anti-COXIV and polyclonal anti-PGK antibodies as loading control. 
Low-iron sensing genes are required during the PDTC response 
Aft1 is required for growth under iron-limited conditions (Yamaguchi-Iwai et al., 1995), 
although Aft1 does not directly sense low-iron conditions. The signal is rather transmitted 
by mitochondrial iron-sulfur cluster (ISC) biosynthesis genes requiring a cytosolic complex 
of Grx3-Grx4-Fra1-Fra2 (Kumanovics et al., 2008). Consistently, the aft1∆, fra2∆, and 
grx3∆ strains were hypersensitive to PDTC when compared to the corresponding wild 
type control. Iron-supplementation specifically rescued this sensitivity phenotype, thus 
showing that PDTC mimicked or caused a lack of iron availability (Fig.11A). Moreover, iron 
supplementation significantly reduced the induction of Aft1-target genes after PDTC 
treatment at the mRNA level (Fig.11B), whereas supplementation of calcium or copper 
failed to change mRNA levels of PDTC-induced genes (Fig.11C,D).  
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Figure 11: Iron supplementation rescued the PDTC-induced effects. A. Spot assays comparing wild type yeast growth to 
mutants of the iron sensing machinery. B: Northern blot analysis investigating the effect of iron supplementation during 
PDTC treatment. C, D. Calcium and copper failed to suppress the induction of PDTC-responsive genes.  
Neither calcium nor magnesium could override the PDTC-induced effects 
The aft1∆ strain is sensitive to a variety of stress conditions, including lack of iron, alkaline 
pH, hydroxyurea, excess zinc, nickel, cobalt and manganese (Fig.12, (Stadler and 
Schweyen, 2002; Serrano et al., 2004; Dubacq et al., 2006)). Consequently, we questioned 
whether supplementation of metal ions could influence growth and gene expression 
levels during PDTC treatment. Interestingly, except for iron, other ions such as Ca2+, Mg2+, 
Zn2+, and Mn2+ failed to rescue the PDTC-dependent growth inhibition. Cd2+ 
supplementation even increased PDTC-sensitivity. Notably, copper supplementation 
rescued growth of the aft1∆ strain in the presence of PDTC, but impaired PDTC-tolerance 
of the wild type strain (Fig.12).  
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PDTC induced stress-responsive genes in the aft1∆ strain 
To identify Aft1-independet target genes of PDTC, we performed genome-wide 
microarray analysis with untreated and PDTC-stressed aft1∆ cells and compared these 
results to the transcriptional response in the wild type strain. We identified 47 genes 
differentially expressed upon PDTC treatment in the aft1∆ strain. As expected, upon 
deleting the main regulator of the iron regulon, no iron-responsive genes were induced. 
Comparison with the wild type PDTC data revealed an overlap of 31 genes including 
GRE2, SOD1 or STP22. By functionally categorizing them, we mainly observed genes 
involved in response to stress, especially to toxin or oxidative stress (Table 5).  However, 
we identified 16 genes that were exclusively differentially expressed in the aft1∆ strain 
upon PDTC treatment, including CUP1, AAD4, HSP12, AAD10, DUG2, YGP1, GLK1, 
YOL150C, TFS1, TSA2, IRC14, IDH2, RPL5 and HYR1. CUP1 encodes a metallothionein that 
binds to copper and mediates resistance to copper and cadmium (Winge et al., 1985). 
Aad4 is a putative aryl-alcohol dehydrogenase involved in oxidative stress response 
(Dickinson et al., 2003). The HSP12 gene is induced upon several stress conditions such as 
heat shock, oxidative or osmotic stress, as well as glucose depletion or stationary phase 
entry (Sales et al., 2000). HYR1 encodes a thiol peroxidase sensing intracellular 
hydroperoxide levels and transducing a redox signal to the Yap1 transcription factor 
(Delaunay et al., 2002). In summary, stress response genes and metallothioneins were the 
main gene sets regulated in the aft1∆ strain. 
 
Figure 12: PDTC induced growth deficiency is iron-dependent. 
Growth inhibition assay with serial dilutions of wild type and 
aft1∆ cells on media containing PDTC and/or different ions.  
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Categories p-value Genes names 
response to 
stimulus  
2.77e-09 FRM2, YCR102C, AAD3, YDL124W, AAD4, TSA2, GRX2, HSP12, AAD6, AAD16, 
TRX2, YHB1, CUP1-1, CUP1-2, STB5, HYR1, SOD1, AAD10, YML131W, DDR48, 
HOR7, YGP1, GRE2, OYE3 
cellular aldehyde 
metabolic 
process  
2.69e-07 AAD3, AAD4, AAD6, AAD16, YJL068C, AAD10 
response to 
oxidative stress  
3.86e-06 YDL124W, TSA2, GRX2, HSP12, TRX2, STB5, HYR1, SOD1 
response to 
copper ion  
0.00024 YCR102C, CUP1-1, CUP1-2 
Table 5: Functional categories of differentially expressed genes during PDTC treatment in aft1∆ cells. Genes that were 
at least 2-fold (p-value ≤ 0.05) differentially expressed on our microarrays were categorized using the Saccharomyces 
Gene Database Gene Ontology termfinder (www.yeastgenome.org). 
Metallothioneins are low-molecular weight proteins that bind ions, thereby regulating 
intracellular ion homeostasis and conferring resistance to certain ions. Since we observed 
the CUP1 gene to be differentially regulated in the aft1∆ strain upon PDTC treatment, we 
confirmed its transcript levels by Northern analysis (Fig.13A). Moreover, in wild type cells 
supplementing both copper and PDTC was highly toxic, whereas copper rescued the aft1∆ 
sensitivity phenotype (Fig.13B). CUP1 was highly induced in the aft1∆ strain, which might 
explain the increased copper-tolerance when compared to the wild type control.  
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Figure 13: A. Northern analysis probing the 
metallothioneine gene CUP1. BY4741 aft1∆ 
cells were incubated with PDTC for 1 and 3 
hours, respectively.  After harvesting cells, total 
RNA was extracted and 15µg were blotted onto 
a PVDF membrane after agarose gel 
fractionation. B. Spot assays comparing growth 
of wild type and aft1∆ cells on YPD medium 
containing PDTC and copper sulfate, 
respectively.  
PDTC interferes with intracellular zinc levels 
On the one hand, PDTC caused strong induction of the iron uptake machinery. On the 
other hand, it was striking to note that PDTC also strongly altered expression of plasma 
membrane and vacuolar zinc transporters (Fig.14A). In detail, expression of the plasma 
membrane low-affinity zinc transporter Zrt2 and the vacuolar zinc exporter Zrt3 was 
strongly decreased upon PDTC treatment, whereas the transporter importing zinc into 
the vacuole, Cot1, was highly induced (Fig.14B). Transcript levels of the high-affinity zinc 
transporter Zrt1 stayed unchanged; however Zrt1 is regulated post-translationally via 
ubiquitination and endocytosis (Gitan and Eide, 2000). Although yeast lacks a cellular zinc 
exporter, free zinc concentrations are kept low because excess zinc is highly toxic for cells. 
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Spare zinc is bound to proteins or stored in vesicular compartments such as the vacuole 
as major site of storage and detoxification (Eide, 2009). 
A 
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Figure 14: A. PDTC altered expression of zinc transporters. Cells were grown in YPD to an OD600 of ~0.8  and 75µM PDTC 
was supplemented. Cells were harvested at the indicated time points, total RNA was extracted and 15µg of each sample 
were used for Northern analysis. B: Induction of the COT1 gene upon PDTC treatment was independent of Aft1. 
Beside zinc sequestration in compartments, cells upregulate zinc-binding proteins like 
metallothioneins. In addition, large amounts of zinc are bound by the copper/zinc 
superoxide dismutase Sod1, as well as the alcohol dehydrogenase Adh1 and the 
ribosomes. Sod1, Adh1 and ribosomal zinc account for about 20% of the whole zinc quota 
per cell (Eide, 2006). Consistent with our notion of PDTC-mediated intracellular zinc 
excess, transcript levels of the major zinc-conserving proteins like alcohol 
dehydrogenases (ADHs) and superoxide dismutase 1 (Sod1) were increased. We 
confirmed the induction of the cytoplasmic superoxide dismutase SOD1 gene by Northern 
blotting. In the aft1∆ strain, SOD1 gene induction was even more pronounced than in the 
wild type control (Fig.15B).   
Consistently, Sod1 deficiency led to increased PDTC, as well as zinc-sensitivity, whereas 
deletion of the manganese superoxide dismutase Sod2 had less severe effects (Fig.15A). 
Interestingly, iron supplementation failed to rescue the PDTC-induced growth defect of 
the sod1∆ strain. However, this failure might be due to a previously reported increase in 
iron demand of the sod1∆ mutant per se and its involvement in zinc detoxification (De 
Freitas et al., 2000; Tarhan et al., 2007). In this case, PDTC would worsen the lack of iron 
availability, thereby increasing the sensitivity of the sod1∆ strain. Taken together, the 
observed regulation of zinc homeostasis genes in response to PDTC indicates excess 
cytoplasmic zinc, leading to subsequent zinc detoxification by sequestration into the 
vacuole and by induction of zinc-binding proteins. 
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Figure 15: A. Sensitivity of SOD mutants to PDTC and different 
ions. Serial dilutions of the indicated strains were spotted on YPD 
plates and YPD plates containing PDTC and /or diverse ions.  
Growth was monitored after 2 days. B. Northern analysis 
confirming PDTC-caused induction of the SOD1 gene. Wild type 
and aft1∆ cells were harvested at indicated time points after PDTC 
supplementation. Total RNA was isolated and blotted onto a PVDF 
membrane after agarose gel fractionation. Radiolabeled probes 
were hybridized to the membrane specifically detecting FIT2 (Aft1-
dependent) and SOD1 (Aft1-independent) RNAs.   
 
As PDTC induced Sod1, we further investigated the role of oxidative stress and 
accumulation of reactive oxygen species (ROS) in the PDTC response. Superoxide 
dismutases are required for detoxification by catalyzing the breakdown of superoxide 
anions into oxygen and hydrogen peroxide. In S. cerevisiae, there exist two types of 
superoxide dismutases, Sod1 and Sod2. The SOD1 gene encodes a Cu/Zn superoxide 
dismutase localized to the cytoplasm and mitochondria (Lyons et al., 2000), whereas 
Sod2, a manganese superoxide dismutase is found in the mitochondrial matrix (Luk et al., 
2005).  
To investigate ROS accumulation in PDTC-treated cells, we labeled cells with 
dihydroethidium (DHE), dihydrorhodamine (DHR) and dichlorodihydrofluorescein 
diacetate (H2DCFDA), respectively. DHE detects mitochondrial superoxide anion, DHR 
detects hydrogen peroxide, hypochlorous acid and peroxynitrite anion, whereas H2DCFDA 
detects hydrogen peroxide, hydroxyl radical, peroxyl radical and peroxynitrite anion. 
Labeled wild type, sod1∆, sod2∆ and sod1∆ sod2∆ cells were treated with PDTC and 
analyzed by FACS. We failed to detect ROS by using H2DCFDA or DHR (data not shown). 
However, we detected a chemoluminsecent shift upon PDTC treatment in DHE-labeled 
sod2∆ cells (Fig.16C). Therefore, we suggest that PDTC only caused a weak ROS 
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generation in yeast cells. Indeed, we only managed to detect mitochondrial ROS 
accumulation in the sod2∆ strain (Fig.16). Probably, these ROS are rapidly dismutated in 
the wild type strain or cytoplasmic ROS levels were below the detection limit. Notably, 
microarray analysis indicated down-regulation of the CCP1 gene encoding the 
mitochondrial cytochrome c oxidase, which is involved in ROS degradation in the 
mitochondria (Charizanis et al., 1999). Repression of Ccp1 in the presence of PDTC might 
explain the increased ROS levels in the mitochondria.  
A 
 
              wild type 
B 
 
           sod1∆  
C 
 
             sod2∆  
Figure 16: FACS analysis detecting mitochondrial ROS accumulation in wild type, sod1∆, sod2∆ and sod1∆ sod2∆ cells 
using the fluorescent dye dihydroethidium (DHE).   
Sod1 is required for oxidative stress defense, but it also links ROS response to metal ion 
homeostasis and pH sensitivity. For example, Sod1 requires the metallochaperone Ccs1 
for copper loading in vivo (Culotta et al., 1995). Moreover, Atx1, a metallochaperone for 
copper-dependent iron absorption, suppresses the superoxide sensitivity phenotype of 
mutants lacking superoxide dismutases. Atx1 can be induced by iron via Aft1, although it 
is not strictly Aft1-dependent (De Freitas et al., 2000). Similar to aft1∆, the sod1∆ strain 
shows increased sensitivity to zinc and cadmium excess, alkaline pH and hydroxyurea 
stress, all of which activate Aft1 and correspondingly the iron regulon.  
PDTC causes immediate zinc influx into yeast cells 
To directly monitor PDTC-induced zinc accumulation inside yeast cells in real time, we 
used the fluorescent dye mag-fura-2 (Molecular Probes). As the dye is normally effluxed 
from cells, all experiments were carried out in a strain lacking the ABC transporters Pdr5 
and Pdr12 (Piper et al., 1998; Holyoak et al., 1999). The excitation wavelength of mag-
fura-2 is shifted from 380 to 340 nm when binding bivalent cations (Raju et al., 1989; 
Simons, 1993). After loading yeast cells with mag-fura-2, cells were extensively washed, 
and ZnSO4, CuSO4, CaCl2 or MgCl2, PDTC and EDTA were added at indicated time points. 
While adding ZnSO4 had only minor effects on the fluorescent ratio, the supplementation 
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of PDTC caused a rapidly increasing signal as a readout for intracellular zinc accumulation 
(Fig.17). As expected, adding EDTA reduced the signal immediately. Other metal ions, 
including Mg2+, Cu2+ and Ca2+, had no effect on the fluorescent signal. Thus, PDTC caused 
an immediate influx of Zn2+ ions into yeast cells and elevated intracellular zinc levels. 
 
Figure 17: PDTC induces 
immediate influx of zinc ions 
into yeast cells. Cells were 
loaded with the mag-fura-2 
dye and fluorescence was 
monitored in real-time after 
adding metal ions such as 
ZnSO4, CaCl2, CuSO4, MgCl2, 
PDTC and EDTA at the 
indicated time points. The 
excitation wavelength of mag-
fura-2 is shifted by binding 
bivalent metal ions. Thus, 
change of the fluorescent ratio 
of F340/380nm following 
addition of zinc and PDTC, but 
not by calcium, magnesium or 
copper, show accumulation of 
intracellular labile zinc. 
PDTC triggers a cross-talk between iron and zinc homeostasis 
As both iron and zinc homeostasis were disturbed by PDTC, we aimed to investigate a 
thus potential cross-talk between the iron and zinc regulons. Supporting this notion, it 
was previously reported that zinc overload activates the iron regulon (Pagani et al., 2007). 
In addition, aft1∆ cells are sensitive to high concentrations of extracellular zinc, which 
indicates that Aft1 is required to counteract the growth defect caused by excess zinc 
(Pagani et al., 2007). Hence, we performed viability assays with wild type and aft1∆ 
strains in the presence of PDTC, Zn2+ and Fe3+, respectively (Fig.18). Colony forming units 
were determined after 24h stress treatment with 200µM PDTC in liquid medium and set 
relative to the untreated wild type. As expected, iron supplementation rescued the 
cytotoxic effect of PDTC in wild type and aft1∆ cells. In contrast, this effect was enhanced 
by excess zinc. Growth deficiency of aft1∆ cells on high excess zinc was rescued by iron 
supplementation. Strikingly, the combined effect of PDTC, iron and zinc was almost fully 
rescued in the aft1∆ background but not in the wild type strain (Fig. 18). These data 
suggest that in wild type cells, Aft1 also controls a yet unidentified cellular function 
counteracting zinc detoxification, at least in the presence of PDTC. 
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Figure 18: Cell viability assays to 
investigate the cross-talk between 
iron and zinc homeostasis. Wild 
type and aft1∆ were grown in 
liquid rich medium for 24h in the 
presence of PDTC, ZnSO4 and FeCl3, 
respectively. Afterwards, cells 
were plated on YPD and colony 
forming units (CFU) were 
determined after 2 days incubation 
at 30°C. Data are presented as 
percent CFU relative to the 
untreated wild type. Error bars 
represent ± 1 SD of three 
independent growth experiments; 
stars indicate significance of data 
valued by a student t-test.  
Functional screening of the EUROSCARF deletion collection 
Whole-genome transcriptome analysis undoubtedly yields important clues on changing 
gene expression levels. However, it will certainly miss all genes whose mRNA levels do not 
change during the PDTC response or inhibition by PDTC. This is particularly true for many 
signal transduction genes whose mRNA levels often do not significantly change. For 
example, kinase and phosphatase activites are often modulated by post-translational 
modifications (Theodosiou and Ashworth, 2002).  
Genes involved in vacuolar maintenance and transport confer PDTC resistance  
To identify genes that confer tolerance to PDTC, we screened the EUROSCARF deletion 
collection comprising of about 4800 haploid single knock-outs for altered growth in the 
presence of PDTC. Strains of the deletion collection were replicated on YPD and PDTC-
containing plates and grown at 30°C for 6 days inspecting growth every day. The 
previously identified PDTC hypersensitivity of aft1∆ was used as a control in the screening 
procedure. Serial dilutions of mutants showing increased PDTC sensitivity were manually 
respotted on several PDTC concentrations to confirm the phenotype.  
Among the about 4800 haploid single deletion strains, we identified 140 mutants as 
PDTC-sensitive. To categorize the PDTC-sensitive strains, we grouped them based on GO 
enrichment using the Saccharomyces cerevisiae Gene Database GO Termfinder (Fig. 19). 
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The main functional categories comprised of vacuolar acidification and vacuolar 
transport, protein modifications, mitochondrial organization and translation. 
Interestingly, many mutants related to membrane and vesicular trafficking and transport 
systems were also PDTC-sensitive [e.g., endosomal sorting complex required for transport 
(ESCRT); Golgi-associated retrograde protein complex (GARP); homotypic fusion and 
vacuole protein sorting (HOPS) complex]. Furthermore, mutants involved in the Rim101 
pH sensing pathway were PDTC-sensitive. As the Rim101 pathway is connected to the 
ESCRT complexes, this might explain the overlapping sensitivity phenotypes (Hayashi et 
al., 2005). 
 
p-value ≤ 0.05 
 
Figure 19: Functional screening identified 
processes mediating PDTC tolerance. The 4800 
deletion strains were screened on YPD and PDTC-
containing plates using a Singer RoTor HAD Robot. 
Growth was monitored every day for 6 days. 
Sensitive strains were verified by manual 
respotting and clustered into functional categories 
using the GO termfinder. The number of genes per 
category and the percentages of each category to 
the dataset are indicated.  
 
The vacuole and a functional V-ATPase are crucial during PDTC treatment 
Interestingly, mutants with impaired vacuolar trafficking and/or vacuolar proteins sorting, 
including VPS4, VPS8, VPS18, VPS33, VPS41, VPS45, as well as function and assembly of 
the V-ATPase such as VMA8, VMA22, VMA2, TFP1, VMA21, VMA6, and PPA1 were PDTC-
sensitive, suggesting that vacuolar function and maintenance is pivotal for cells 
responding to PDTC (Fig.20A,B).  The sensitivity phenotype of these mutants towards 
PDTC was reversed by iron supplementation (Fig. 20B). The vacuole is the main 
compartment for storage and detoxification, osmoregulation, ion and pH homeostasis 
and macromolecular degradation. Several trafficking complexes coordinate specific 
transport of proteins, ions, amino acids, polyphosphates and other substances (for review 
see (Kane, 2006)). Thus, components involved in vacuolar biogenesis and trafficking are 
essential under various stress conditions. For example, a functional V-ATPase is crucial for 
establishing a proton gradient across the membrane to ensure vacuolar import of ions, 
especially for zinc sequestration (Fig.20B, (MacDiarmid et al., 2002)).  
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Figure 20: A functional V-ATPase is pivotal for PDTC-tolerance. Mutants disrupting assembly or biogenesis of the V-
ATPase are PDTC-sensitive. A. Protein interaction network retrieved from the STRING database using the default 
parameters (von Mering et al., 2007). Strong associations are represented by thicker connecting lines, whereas thin 
lines correspond to weaker associations. B. Mutants lacking a functional V-ATPase or restricted in vacuolar assembly or 
biogenesis are PDTC as well as zinc-sensitive. Mutants required for vacuolar protein sorting, the V-ATPase and its 
assembly were assayed for growth on YPD plates and plates containing PDTC and/or FeCl3, ZnSO4. Serial dilutions of the 
indicated strains were spotted and growth was monitored after 2 days.  
‘Complex’ response to PDTC 
In detail, vacuolar trafficking to and from the vacuole involves about 60 actors referred to 
as vacuolar protein sorting (VPS) genes. Protein sorting into multivesicular bodies (MVB) 
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is a pathway required for protein degradation, secretion and recycling, including class E 
Vps proteins as the main components. Proteins targeted for degradation are mainly 
passed through the ESCRT complexes (for review see (Raiborg and Stenmark, 2009)). 
ESCRT I, II and III are well-conserved multisubunit complexes that are subsequently acting 
on endosomal membranes, driving internalization of protein cargo into MVBs. ESCRT I 
(Vps23, Vps28, Vps37) recognizes ubiquitinated protein cargo. ESCRT II (Vps22, Vps25, 
Vps36) acts downstream of ESCRT I and is required for recruiting membranes to ESCRT III. 
ESCRT III (Did4/Vps2, Vps20, Vps24, Snf7/Vps32) concentrates protein cargo into MVB 
particles and coordinates MVB accessory factors like Vps4 or Doa4. Vps4, an AAA-type 
ATPase, catalyzes dissociation of the ESCRT complexes. Interestingly, several mutants 
lacking components of the ESCRT complexes were PDTC-sensitive (Fig. 21B). 
Furthermore, we identified members of the CORVET, HOPS or GARP complexes as PDTC-
sensitive (Fig.21A,B). The CORVET (class c core vacuole/endosome tethering) complex 
acts in cooperation with Rab GTPases as an endosomal tethering complex (Peplowska et 
al., 2007). It captures endosomal vesicles and is required for transport between 
endosome and vacuole, as well as for endo-lysosomal biogenesis. The S. cerevisiae 
complex consists of Pep3, Pep5, Vps16, Vps3, Vps33, and Vps16. Mutants lacking the 
PEP3, PEP5, VPS33 or VPS8 genes are PDTC-hypersensitive. Some of them (VPS33, VPS16, 
PEP3, and PEP5) are part of the CORVET complex and the HOPS complex. The HOPS  
complex is involved in vacuolar protein sorting and vacuole fusion by binding to the 
vacuolar membrane (Wickner, 2010). In addition, we found mutants belonging to the 
GARP (Golgi-associated retrograde protein) complex, which is involved in recycling of 
proteins from endosomes to the late Golgi  to be PDTC-sensitive (Fig 21.A,B). 
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Figure 21: A. Several PDTC-sensitive mutants belong to protein complexes mainly involved in intracellular trafficking, 
which are indicated in the scheme. B. Deletion strains were re-tested by spotting serial dilutions on PDTC-containing 
plates.  C. Venn diagram showing overlaps between PDTC-sensitive mutants and screening data on excess cadmium, 
zinc and alkaline pH (p-value ≤ 0.05). 
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As several PDTC-sensitive mutants have been grouped as multidrug resistance genes or 
genes involved in environmental stress response, we compared our data set with 
published large scale screenings (Fig. 21.C). Genes referred to as multidrug resistance 
genes show increased sensitivity to a variety of stress conditions as analyzed in 
(Hillenmeyer et al., 2008). Remarkably, we found a significant overlap of PDTC-sensitive 
mutants and deletion strains sensitive to excess zinc, cadmium, oxidative stress, and 
alkaline pH ((Serrano et al., 2004; Outten et al., 2005; Pagani et al., 2007; Jin et al., 2008). 
For example, cadmium, nickel, zinc and alkaline pH interfere with the cellular iron 
homeostasis. The underlying mechanisms vary from decreased iron solubility at low pH, 
to competition at the level of uptake (zinc, cadmium) or competition at the level of iron-
regulated enzymes (nickel) (Serrano et al., 2004; Pagani et al., 2007; Ruotolo et al., 2008). 
Thus, PDTC tolerance requires several cellular processes and mechanisms to avoid 
collapse of cellular ion homeostasis. 
Aberrant vacuole morphology in response to PDTC 
Based on the involvement of genes encoding proteins implicated in vacuolar functions in 
response to PDTC, we asked whether PDTC caused changes in vacuolar morphology. Thus, 
we visualized the vacuole using three approaches. First, we took advantage of the W303-
1A yeast wild type strain auxotrophic for adenine, which accumulates an endogenous 
fluorescent adenine-derived dye in its vacuole (Weisman et al., 1987). Second, we 
investigated the vacuolar accumulation of cDCFDA in the absence or presence of PDTC. 
Third, we stained cells with FM4-64 to track endocytic intermediates from the plasma 
membrane to the vacuolar membrane (Vida and Emr, 1995).  
In general, yeast vacuoles are highly dynamic organelles that rapidly change their 
morphology throughout the cell cycle. Typically, a large round-shaped vacuole fragments 
and is then separated into mother and daughter cells during cell division (Wickner, 2002). 
In contrast, in PDTC-stressed cells, we observed highly fragmented vacuoles and multiple 
vesicles surrounding the “main” vacuole (Fig.22).  
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Figure 22: PDTC changes vacuolar morphology. W303-1A wild type cells were grown in rich medium to an OD600~0.6 
and stressed with 200µM PDTC for 2h or left untreated, washed and resuspended in 1xPBS. Pictures were taken using 
the Olympus Cell R Live Cell Image Microscope.  
cDCFDA is a colorless compound that passively diffuses into cells, where the diacetate 
groups are cleaved by intracellular esterases to yield the fluorescent 5-(and-6)-carboxy-
2',7'-dichlorofluorescein (cDCF), (Roberts et al., 1991), which accumulates in the yeast 
vacuole. Interestingly, PDTC inhibited vacuolar accumulation of cDCF resulting in diffuse 
cytoplasmic fluorescence (Fig.23). This inhibitory effect was independent whether cells 
were stained with cDCFDA before or after PDTC treatment for two hours, thus indicating 
impaired vacuolar functions and vacuolar trafficking in the presence of PDTC.  
Therefore, we aimed to investigate the endocytic trafficking to the vacuole by labeling the 
cells with FM4-64 tracking the fluorescent dye from the plasma membrane to vesicular 
intermediates and the vacuolar membrane. After staining, cells were washed, 
resuspended in rich medium and incubated with PDTC for the indicated time points or left 
untreated, washed and used for microscopy.  In untreated cells, FM4-64 accumulated in 
small punctate intermediate compartments in the cytoplasm after 15 minutes, which 
disappeared concomitantly with staining of the vacuolar membrane after 45 minutes. 
Finally, FM4-64 specifically stained the vacuolar membrane. In contrast, in PDTC-treated 
cells, FM4-64 trafficking was impaired, leading to diffuse stained structures at 15 and 45 
minutes and staining of multiple vesicles after two hours (Fig.24). Thus, PDTC caused 
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aberrant vacuolar morphology leading to fragmented vacuoles, comparable to the 
vacuolar maintenance of vps morphological group B mutants, e.g., vps17∆ (Vida and Emr, 
1995), or preventing vacuolar fusion of endocytic vesicles. 
 
Figure 23: PDTC inhibits vacuolar accumulation of cDCFDA. BY4741 wild type cells were either pre-labeled with cDCFDA 
for 30 minutes, washed and stressed with 200µM PDTC or first stressed with PDTC, washed and stained with cDCFDA 
afterwards. Cells were washed with 1x PBS and resuspended in PBS. Pictures were taken using the Olympus Cell R Live 
Cell Imaging Microscope. 
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Figure 24: PDTC causes vacuolar fragmentation. Cells were labeled with FM4-64 for 15 minutes, washed, resuspended 
in rich medium and stressed with 200µM PDTC or left untreated. At the indicated timepoints, cells were intensely 
washed, and pictures were taken using the Olympus Cell R Live Cell Imaging Unit. 
Mutants of pH-responsive genes and ESCRT complexes are PDTC-sensitive 
Additional to vacuolar acidification, another important function of the vacuole is the 
maintenance of the intracellular pH in general. Changes in environmental pH are mainly 
interpreted by the Rim101 transcription factor. Activation of Rim101 depends on a 
proteolytic processing cascade that includes various components. Rim9, Rim21 (the pH 
sensors) and Rim8 are required for complex formation of Rim20-(Vps20-Snf7)-Rim13. 
Rim20 is the adaptor bringing the protease Rim13 into close proximity to its substrate 
Rim101. Notably, formation of the cleavage complex requires components of the ESCRT 
complexes, thereby linking multivesicular body sorting to alkaline pH response (Hayashi et 
al., 2005). This link might be dependent on the requirement for a functional proton 
gradient during MVB sorting and its malfunction when disrupted. Under these conditions 
formation of the Rim101-activation complex would be promoted (Fig. 25) as proposed in 
(Hayashi et al., 2005).  
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Figure 25: Proteolytic activation of Rim101 requires an activation cascade including components of the ESCRT 
complexes. Rim101 processing occurs at the endosomal membrane elicited by the Rim13 protease. Active Rim101 is a 
negative regulator of other transcription factors like Nrg1 or Smp1.  
PDTC inhibits Rim101 processing 
As the Rim101 pathway was required to cope with PDTC stress conditions, we 
investigated Rim101 activation in PDTC-treated cells. Strikingly, immunoblotting showed 
that PDTC inhibited proteolytic processing and thus activation of Rim101 in the AMP1604 
strain carrying a genomic integrated Rim101-HA2 construct in a dose-dependent manner 
and independent of pH (Fig.26B,C). The processing was comparable to the cleavage 
pattern in the constitutive inactive control strain AMP1603 (Rim101-HA2, rim13∆) lacking 
the protease Rim13 (Li and Mitchell, 1997).  
Although growth defects of Rim101 pathway mutants were rescued by iron 
supplementation, the processing defect of Rim101 in the presence of PDTC remained 
unchanged. Hence, we investigated whether this inhibition required metal ions by 
comparing cell extracts of cells stressed in PBS with PDTC, ZnSO4, FeCl3, and combinations 
of those (Fig.26D). In PBS, PDTC failed to inhibit Rim101 cleavage. Zinc supplementation in 
combination with PDTC restored the inhibitory effect, whereas iron had no effect in 
Rim101 processing (Fig.26D). Neither magnesium, calcium or copper supplementation 
affected Rim101 processing in the presence of PDTC (data not shown). As a control for 
constitutive active Rim101, we used a strain expressing a mutated form of Rim101 
(Rim101-HA2-531; AMP1600). 
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Figure 26: PDTC blocks Rim101 processing. A. RIM101 pathway mutants and ESCRT deletion strains are PDTC-sensitive. 
Wild type and deletion strains were spotted in serial dilutions on YPD and PDTC-containing plates and grown at 30°C for 
2 days. B. PDTC inhibits Rim101 cleavage at various pH. AMP1604 expresses a HA-tagged version of Rim101. AMP1603 
was used as a constitutively inactive control strain, carrying the Rim101-HA2 construct, but lacking the Rim13 protease. 
AMP1600 carries a mutation that constitutively activates Rim101-HA2. AMP1605 and AMP1606 were used as untagged 
negative controls. C. PDTC-induced inhibition of Rim101-processing is dose-dependent. D. Inhibition of Rim101 
processing by PDTC is strictly dependent on zinc ions in the medium. Cells were stressed in 1xPBS and supplemented 
with 200µM PDTC, 100µM ZnSO4 or 1mM FeCl3, respectively.  
Thus, PDTC-induced inhibition of Rim101 cleavage strictly required zinc ions in the 
medium. Taken together, our data identified a potential host cell drug target for the 
antiviral drug PDTC. PDTC is to the best of our knowledge the first known small-molecule 
inhibitor of Rim101 processing in yeast, requiring zinc ions for exerting the inhibitory 
action.     
As vacuolar functions and zinc storage during PDTC response were tightly connected, we 
aimed to identify an additional putative link to the Rim101 pathway. Therefore, we 
compared growth phenotypes and vacuolar morphology of single and double deletion 
strains lacking components of the RIM101 pathway and ESCRT complex in the presence 
and absence of PDTC. By determining the inhibitory concentrations of PDTC, we observed 
a synergistic effect in the rim101∆ vps4∆ double deletion strain, whereas a rim9∆ vps4∆ 
strain showed the same sensitivity as the single deletion strains (Fig. 27.B). Therefore, we 
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focused on the impact of Vps4, an AAA-type ATPase involved in MVB sorting and 
disassembly of the ESCRT III complex (Davies et al., 2009), on the Rim101 pathway in 
response to PDTC.   
A 
 
 
B 
 
 
Yeast strains  PDTC 
IC50  
wild type  72  
rim101∆  41  
vps4∆  53  
rim101∆ vps4∆  28  
rim9∆  40 
rim9∆ vps4∆  43  
Figure 27: A. Schematic presentation of components involved in the Rim101 processing cascade. B.  We performed growth 
curves in the presence of various PDTC concentrations [µM] and determined the inhibitory concentrations of PDTC in the 
wild type and different deletion strains. 
 
Mutants lacking Vps4 showed weak vacuolar membrane staining, but another intensely 
stained membrane-associated structure, comparable to vps morphological group E 
mutants (Vida and Emr, 1995). The punctate structure might be due to the failure of cells 
lacking Vps4 to disassemble the ESCRT III complex. Interestingly, deletion of Vps4 
prevented vacuolar fragmentation in response to PDTC (Fig.28). Vacuolar staining in 
rim101∆ and aft1∆ cells was comparable to the wild type vacuolar morphology. However, 
in PDTC-treated rim101∆ cells, the dye accumulated in punctate structures rather than in 
fragmented vacuoles. In the double deletion strain, lacking both, Vps4 and Rim101, FM4-
64 stained a membrane-enclosed structure similar to the Vps4 single deletion strain, 
which persisted during PDTC treatment. Thus, additional deletion of Vps4 suppressed the 
effect of the Rim101 deletion in response to PDTC. Hence, Vps4 might be an important 
player implicated in vacuolar trafficking and in the PDTC-dependent inhibition of Rim101 
activation by PDTC. 
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Figure 28: FM4-64 staining 
in wild type, rim101∆, 
vps4∆, and rim101∆ vps4∆ 
in response to PDTC.  Cells 
were grown in YPD, 
stained with FM4-64 for 15 
minutes, washed and 
resuspended in YPD. Cells 
were either stressed with 
PDTC for 2 hours or left 
untreated, washed and 
used for microscopy.   
 
 
Deletion of Vps4 inhibited vacuolar fragmentation or fusion in response to PDTC. A similar 
phenotype has been observed in response to high osmotic stress. High salt 
concentrations cause vacuolar fragmentation, which is restored by disruption of the V-
ATPase (Bonangelino et al., 2002; Baars et al., 2007). Thus, we asked whether ATPase 
activity was required to prevent changes in vacuolar morphology upon PDTC treatment. 
Consequently, we compared vacuolar morphology of cells lacking either Vps4, Vma2 or 
Stp22 to vacuoles in wild type cells (Fig.29). Deletion of Vma2, encoding the B subunit of 
the V-ATPase, results in the loss of vacuolar acidification (Kane, 2006). Stp22 is a 
component of the ESCRT-I complex involved in vacuolar protein sorting into the 
endosome (Katzmann et al., 2001).  In the wild type and in the stp22∆ strain, we observed 
regular vacuolar morphology as in untreated cells, which changed to multiple small 
vesicles upon PDTC treatment. In contrast, lack of the Vps4 ATPase activity at the 
endosomal membrane as well as vacuolar ATPase activity due to deletion of Vma2, 
resulted in large single vacuoles instead of multiple smaller vesicles in response to PDTC.  
Thus, as proton translocation by the V-ATPase is essential for vacuole fragmentation 
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(Baars et al., 2007), the Vps4 ATPase activity might as well be implicated in this process, 
at least in response to PDTC.  
 
 
Figure 29: Lack of Vma2 and 
Vps4 inhibit vacuolar frag-
mentation in response to 
PDTC. Cells were grown to an 
OD600 ~0.6, labeled with FM4-
64 for 15 minutes, washed 
with PBS, resuspended in 
YPD. After stressing the cells 
with PDTC for 2 hours, 
untreated control cells as well 
as PDTC-treated cells were 
washed with PBS and used for 
microscopy. Pictures were 
taken using the Olympus Cell 
R Live Cell Imaging Unit.  
 
 
 
Moreover, we investigated the effect of genetically deleting Vps4, Rim101, as well as both 
on the transcriptional profile in untreated and PDTC-treated cells. As in the wild type, 
PDTC strongly affected the iron metabolism by activating genes of the Aft1-dependent 
iron regulon and stress responsive genes in these deletion strains (Fig.30). Rim101, a 
repressor of Nrg1 and Smp1, also regulates cell wall-related genes (e.g., CWP1, KTR5, 
YJR061W), as well as genes involved in the mating response (e.g., AGA1, FUS1, BAR1, 
MFA1). Interestingly, deletion of Rim101 already modulates iron and zinc transport genes 
(Fig.30, (Lamb and Mitchell, 2003)). In detail, lack of Rim101 induced genes involved in 
siderophore iron transport (ARN1, ARN3, FIT2, FIT3), as well as the high-affinity iron 
uptake system (FET3, FTR1), (Table 6). However, the endosomal ferric enterobactin 
transporter gene ARN4 was downregulated in rim101∆ cells, whereas the high affinity 
zinc transporter gene ZRT1 was induced. Strikingly, PDTC treatment reversed the effect by 
inducing ARN4 and downregulating ZRT1. The activation of iron transport genes the 
absence of Rim101 indicates either changed iron availability upon varying pH levels or a 
potential cross-regulation with the iron-responsive transcription factor Aft1. Indeed, 
Rim101 and Aft1 have been recently suggested to act in parallel, since double deletion of 
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Rim101 and Aft1 causes synthetic sickness, which is ameliorated by iron supplementation 
(Berthelet et al., 2010).  
Gene 
name 
fold wt vs 
wt PDTC 
fold 
rim101∆ 
vs 
rim101∆  
PDTC 
fold 
rim101∆ vs 
wt 
Description 
FIT2  13,74 9,65 2,30 Mannoprotein that is incorporated into the cell wall via a glycosylphosphatidylinositol GPI 
anchor involved in the retention of siderophore-iron in the cell wall  
FIT3  12,21 12,30 3,05 Mannoprotein that is incorporated into the cell wall via a glycosylphosphatidylinositol GPI 
anchor involved in the retention of siderophore-iron in the cell wall  
FIT1  7,89 3,81 1,10 Mannoprotein that is incorporated into the cell wall via a glycosylphosphatidylinositol GPI 
anchor involved in the retention of siderophore-iron in the cell wall  
ARN1  25,99 5,90 8,69 
Transporter member of the ARN family of transporters that specifically recognize 
siderophore-iron chelates; responsible for uptake of iron bound to ferrirubin ferrirhodin 
and related siderophores  
ARN2| 
TAF1  
19,70 11,55 1,64 Transporter member of the ARN family of transporters that specifically recognize 
siderophore-iron chelates; responsible for uptake of iron bound to the siderophore 
triacetylfusarinine C  
SIT1| 
ARN3  
9,92 1,80 3,71 
Ferrioxamine B transporter member of the ARN family of transporters that specifically 
recognize siderophore-iron chelates; transcription is induced during iron deprivation and 
diauxic shift; potentially phosphorylated by Cdc28p  
ENB1| 
ARN4  
5,66 6,82 -2,87 
Endosomal ferric enterobactin transporter expressed under conditions of iron deprivation; 
member of the major facilitator superfamily; expression is regulated by Rcs1p and affected 
by chloroquine treatment  
FET3  7,31 2,06 3,34 Ferro-O2-oxidoreductase required for high-affinity iron uptake and involved in mediating 
resistance to copper ion toxicity belongs to class of integral membrane multicopper 
oxidases  
FTH1  2,69 2,51 1,57 
Putative high affinity iron transporter involved in transport of intravacuolar stores of iron; 
forms complex with Fet5p; expression is regulated by iron; proposed to play indirect role in 
endocytosis  
FTR1  4,96 1,89 2,03 High affinity iron permease involved in the transport of iron across the plasma membrane; 
forms complex with Fet3p; expression is regulated by iron  
FRE3  4,53 2,19 1,67 Ferric reductase reduces siderophore-bound iron prior to uptake by transporters; 
expression induced by low iron levels  
FRE2  3,89 1,80 1,89 
Ferric reductase and cupric reductase reduces siderophore-bound iron and oxidized copper 
prior to uptake by transporters; expression induced by low iron levels but not by low 
copper levels 
 
ZRT1 -3,51 -9,19 4,92 
High-affinity zinc transporter of the plasma membrane responsible for the majority of zinc 
uptake; transcription is induced under low-zinc conditions by the Zap1p transcription 
factor 
ZRT2 -4,82 -5,03 1,27 
Low-affinity zinc transporter of the plasma membrane; transcription is induced under low-
zinc conditions by the Zap1p transcription factor 
IZH1 -1,45 -2,17 -1,47 
Membrane protein involved in zinc metabolism member of the four-protein IZH family; 
transcription is regulated directly by Zap1p expression induced by zinc deficiency and fatty 
acids; deletion increases sensitivity to elevated zinc 
ZRC1|O
SR1 -1,72 -2,60 1,58 
Vacuolar membrane zinc transporter transports zinc from the cytosol into the vacuole for 
storage; also has a role in resistance to zinc shock resulting from a sudden influx of zinc 
into the cytoplasm 
COT1 2,91 3,14 1,04 
Vacuolar transporter that mediates zinc transport into the vacuole; overexpression confers 
resistance to cobalt and rhodium 
Table 6: Genes related to iron or zinc transport that were differentially regulated in the rim101∆ strain compared to its 
wild type, as well as in response to PDTC. Upregulated genes (fold-change ≥ 2) are shaded in red, downregulated genes 
(fold-change ≤ -2) in green, (p-value ≤ 0.05).  
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rim101∆ vs wild type 
 
 
 
Figure 30: Functional 
categories of genes 
differentially expressed in 
a rim101∆ strain 
compared to its 
corresponding wild type. 
Lack of Rim101 causes 
activation of the Aft1-
dependent iron regulon 
as well as downregulation 
of sporulation-related 
genes.  
 
 
Lack of Vps4 caused differential expression of genes mainly involved in amino acid 
metabolic process. The transcriptional profile of the rim101∆ vps4∆ double deletion strain 
was highly similar to the rim101∆ transcriptome. In the vps4∆ strain, PDTC treatment 
caused significant induction of genes related to the proteasomal turnover (Fig.31A), thus 
indicating a need for enhanced proteolytic activity if the ATPase activity of Vps4 at the 
endosomal membrane is abolished. Moreover, a strain lacking the proteasomal subunits 
Pre1 and Pre2 showed increased PDTC-sensitivity (Fig.31B), (Heinemeyer et al., 1993). 
Hence, Vps4 might be involved in Rim101 processing because of a changed proteasomal 
activity in response to PDTC.  
A 
 
Figure 31: A. Venn diagramm 
of PDTC-regulated genes in the 
wild type, rim101∆ and vps4∆ 
strain. Strikingly, we identified 
proteasome-related genes 
upregulated specifically in the 
vps4∆ strain in response to 
PDTC. B. Lack of proteasomal 
subunits caused PDTC-
sensitivity. Mutants lacking 
components of the 
proteasome were spotted in 
serial dilutions on YPD and 
PDTC-containing plates 
monitoring growth after two 
days.  
 
B
              
                    YPD                            15µM PDTC                      20µM PDTC 
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To further investigate the impact of the Rim101 pathway on PDTC-induced disturbance of 
metal ion homeostasis, we used reporter strains expressing citrine under the control of 
the ARN4 promoter. ARN4 is downregulated in a rim101∆ strain, hence positively 
regulated by Rim101 in the wild type situation (Table 6, (Lamb and Mitchell, 2003)). 
Moreover, ARN4 encoding the enterobactin siderophore iron transporter is a known 
target of Aft1 (Yamaguchi-Iwai et al., 1996; Philpott and Protchenko, 2008). As Rim101 is 
activated upon alkaline pH stress, we performed experiments at pH 4, 6.5, and 9 with or 
without supplemented PDTC monitoring reporter fluorescence by microscopy (Fig.32A). 
In a control experiment, we verified that the fluorescent signal of citrine was stable and 
pH-independent using the STL1-citrine promoter-tagged strain (Fig. 32C), a reporter for 
the high osmolarity glycerol (HOG)-pathway inducible with salt stress. As expected, 
alkaline pH activated the ARN4 promoter resulting in an increased fluorescent signal that 
was quantified by measuring average grey values of fluorescent cells (Fig.32B). 
Furthermore, PDTC treatment induced ARN4 promoter activity at pH 4 and 6.5, which was 
additionally increased in combination with alkaline pH, leading to a contradictory 
observation. On the one hand, PDTC treatment induced ARN4 expression, whereas on the 
other hand, PDTC inhibited cleavage of Rim101 in a zinc-dependent manner. Chromatin IP 
experiments investigating the Rim101 association state to various promoters revealed 
that Rim101 might only indirectly activate ARN4 (Lamb and Mitchell, 2003). In agreement, 
deletion of Rim101 weakened the fluorescent signal, but the ARN4 promoter was still 
activated upon alkaline pH and PDTC treatment. In context with the previously reported 
role of Rim101 in ion tolerance and the suggestion that Rim101 and Aft1 act in parallel, 
we expected that deletion of Aft1 prevented promoter activation of ARN4. Indeed, the 
promoter activity of ARN4 was completely abolished in the aft1∆ strain, indicating that 
ARN4 expression in response to PDTC is Aft1-dependent. However, due to an overall 
decrease in the fluorescence intensity in the rim101∆ strain (Fig.32A,B), our results might 
indicate a potential additive effect of Rim101 and Aft1.   
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Figure 32: PDTC activates the ARN4 promoter. A. Microscopy of ARN4-Cit promoter activity in the wild type, rim101∆, 
and aft1∆ strain. Cells were grown in YPD adjusted to pH 4, 6.5 or 9, stressed with 200µM PDTC for 2h or left untreated. 
After extensive washing in PBS cells, were used for microscopy. Pictures were taken using the Olympus Cell R Live Cell 
Imaging Unit.  B. Quantification of the fluorescent signal by measuring average grey values. Average values of at least 15 
cells per strain are shown. C. STL1-Cit was used as control to ensure pH-independency of citrine fluorescence intensity. 
Therefore, we grew STL1-Cit at pH 4, 6.5, and 8.5. Activation of the STL1 promoter was induced by 0.5M NaCl for 2h.  
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As PDTC caused inhibition of Rim101 processing in a zinc-dependent manner, and iron 
supplementation rescued the PDTC-caused growth defect of the Rim101 pathway and 
ESCRT complex deletion mutants, we investigated the effect of iron and zinc on ARN4-
promoter activity. Activation of the ARN4 promoter was dose-dependent as shown by 
FACS analysis (Fig.33A). In agreement with our suggested cross-talk between iron and zinc 
regulons, supplementing Zn++ also activated the ARN4 promoter (Fig.33B). Iron 
supplementation inhibited the basal expression level of ARN4-citrine in rich medium, but 
failed to reverse PDTC-induced activation in the wild type and the rim101∆ strain 
(Fig.33C,D).  
A 
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Figure 33: Effect of iron and zinc supplementation on ARN4 promoter activity. Wild type cells carrying the ARN4-Cit 
reporter construct were grown to an OD600~ 0.6 and stressed for 2 hours with various concentrations of PDTC, FeCl3 and 
ZnSO4, respectively, washed with PBS and fluorescence was monitored using a FACS Calibur. A. PDTC caused dose-
dependent activation of ARN4-Cit. B. In agreement with the proposed cross-talk between zinc and iron regulon, zinc 
supplementation induced ARN4 promoter activity.  C. Iron supplementation abolished the basal activity of the ARN4 
promoter, but failed to compensate or decrease its activity in response to PDTC. D. In a rim101∆ strain carrying the 
ARN4-Cit promoter reporter construct, we observed the same activity pattern as in the wild type, however concomitant 
with an overall decrease in fluorescence.  
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Furthermore, we tested whether other stress conditions activated the reporter. In 
summary, the ARN4 promoter was activated upon alkaline pH, PDTC, high excess zinc and 
MMS. Contrary, cell wall stress like SDS, calcofluor white and zymolyase failed to activate 
the ARN4 promoter (Fig.34). Interestingly, PDTC activated the MLP1 promoter, which was 
used as a reporter for the PKC pathway. A MLP1-citrine reporter strain lacking the MAPK 
Slt2 was used as control. Rim101 is a regulator of cell wall stress, thus PDTC might exert 
effects on the Rim101 pathway that are connected to the PKC pathway signaling. 
 
Figure 34: FACS analysis of ARN4-Cit. Upper left panel, PDTC caused dose-dependent activation of the ARN4 
promoter. Upper right panel, the ARN4 promoter was activated upon excess zinc, MMS treatment and PDTC. Lower 
left, cell wall stress failed to activate the ARN4 promoter. Lower right, the MLP1 promoter was activated in response 
to PDTC.  
In a nutshell, we propose that PDTC causes an immediate zinc influx into yeast cells, 
storage of the excess zinc in the vacuole and a zinc-dependent disruption of the iron 
homeostasis thereby activating the iron-dependent transcription factor Aft1 and 
interference with the Rim101 pathway. Strikingly, PDTC inhibited activation of Rim101 in 
a zinc-dependent manner. PDTC is to the best of our knowledge the first known small-
molecule inhibitor of Rim101 processing in yeast, requiring zinc ions for exerting the 
inhibitory action. Furthermore, PDTC is known to inhibit cleavage of the eukaryotic 
translation initiation factor eIF4G (Gaudernak et al., 2002), as well as activation the 
transcription factor nuclear factor kappa B (Meyer et al., 1993). Taken together, our data 
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identify a potential host cell drug target for the antiviral drug PDTC, thereby linking our 
data found in yeast to the function of PDTC in higher eukaryotes. In essence, the results 
underscore the important role of cellular trafficking, ion homeostasis and the 
involvement of multiple pathways in response to stress.   
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7. DISCUSSION 
In this study, we take advantage of a yeast genetic approach combining transcriptional 
profiling and genome-wide phenotypic screenings to identify potential cellular targets of 
the antiviral compound pyrrolidine dithiocarbamate (PDTC). The transcriptional profile 
indicates disturbance of metal ion homeostasis, including a strong induction of the iron 
regulon as well as regulation of zinc transport. The screening of the yeast gene deletion 
collection for mutants with increased PDTC susceptibility identifies numerous genes 
essential for PDTC tolerance, including those required for vacuolar functions and 
transport complexes. In more detail, this study provides data showing: 
• PDTC has antifungal activity by inhibiting growth of various yeast species. 
• The transcriptional profile, comprising of about 200 differentially expressed genes, 
reveals strong similarities to the transcriptional remodeling upon iron deprivation. 
• The low-iron sensing genes including the iron-responsive transcription factor Aft1 
as well as components of mitochondrial iron-sulfur complexes and glutaredoxins 
refer PDTC resistance. 
• Iron supplementation rescues the PDTC-induced growth defect and abolishes 
activation of the iron regulon.  
• PDTC, a zinc ionophore, causes immediate zinc influx into cells and changes the 
transcript levels of cellular zinc transporters driving vacuolar sequestration. 
• Viability assays investigating the supplementary effect of zinc and iron on PDTC-
treated cells indicate a cross-regulatory network linking zinc and iron homeostasis.  
• Functionally screening of the yeast deletion collection identifies about 130 genes 
as PDTC-sensitive. The corresponding proteins are mainly involved in vacuolar 
assembly, biogenesis and vesicular and vacuolar transport and trafficking. 
• PDTC causes ATPase-dependent vacuole fragmentation or a defect in fusion. 
• RIM101 pathway and ESCRT complex mutants are hypersensitive to PDTC. 
Strikingly, PDTC inhibits proteolytic cleavage of the Rim101 transcription factor.  
Taken together, our data demonstrate that several cellular processes and regulatory 
networks tightly act together forming a complex and interdependent response to PDTC.  
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PDTC disrupts ion homeostasis causing massive cellular remodeling  
Sudden stress conditions require quick responses and changes of yeast cells by activating 
signaling cascades, as well as initiating a stress-dependent gene expression program to 
adapt to changes in their environment. This adaptation process involves a precisely 
coordinated program of specific and general stress response mechanisms to promote a 
preferably positive outcome for cells, thus being cell survival. The main requirement 
following stress is to save energy. Thus, many genes involved in protein synthesis and 
cellular growth are shut down. Simultaneously, cells respond specifically to a certain 
stress inducing a genomic response dedicated to adaptation. Thereby, cells build up an 
additive response to many stresses which might strengthen the adaptation to the new 
stress environment (Gasch et al., 2000; Gasch and Werner-Washburne, 2002).  
PDTC treatment induces transcriptional changes of more than 2oo genes including 
general stress response genes but also specific adaptations. The general stress response 
genes are involved in growth related processes, RNA metabolism and repression of 
ribosomal protein genes. In contrast, the specific response indicates massive disturbance 
of metal ion homeostasis, including a strong induction of the Aft1-dependent iron 
regulon, as well as regulation of zinc homeostasis.  
Activation of the iron regulon leads to induction of the iron uptake machinery, as well as 
several metabolic changes, including downregulation of various factors to switch to less 
iron-consuming pathways. Possibilities for activation of the iron regulon are i) inhibition 
of iron uptake, ii) interference with iron sensing, iii) competition with iron for protein 
binding sites, iiii) changes in iron utilization, iiiii) variations in copper availability. Beside 
iron deprivation, the iron regulon is activated by various stress conditions, ranging from 
changes in ion concentrations caused by excess zinc (Pagani et al., 2007) or cobalt (Stadler 
and Schweyen, 2002), to physiological changes induced by lactic or acetic acid (Kawahata 
et al., 2006), as well as glucose depletion occurring during the diauxic shift (Haurie et al., 
2003). Moreover, drugs such as the fungicide mancozeb (Santos et al., 2009), chloroquine 
(Emerson et al., 2002), hydroxyurea (Dubacq et al., 2006), or the anticancer drug cisplatin 
(Kimura et al., 2007) trigger activation of the iron regulon.  
Apart from environmental changes, genetic manipulations identified components whose 
deletion activates the iron regulon: Depletion of the mitochondrial ISC machinery 
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constitutively activates Aft1-dependent transcription (Hausmann et al., 2008). 
Interestingly, deletion of the mediator tail component SSN3 (also referred to as CDK8 or 
SRB10) or inhibition of Med2 phosphorylation upregulates Aft1-dependent genes, linking 
the general transcription coactivator machinery to the iron-specific signaling cascade (van 
de Peppel et al., 2005). Furthermore, the pH-responsive transcriptional regulator Rim101 
has been implicated in iron transport (Lamb and Mitchell, 2003; Berthelet et al., 2010), 
because iron transport genes are differentially expressed in a rim101∆ strain. Recently, 
iron-dependent down-regulation of genes at the level of regulatory metabolites provides 
another layer of adaptation (Ihrig et al., 2009). 
Like PDTC, the fungizide mancozeb is an ethylene-bis-dithiocarbamate that complexes 
manganese and zinc and also activates the iron regulon. Proteomic analysis suggests that 
mancozeb induces oxidative stress response genes, as well as genes involved in 
translation and protein degradation (Santos et al., 2009). An important property of 
dithiocarbamates is their metal-chelating activity, thereby forming lipophilic 
dithiocarbamate-metal complexes able to enter cells. In detail, PDTC shows the highest 
affinity to zinc, although also chelating other ions such as copper or iron (Krenn et al., 
2005). Thus, PDTC or dithiocarbamates in general might complex significant amounts of 
extracellular iron or disturb the intracellular copper homeostasis activating the iron 
regulon. Moreover, PDTC causes zinc influx (Fig.17) and changes transcript levels of genes 
encoding zinc transporters (Fig.14).  
Mutants sensitive to PDTC were also essential during excess zinc conditions (Fig.21). Thus, 
by changing the delicate ion balance in the cell, excess ions alter enzyme activities and 
metabolic functions. Since high zinc levels provoke activation of the iron regulon (Pagani 
et al., 2007), PDTC-induced activation of the iron regulon might be an indirect effect due 
to increased intracellular zinc levels. This hypothesis is supported by the observation that 
the induction of the iron-responsive genes is delayed when compared to the 
transcriptional regulation of zinc transporters (Fig.14). 
Metal ion homeostasis is a delicate system precisely monitored and controlled in yeast. 
Since diverse stimuli provoke activation of the iron regulon, interconnections between 
responses to different ions have been proposed due to overlapping regulatory networks. 
For instance, iron and copper are tightly connected as copper is the essential cofactor in 
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the high-affinity iron permease complex Ftr1/Fet3 (Gross et al., 2000). Consequently, 
inhibition of copper uptake results in reduced iron uptake. Fet3 is a multicopper 
ferroxidase whose deletion renders cells highly sensitive to transition metal stress, 
alkaline pH and it causes impaired growth on ethanol and galactose/raffinose (Rutherford 
and Bird, 2004). Moreover, relationships between cobalt-iron (Stadler and Schweyen, 
2002) and zinc-iron (Santos et al., 2003; Pagani et al., 2007) were identified. Notably, the 
vacuolar transporter Cot1, normally involved in zinc transport into the vacuole and cobalt 
accumulation, is induced under iron limitation (Li and Kaplan, 1998). High excess zinc 
disrupts iron homeostasis by altering the intracellular iron content and iron-dependent 
enzyme activities such as cytochrome c oxidase, and aconitase, linking zinc, iron and 
iron/sulfur cluster (ISC) metabolism (Santos et al., 2003; Pagani et al., 2007). Studies of 
the yeast ionome, as well as the interplay of alkaline pH stress and ion metabolism 
confirm a tight and dynamic co-regulation at genomic levels (Serrano et al., 2002; Serrano 
et al., 2004; Eide et al., 2005). For instance, at alkaline pH conditions, copper loading of 
Fet3 is impaired due to reduced bioavailability of iron. 
Here, we show the impact of various metal ions in combination with PDTC on the cellular 
ion homeostasis. For example, the aft1∆ strain is sensitive to nickel, calcium, manganese, 
cobalt, zinc and alkaline pH (Fig.12, (Stadler and Schweyen, 2002; Serrano et al., 2004)). 
These growth defects can be compensated by the supplementation of high iron to the 
growth media, thereby increasing intracellular iron concentrations. In the case of glucose 
exhaustion, iron addition fails to rescue the growth defect, indicating two independent 
signals activating the iron regulon (Haurie et al., 2003). In cells lacking the AFT1 gene, the 
copper-binding metallothionein gene CUP1 is highly induced by PDTC treatment, which 
might explain the increased copper-tolerance of the mutant when compared to the wild 
type (Fig.13). Consistent with the fact that PDTC is a zinc ionophore mediating zinc influx 
into HeLa cells (Krenn et al., 2005), as well as into yeast cells, it triggers changes in 
transcript levels due to the intracellular ionic imbalance.   
Genes involved in vacuolar maintenance & traffic confer PDTC tolerance  
By functionally screening the yeast gene deletion collection for PDTC hypersensitivity, we 
identify genes encoding proteins involved in vacuolar functions and transport complexes 
that are also essential under other stress conditions such as alkaline pH and excess zinc 
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(Fig.21). Recently, a chemical genomic profile of yeast has uncovered a set of genes 
required for a variety of stress conditions classified as multidrug resistance (MDR) genes, 
encompassing functional categories such as endosomal transport, vacuolar degradation, 
and transcription (Hillenmeyer et al., 2008). In context with their cellular processes, these 
factors build a complex system of endocytosis and vacuolar degradation, as well as 
synthesis of new proteins to adapt corresponding to changing conditions.  
As the vacuole is the main site for intracellular detoxification, storage and maintenance of 
the cellular pH, lack of vacuolar biogenesis genes results in sensitivity phenotypes to 
various stress conditions. For example, vacuolar acidification, which is driven by a proton 
gradient across the vacuolar membrane through the V-ATPase, is required for vacuolar 
import of ions, especially for zinc sequestration (MacDiarmid et al., 2002). The immense 
zinc storage capacity of the yeast vacuole is required to cope with PDTC-induced influx of 
zinc.  
Maintenance of vacuolar functions and assembly also requires a complex regulation 
network modulating trafficking to and away from the vacuole. Thus, the vacuole is a 
highly dynamic structure undergoing constant fission and fusion throughout the cell cycle. 
Shape, size and numbers ranging from 1-5 vacuoles per cell vary dependent on the cell 
cycle state and in due course on adaptations in response to environmental changes. Due 
to constant fission and fusion, vacuoles are connected to endosomal transport and 
trafficking complexes permanently coordinating transport of proteins, amino acids and 
other substances (Wickner, 2002; Kane, 2006).  As shown by microscopy, PDTC treatment 
causes aberrant vacuolar morphology (Fig.22) and inhibition of vacuolar accumulation of 
the fluorescent dye cDCF (Fig.23). By tracking the fluorescent dye FM4-64 from the 
plasma membrane along the endocytic pathway to the vacuolar membrane, we observe 
vacuolar fragmentation into multiple small vesicles (Fig.24). Fragmentation of vacuoles 
implies a defect in membrane fusion. For instance, vacuoles fragment into multiple 
vesicles due to disruption of microtubule polymerization in response to nocodazole 
treatment (Guthrie and Wickner, 1988). Furthermore, high osmotic stress also causes 
vacuolar fragmentation, a phenotype, which strictly requires proton translocation and 
that is inhibited by disruption of the V-ATPase (Bonangelino et al., 2002; Baars et al., 
2007). Strikingly, mutants lacking Vps4 or Vma2 display large single vacuoles instead of 
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the vacuolar fragmentation phenotype in response to PDTC (Fig.29). Thus, lack of either 
the Vps4 ATPase activity at the endosomal membrane or the V-ATpase activity at the 
vacuole itself reinstates normal vacuolar morphology, indicating that vacuolar 
fragmentation is dependent on either ATPase activity. This observation is consistent with 
the suggested regulatory function of the V-ATPase in vacuolar morphology and 
membrane dynamics (Baars et al., 2007). Thus, Vps4 ATPase activity might as well be 
implicated in this process, at least in response to PDTC. Proton translocation activity, 
establishing an electrochemical gradient across the membranes, is crucial for pH 
regulation, ion transport and intracellular flux. Fragmentation of vacuoles changes the 
surface-volume ratio, thus providing a complex regulatory mechanism, which, for 
instance, avoids vacuolar lysis due to water loss during high osmotic shock conditions 
(Bonangelino et al., 2002). 
Moreover, deletion of the copper-zinc superoxide dismutase Sod1 causes vacuolar 
fragmentation in yeast, which is oxygen-mediated and ameliorated by iron starvation, 
indicating that oxidative stress also changes iron homeostasis (Corson et al., 1999). 
However, deletion of Sod1 leads to an increased intracellular iron content compared to its 
wild type, as well as induction of the high-affinity iron uptake gene FET3, indicating iron 
limitation in the sod1∆ strain (De Freitas et al., 2000).  Interestingly, the SOD1 gene is 
induced in response to PDTC, and its deletion renders cells PDTC-sensitive, a growth 
defect which cannot be restored by iron supplementation (Fig.15). However, this failure 
might be due to an increase in iron demand of the sod1∆ mutant per se and its 
involvement in zinc detoxification as zinc-binding protein (De Freitas et al., 2000; Tarhan 
et al., 2007). In this case, PDTC would worsen the lack of iron availability, thereby 
increasing the sensitivity of the sod1∆ strain.  
By disrupting metal ion homeostasis, PDTC induces a complex regulatory network, 
ranging from endocytic traffic to protein synthesis and degradation to vacuolar functions. 
ATPase activity establishes an electrochemical gradient, which might influence pH levels 
or pH-dependent processes such as transport of amino acids and ions across the vacuolar 
membrane (Baars et al., 2007). The endocytic pathway, including the endosomal sorting 
complexes required for transport (ESCRT complexes), is tightly connected to both, 
vacuolar acidification, as well as pH regulation. First, several mutants involved in 
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endocytosis are synthetic lethal with vma mutants lacking V-ATPase activity (Munn and 
Riezman, 1994). Second, various components of the ESCRT complexes are required for 
proteolytic activation of the pH-responsive transcription factor Rim101.  
PDTC inhibits proteolytic activation of the Rim101 transcription factor 
Strikingly, PDTC also strongly interferes with the Rim101 pathway and ESCRT complexes 
by inhibiting the proteolytic activation of Rim101 (Fig.26). PDTC response involves metal 
ion homeostasis, inhibition of the Rim101 processing cascade, as well as vacuolar 
trafficking and functions. By comparing transcriptional profiles of rim101∆, vps4∆ and the 
rim101∆ vps4∆ double deletion in response to PDTC, we identify a potential link between 
these pathways. Rim101 interferes with the cellular ion homeostasis, since it differentially 
regulates genes involved in metal ion homeostasis (Table 6, (Lamb and Mitchell, 2003)). 
Deletion of Rim101 induces genes of the iron regulon (ARN1, ARN3, FIT2, FIT3, FET3, 
FTR1). However, the endosomal ferric enterobactin transporter gene ARN4 is down-
regulated in a rim101∆ strain, whereas the high affinity zinc transporter gene ZRT1 is 
induced. Strikingly, PDTC causes the vice-versa effect by inducing ARN4 and 
downregulating ZRT1. 
 The activation of iron transport genes in a strain lacking Rim101 indicates either changed 
iron availability upon varying pH levels or a potential cross-regulation with the iron-
responsive transcription factor Aft1. Accordingly, the genetic interaction network of Aft1 
includes several components of the Rim101 pathway. For instance, double deletion of 
Rim101 and Aft1 causes synthetic sickness, which is ameliorated by iron supplementation 
(Berthelet et al., 2010). Rim101 is involved in sporulation, pH response and cell wall 
assembly, thus its deletion causes  increased sensitivity to cell wall stress and alkaline pH 
(Lamb et al., 2001). Based on these observations and in context with the sensitivity of 
aft1∆ cells to cell wall-damaging agents such as calcofluor white (CFW) and caffeine, 
Rim101 and Aft1 are suspected to act in parallel (Berthelet et al., 2010). By using 
promoter-tagged citrine reporter strains, we observe reduced fluorescent signal in a 
rim101∆ strain, but still activation of the promoter in response to alkaline pH and PDTC. 
Deletion of Aft1 inhibits ARN4 promoter activity, thus indicating that ARN4 is Aft1-
dependent and may only be indirectly activated by Rim101 (Fig.32). This observation is in 
agreement with chromatin IP experiments suggesting indirect activation of ARN4 gene 
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expression by Rim101 (Lamb and Mitchell, 2003). Furthermore, the ARN4 promoter is 
activated upon alkaline pH, PDTC, high excess zinc and MMS, whereas cell wall stress such 
as SDS, calcofluor white and zymolyase fail to induce promoter activity. Consistent with 
an overall decrease in the fluorescent signal in a rim101∆ strain, we suggest an additive 
effect of Rim101 and Aft1 signalling in iron homeostasis and response to PDTC. Notably, 
based on our hypothesis of intracellular cross-talks, iron homeostasis is disturbed due to 
immense zinc influx into the cytoplasm in response to PDTC, which in turn prevents 
proteolytic activation of Rim101.   
 
Figure 35: In yeast as well as in higher eukaryotic cells, PDTC causes zinc-dependent inhibition of a transcription factor. 
In yeast, PDTC inhibits the Rim101 processing cascade. Thus, the PDTC mode of action identified in yeast might provide 
an important linkage to higher eukaryotes, where PDTC is a known inhibitor of NF-κB activation. 
  
Interestingly, in higher eukaryotes, PDTC is a known inhibitor of NF-κB activation, which 
requires ubiquitin/proteasome-dependent degradation of the inhibitory protein IκB 
(Fig.35,(Schreck et al., 1992)). In both cases, inhibition of Rim101, as well as NF-κB 
activation, PDTC-caused zinc influx plays a vital role in the inhibitory activity of a 
transcription factor. Moreover, PDTC is known to inhibit cleavage of the eukaryotic 
translation initiation factor eIF4G in rhinovirus-infected HeLa cells, thus preventing virus-
induced host-cell shut-off (Gaudernak et al., 2002). PDTC prevents protein degradation by 
inhibiting an E3 ubiquitin ligase (Hayakawa et al., 2003) or the proteasome (Kim et al., 
2004) in a zinc-dependent manner. In a vps4∆ strain, we observe induction of genes 
required for the proteasome function in response to PDTC (Fig.31), indicating an 
increased need for proteolytic processing in the absence of the Vps4 ATPase activity at 
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the endosomal membrane, which is also involved in Rim101 activation (Hayashi et al., 
2005). Thus, the zinc-dependent inhibition of Rim101 cleavage by PDTC is an important 
discovery. To date, and to the best of our knowledge, only genetic alterations have been 
shown to block Rim101 processing under activating conditions in yeast (Hayashi et al., 
2005). Furthermore, inhibition of a proteolytic cleavage cascade in yeast might indicate a 
conserved mechanism in the response to PDTC, which is mediated by zinc. Zinc has 
previously been shown to directly inhibit proteases. For instance, it blocks caspase-3 
activity during apoptosis (Perry et al., 1997). Hence, based on our data obtained in yeast 
and known effects of PDTC, we suggest that the antiviral activity of PDTC is primarily 
mediated by facilitation of zinc influx and a cumulative effect of zinc-dependent 
inhibitions of proteolytic activities, including the proteasome, protease-requiring 
activation cascades or maybe even by blocking the viral proteases 2A und 3C themselves 
directly.  
 
 
Figure 36: The ionic imbalance 
model. PDTC mediates intra-
cellular zinc accumulation, 
leading to zinc detoxification by 
vacuolar sequestration, thereby 
causing a decrease in iron 
availability. Hence, the iron-
responsive transcriptional factor 
Aft1 activates the iron regulon, 
stimulating cellular remodeling 
as under iron-limited conditions.  
Moreover, PDTC prevents 
proteolytic activation of the 
Rim101 transcription factor, 
requiring zinc ions to exert the 
inhibitory action. Consequently, 
PDTC links intracellular dis-
turbance of iron and zinc 
homeostasis to other cellular 
processes, including vacuolar 
and vesicular transport, as well 
as pH regulation.  
 
In summary, based on our data, we propose the “ionic imbalance” model for the cellular 
response to PDTC exposure and the PDTC mechanism of action (Fig.36). Viability assays 
investigating the supplementary effect of zinc and iron on PDTC-treated cells as well as 
transcriptome data point towards a cross-regulation of networks linking zinc and iron 
homeostasis (Fig.18). Iron supplementation rescues the PDTC-induced growth defects in 
both wild type and aft1∆ cells. In contrast, additional zinc in combination with PDTC is 
highly toxic. By investing the cumulative effect of zinc plus iron in combination with PDTC, 
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the aft1∆ mutant was rescued, whereas the wild type was hypersensitive. This cross-
regulation with Aft1 as a central player is required to maintain the proper yeast ionome. 
Furthermore, this drastic modulation of metal ion homeostasis has a significant impact on 
cellular trafficking, intracellular pH as well as on vacuolar functions, including zinc-
dependent inhibition of the Rim101 activation cascade, vesicular transport, and the 
endocytic trafficking pathway leading to fragmented vacuoles. Thus, cells establish a 
multilayer regulatory adaptation network to cope with PDTC-induced environmental 
changes.  
Taken together, this work underscores the importance of yeast as a model system and its 
high potential for drug target identification. By combining transcriptional profiling 
datasets and genome-wide phenotypic screening, it is possible to identify complex and 
highly dynamic regulatory networks to disclose various biological processes involved in 
the response to a single drug. Notably, apart from deciphering specific drug targets by 
expression and sensitivity profiling of drugs, large-scale screenings in yeast can uncover 
off-targets, which are important for the understanding of unwanted side effects.   
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ABSTRACT 
 
Pyrrolidine dithiocarbamate (PDTC), a known inhibitor of NFκB-activation, has anti-
oxidative as well as antiviral activities. PDTC is effective against several virus families, 
indicating that its antiviral mechanism targets host rather than viral functions. To 
investigate its mode of action, we used baker’s yeast as a simple eukaryotic model 
system and two types of genome-wide analysis. First, expression profiling using whole-
genome DNA microarrays identifies more than 200 genes differentially regulated upon 
PDTC exposure. Interestingly, the Aft1-dependent iron regulon is a main target of PDTC, 
indicating a lack of iron availability. Moreover, the PDTC-caused zinc influx triggers a 
strong regulatory effect on zinc transporters due to the cytoplasmic zinc excess. Second, 
phenotypic screening the EUROSCARF collection for PDTC hypersensitivity identifies 
numerous mutants implicated in vacuolar maintenance, acidification as well as in 
transport, mitochondrial organization and translation. Notably, the screening data indicate 
significant overlaps of PDTC-sensitive genes and those mediating zinc-tolerance. Hence, 
we show that PDTC induces cytoplasmic zinc excess, eliciting vacuolar detoxification, 
which in turn disturbs iron homeostasis and activates the iron-dependent regulator Aft1. 
Our work reveals a complex cross-talk in yeast ion homeostasis and the underlying 
regulatory networks. 
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INTRODUCTION 
 
Pyrrolidine dithiocarbamate (PDTC), a low-molecular weight thiol compound, is a 
multifunctional drug exerting various effects in biological systems. For instance, it is an 
inhibitor of the nuclear factor kappa B (NFκB) activation (Schreck et al., 1992) and it can 
exert both pro-apoptotic and anti-apoptotic effects depending on the cellular host system 
(Morais et al., 2006, Erl et al., 2000). Furthermore, PDTC shows inhibitory effects on 
protein degradation (Hayakawa et al., 2003, Kim et al., 2004), and elicits an oxidative 
stress response by inducing transcription of the manganese superoxide dismutase and 
the heme oxygenase HO-1 (Borrello & Demple, 1997, Hartsfield et al., 1998). 
Interestingly, PDTC displays antiviral activity against picornaviruses including human 
rhinovirus, poliovirus and coxsackievirus (Gaudernak et al., 2002, Lanke et al., 2007), as 
well as on influenza viruses, the latter being orthomyxoviruses with a very different life 
cycle (Uchide et al., 2002). Interestingly, PDTC prevents polyprotein processing and 
reduces virus titers mainly by shuttling zinc ions into host cells (Krenn et al., 2005). Since 
different virus families are inhibited, and no resistant strains have been observed to date, 
it has been speculated that the antiviral mechanism of PDTC might target host cell rather 
than viral functions. To gain insight into the cellular mechanisms and control programs 
affected by PDTC, we decided to use the yeast Saccharomyces cerevisiae as a simple 
eukaryotic model system, since PDTC shows antifungal activity in yeast. Yeast is a model 
organism for chemogenomic approaches that has proven itself invaluable for the 
unraveling of many fundamental biological processes including drug target gene 
identification (Giaever, 2003, Parsons et al., 2004). Due to the high evolutionary 
conservation of many cellular processes (Foury, 1997), phenotypic screening techniques 
in yeast have become advantageous for drug development and pharmacokinetic studies 
(Bharucha & Kumar, 2007). Phenotypic screening of the haploid yeast deletion collection 
revealed important insights in cellular processes and pathways affected by certain stress 
conditions or drug treatments (Tucker & Fields, 2004, Parsons et al., 2004). Likewise, 
microarray profiling using whole-genome DNA microarrays can yield conclusive insights 
into the mode of action of a drug and the genes modulated by comparing untreated to 
drug exposed cells (Hughes et al., 2000). For example, microarray profiling for a set of 
different stresses and environmental conditions identified an extensive transcriptional 
network underlying cellular stress responses (Gasch et al., 2000) but also enables the 
discovery of direct as well as off-targets of bioactive compounds (Ericson et al., 2008, 
Parsons et al., 2006).  
The field of chemical genetics and chemogenomics aims at drug target identification 
by inhibiting gene functions in an entire organism using small-molecule exogenous 
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xenobiotics. Lack of a gene in combination with a sublethal dose of a drug can have a 
synthetic lethal effect such as reduced fitness, thus enabling to identify the pathway or the 
drug target that mediates the toxic effect imposed by the drug (Stockwell, 2000). In this 
study we aimed to apply this chemical genetic approach to decipher the mode of action of 
PDTC, and perhaps to identify a target gene for PDTC inhibition. Thus, we performed 
microarray-based profiling of the yeast PDTC response, as well as a genome-wide 
functional screening of the EUROSCARF yeast gene deletion collection. Strikingly, our 
data unravel major changes in cellular ion homeostasis, including the cross-talk of iron 
and zinc regulatory networks.  
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MATERIAL & METHODS 
 
Yeast strains and growth conditions  
All yeast strains used in this study are listed in the supplementary file S1. Rich medium 
(yeast extract-peptone-dextrose [YPD]) was prepared as described in (Kaiser, 1994). 
Unless otherwise indicated, all yeast strains were routinely grown at 30°C. Growth 
inhibition assays were performed with logarithmically grown cells, which were adjusted to 
an optical density at 600 nm (OD600) of 0.2. Equal volumes of 1:10 serial dilutions were 
spotted onto agar plates containing different drug concentrations.  S. pombe was grown 
on solid YES medium as described elsewhere (Moreno et al., 1991). For viability assays, 
cells were grown in liquid medium supplemented with PDTC and/or metal ions for 24h. 
Afterwards, cells were plated onto YPD plates and colony-forming units were determined 
after 48h incubation. Stressed cells were normalized to untreated wild type cells. PDTC 
was purchased from Alexis Biochemicals, Lausen, Switzerland.  
 
Functional screening for sensitivity phenotypes in the presence of PDTC 
For large scale phenotypic profiling, the about 4800 haploid viable single gene deletion 
strains of the EUROSCARF deletion collection (http://web.uni-
frankfurt.de/fb15/mikro/euroscarf/index.html) were grown on YPD plates in a 96-well 
format. For transferring strains to PDTC-containing plates and control YPD plates, we 
used the RoToR HAD robot (Singer Ltd., Roadwater, UK). Growth was inspected after 2, 
4 and 6 days incubation at 30°C. After incubation, plates were scanned with an HPScanjet 
G3010, using the Adobe Photoshop CS3 software. All strains displaying PDTC-sensitivity 
in the first screening were manually re-spotted for confirmation. Equal volumes of serial 
dilutions of exponentially growing cells ranging from an OD600 of 0.2 to 2x10-4 were 
spotted onto PDTC-plates and control plates. 
 
Preparation of total yeast RNA and microarray analysis 
Yeast cells were grown in YPD to an OD600 of about 0.4. The medium was supplemented 
with 75µM PDTC; untreated control cells and PDTC-treated cells were harvested as 50ml 
samples after 1, 3 and 5 hours, washed with ice-cold water and frozen immediately at -
80°C. Total RNA was prepared by the hot phenol method (Sambrook, 2001). About 20 µg 
of total RNA from each sample were used for cDNA synthesis using 200 units of 
Superscript II reverse transcriptase (Invitrogen) with either Cy3-dCTP or Cy5-dCTP. 
Labeled cDNAs were pooled, and RNA was hydrolyzed for 20min in 50mM NaOH at 65 
°C, followed by neutralization with acetic acid and probe clean-up with the CyScribe GFX 
purification kit (Amersham). 
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Hybridization to whole genome cDNA microarrays (Yeast 6.4K Arrays, Microarray 
Centre, University Health Network, Toronto (www.microarrays.ca) was done in 
DigEasyHyb (Roche Applied Science) solution at 37 °C overnight with 70µg/ml of salmon 
sperm DNA as a carrier. Microarrays were washed three times in 1x SSC, 0.1% SDS at 
50 °C, followed by a 1-min wash in 1x SSC at room temperature. Glass slides were spun 
dry for 5 min at 500 rpm in a tabletop centrifuge, and scanned in an Axon 4000B scanner 
(Molecular Devices). All microarray experiments were carried out with three independent 
RNA preparations and at least one technical replicate using dye-swaps.  
 
Computational analysis of microarray data and screening results 
Gridding and spot identification on microarrays were performed using the Gene Pix Pro4.1 
software (Axon). For preprocessing, the background was subtracted and subsequently 
normalized, using the print-tip loess method of the limma Bioconductor/R package 
(Wettenhall & Smyth, 2004). To identify differentially expressed genes, a linear model and 
empirical Bayesian-moderated F-statistics were used with cut-off values of 0.001 for the 
adjusted p-value and a 2-fold expression change, as well as A-values ≥ 7 (Smyth, 2004).  
Genes identified either on the microarrays or in the functional screening were 
grouped by gene ontology enrichment according to the predicted biological process using 
the GO Termfinder program provided by the Saccharomyces Gene Database 
(www.yeastgenome.org). Clustering of differentially expressed genes was performed 
using the MEV software using the linkage method and Euclidean distance (Saeed et al., 
2006, Saeed et al., 2003). The clustering files are found in supplementary file S3. All 
microarray experiments were carried out under full MIAME compliancy and data have 
been submitted to the Array Express database. 
 
Northern blot analysis 
For Northern blots, 15µg of total RNA were fractionated in a 1.4% agarose gel and 
transferred to nylon membranes (Amersham Biosciences). Methylene blue staining was 
used as control for equal RNA loading.  Northern blots were pre-hybridized for 3h at 65°C. 
PCR-amplified probes were radiolabeled by incorporation of [α-32P]dCTP using a 
MegaPrime labeling kit (Amersham Biosciences). Radiolabeled probes were purified on 
NICK columns (Amersham Biosciences) before adding to the prehybridization solution. 
Membranes were washed at 65°C three times each in 2xSSC, 1% SDS, in 1x SSC 1% 
SDS and exposed to X-ray films at -80 °C.  
 
β-galactosidase assays and immunoblotting 
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Cells containing a genomically integrated FET3-lacZ reporter construct OCY355 
(Kumanovics et al., 2008) were grown in YPD medium to the mid-exponential growth 
phase. Cells were treated with 100µM PDTC or left untreated. β-galactosidase assays 
were performed in triplicate with cell extracts as described in (Kaiser, 1994).  
For immunoblotting, total cell-free protein extracts were prepared by the 
trichloroacetic acid method exactly as described previously (Mamnun et al., 2004). Cells 
were grown to the mid-logarithmic growth phase, left untreated or stressed with 100µM 
PDTC for 2h. Cell lysates equivalent to 0.5 OD600 units were resolved by 7.5% SDS-PAGE 
and transferred to nitrocellulose membranes. Polyclonal α-Swi6 antibodies (kindly 
provided by Kim Nasmyth) were used to verify equal loading. 
 
Fluorescent detection of zinc influx into yeast cells 
About 2x 108 cells of a pdr5∆ pdr12∆ double deletion strain (kindly provided by Ralf 
Egner) were loaded with 30µM mag-fura-2 (Molecular Probes, Invitrogen) for 30 minutes 
in 1xTBS; cells were washed three times and finally resuspended in 10ml TBS. 
Experiments were performed in 3ml silica cuvettes containing 2ml aliquots of a cells 
suspension with constant agitation. Intracellular zinc accumulation was monitored with 
real-time kinetics over a 500 second-period using a spectrofluorimeter LS-55 (Perkin-
Elmer) by continually alternating the excitation wavelengths of 340 and 380nm in 20ms 
intervals and recording the emission at 509nm. 10µM ZnSO4, 10µM CaCl2 or 10µM 
CuSO4, and 100µM PDTC and 50µM EDTA were added to the cell suspension at 
indicated time points. 
APPENDIX – Manuscript – Landstetter et al, OMICS, in print 
  107    
RESULTS 
 
PDTC shows antifungal activity in various yeast species 
The effect of PDTC on growth of Saccharomyces cerevisiae, Candida albicans, Candida 
glabrata and Schizosaccharomyces pombe was analyzed by growth inhibition assays on 
agar plates. Serial dilutions of the yeast cells were spotted onto PDTC supplemented 
plates. Cell growth was inhibited in both non-pathogenic yeasts as well as in Candida spp, 
although not to the same extent (Fig. 1A). Namely, S. cerevisiae, C. albicans and S. 
pombe were sensitive at 30µM PDTC, whereas C. glabrata was more resistant growing up 
to a concentration of 75µM PDTC. However, it is known that C. glabrata shows increased 
inherent tolerance to antifungals such as azoles when compared to S. cerevisiae and C. 
albicans (Pfaller & Diekema, 2004).  
Moreover, we performed growth curves with Saccharomyces cerevisiae wild type 
cells to investigate PDTC tolerance in liquid culture. Cells were grown in rich medium 
supplemented with increasing concentrations of PDTC and OD600 was monitored over 
time. The growth curves showed a dose-dependent growth inhibition (Fig.1B). At low 
concentrations (25µM), PDTC treated cells responded with an elongated lag-phase and a 
delayed period to reach the stationary phase. At higher concentrations (150µM), PDTC 
caused fungistatic growth inhibition. This broad antifungal activity of PDTC suggested 
using yeast as a model system by exploiting well-established large-scale screening 
techniques for PDTC drug target identification.  
 
The PDTC transcriptome comprises of more than 200 genes 
To identify regulatory effects and the kinetics of PDTC action on the yeast transcriptome, 
we performed whole-genome DNA microarray experiments. Therefore, wild type yeast 
cells were grown to the mid-logarithmic growth phase in rich medium, and treated with 
PDTC for 1, 3 or 5 hours (Fig. 1B). Transcript data of three independent biological and 
one technical replicate at every time point were generated, and PDTC-treated versus 
untreated cells were compared. Microarray results were statistically evaluated considering 
changes more than two-fold as significant. All major changes were confirmed at RNA level 
by Northern analysis. 
PDTC-induced changes in transcriptome profiles consisted of more than 200 
differentially expressed genes (Table 1), indicating a major transcriptional shift in yeast. 
Gene ontology (GO) enrichment of the microarray data using the Saccharomyces Gene 
Database GO Termfinder revealed that the main functional categories included the iron 
regulon, aerobic respiration and general metabolic changes. To identify the regulatory 
associations of the differentially expressed genes, we clustered the genes with 
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YEASTRACT (Teixeira et al., 2006) (see supplementary Table S2). Thereby, differentially 
expressed genes identified through microarrays were grouped according to their 
transcription factors or potential regulators. Supporting the findings of the GO enrichment, 
the main transcription factors required for general and oxidative stress response genes, 
as well as proteasome and multidrug resistance genes were found. These included the 
transcriptional regulators Yap1, Msn2/4, Rpn4 and Sfp1 correlating with the activation of 
general stress response genes as well as with repression of ribosomal genes under 
various stress conditions (Wu et al., 2008, Gasch et al., 2000). Interestingly, the clustering 
specifically identified the iron-responsive transcription factor Aft1 as one of the major 
responders.   
 
PDTC activates the Aft1-dependent iron regulon in yeast 
Among the highest induced genes, we identified several genes of the high-affinity iron 
uptake system (FET3, ARN4), as well as cell wall mannoproteins required for 
siderophore-bound iron retention (FIT1, FIT2, FIT3). This set of genes is referred to as the 
yeast iron regulon, which is under the control of the transcription factors Aft1/Aft2. The 
iron regulon is rapidly activated under iron-limiting conditions (Yamaguchi-Iwai et al., 
1995, Yun et al., 2000). Upon iron depletion, Aft1 traffics into the nucleus to orchestrate 
an immense cellular cascade response, inducing first the iron uptake machinery and 
mobilization of intracellular iron from storage compartments, followed by adaptations of 
metabolic iron usage (Yamaguchi-Iwai et al., 2002). This includes a switch to less iron-
consuming pathways, shutting down non-essential pathways while preserving essential 
ones (Kaplan & Kaplan, 2009). The pathways regulated in response to iron changes 
include the biotin, glutamate and purine biosynthetic pathways, as well as the TCA cycle. 
Furthermore, genes involved in heme biosynthesis and in the respiratory chain are down-
regulated (Hausmann et al, 2008). Indeed, PDTC triggered both the primary and 
secondary wave response genes involved in iron-dependent cellular remodeling (Table 1).  
To confirm the induction of the iron regulon in response to PDTC, and to 
investigate whether this activation is Aft1-dependent and iron-specific, we performed 
Northern analysis and growth inhibition assays comparing the wild type with the aft1∆ 
strain. Activation of the iron regulon (FIT3, FIT2) in response to PDTC was fully Aft1-
dependent, whereas GRE2, encoding a metalloreductase involved in the high osmolarity 
glycerol pathway, served as control for Aft1-independent induction (Fig.2A). Furthermore, 
PDTC strongly induced the promoter of FET3 encoding the ferroxidase of the high-affinity 
iron transport system as shown by a FET3-lacZ reporter assay (Fig.2B).  
Aft1 is required for growth under iron-limited conditions (Yamaguchi-Iwai et al., 
1995). Consistently, the aft1∆ strain was hypersensitive to PDTC when compared to its 
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corresponding wild type, suggesting that Aft1 is required for PDTC tolerance (Fig. 2C). 
Iron-supplementation specifically rescued this sensitivity phenotype (Fig.2C), thus 
showing that PDTC must mimic or cause a lack of iron availability. Other ions such as 
Mg2+, Ca2+, Zn2+ and Mn2+ failed to rescue the PDTC-dependent growth inhibition, and 
Cd2+ supplementation even further increased PDTC-sensitivity. Notably, copper 
supplementation rescued growth of the aft1∆ strain in the presence of PDTC, but impaired 
PDTC-tolerance of the wild type strain. All in all, these data show that activation of the iron 
regulon by PDTC is Aft1-dependent and is required for PDTC-tolerance.   
 
PDTC treatment causes intracellular zinc overload 
On the one hand, PDTC caused activation of the iron uptake machinery. On the other 
hand, it was striking to note that PDTC strongly altered expression of plasma membrane 
and vacuolar zinc transporters (Fig.3A). In detail, expression of the plasma membrane 
low-affinity zinc transporter Zrt2 and the vacuolar zinc exporter Zrt3 was strongly 
decreased upon PDTC treatment, whereas the transporter importing zinc into the vacuole, 
Cot1, was highly induced. Transcript levels of the high-affinity zinc transporter Zrt1 stayed 
unchanged; however Zrt1 is regulated post-translationally via ubiquitination and 
endocytosis (Gitan & Eide, 2000). Although, yeast lacks a cellular zinc exporter, free zinc 
concentrations are kept low because excess zinc is highly toxic for cells. Spare zinc is 
bound to proteins or stored in vesicular compartments such as the vacuole as major site 
of storage and detoxification (Eide, 2009). 
Consistent with our notion of PDTC-induced cellular zinc excess, transcript levels 
of the major zinc-conserving proteins like alcohol dehydrogenases (ADHs) and superoxide 
dismutase 1 (Sod1) were increased on our microarrays. We confirmed induction of the 
cytoplasmic superoxide dismutase SOD1 gene by Northern blotting (Fig.3B). In the aft1∆ 
strain, SOD1 gene induction was even more pronounced than in the wild type.  
Consistently, Sod1 deficiency led to increased PDTC and zinc-sensitivity, whereas 
deletion of the manganese superoxide dismutase Sod2 had less severe effects. (Fig.3B, 
C). Interestingly, iron supplementation failed to rescue the PDTC-induced growth defect of 
the sod1∆ strain. However, this failure might be due to a previously reported increase in 
iron demand of the sod1∆ mutant per se and its involvement in zinc detoxification (Tarhan 
et al., 2007, De Freitas et al., 2000). In this case, PDTC would worsen the lack of iron 
availability, thereby increasing the sensitivity of the sod1∆ strain.  
To directly monitor PDTC-induced zinc accumulation inside yeast cells in real time, 
we used the fluorescent dye mag-fura-2. As the dye is normally effluxed from cells, all 
experiments were carried out in a strain lacking the ABC transporters Pdr5 and Pdr12. 
The excitation wavelength of mag-fura-2 is shifted from 380 to 340 nm when binding 
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bivalent cations (Raju et al., 1989, Simons, 1993). After loading yeast cells with mag-fura-
2, cells were extensively washed and ZnSO4, CuSO4, CaCl2 or MgCl2, PDTC and EDTA 
were added at indicated time points. While adding ZnSO4 had only minor effects on the 
fluorescent ratio, the supplementation of PDTC caused a rapidly increasing signal as a 
readout for intracellular zinc accumulation. As expected, adding EDTA reduced the signal 
immediately. Other metal ions including Mg2+, Cu2+ and Ca2+ had no effect on the 
fluorescent signal. Thus, PDTC caused an immediate influx of Zn2+ ions into the yeast 
cells and elevated intracellular zinc levels (Fig.4). Taken together, the observed regulation 
of the zinc homeostasis in response to PDTC indicates excess cytoplasmic zinc, leading 
to subsequent zinc detoxification by sequestration into the vacuole and by induction of 
zinc-binding proteins (Fig.3A). 
 
PDTC enhances a cross-talk between iron and zinc homeostasis 
Since both zinc homeostasis and the iron regulon were strongly affected by PDTC, we 
aimed to investigate a potential underlying regulatory cross-talk between these two 
pathways. Supporting this notion, it was previously reported that zinc overload activates 
the iron regulon (Pagani et al., 2007). In addition, aft1∆ cells are sensitive to high 
concentrations of extracellular zinc, which indicates that Aft1 is required to counteract the 
growth defect caused by excess zinc (Pagani et al., 2007).  Hence, we performed viability 
assays with wild type and aft1∆ strains in the presence of PDTC, Zn2+ and Fe3+, 
respectively (Fig.3D). Colony forming units were determined after 24h stress treatment 
with 200µM PDTC in liquid medium and set relative to the untreated wild type. As 
expected, iron supplementation rescued the cytotoxic effect of PDTC in wild type and 
aft1∆ cells. In contrast, this effect was enhanced by excess zinc. Growth deficiency of 
aft1∆ cells on high excess zinc was rescued by iron supplementation. Strikingly, the 
combined effect of PDTC, iron and zinc was almost fully rescued in the aft1∆ background 
but not in the wild type strain (Fig.3D). These data suggest that in wild type cells, Aft1 also 
controls a yet unidentified cellular function counteracting zinc detoxification, at least in the 
presence of PDTC. 
 
Functional screening identifies essential processes mediating PDTC tolerance 
To identify genes that confer tolerance to PDTC, we functionally screened the 
EUROSCARF deletion collection for altered growth in the presence of PDTC. Therefore, 
strains of the collection were replicated on YPD and PDTC-containing plates and grown at 
30°C for 6 days monitoring growth every day. The previously identified PDTC 
hypersensitivity of the aft1∆ strain was used as a control in the screening procedure. 
Among more than 4800 haploid single deletion strains, we identified some 140 mutants as 
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PDTC-hypersensitive (see Supplementary File S2). Mutants showing increased PDTC 
sensitivity were manually re-spotted in serial dilutions on several PDTC concentrations to 
re-confirm the phenotype. To categorize the PDTC-sensitive strains, we grouped them 
based on gene ontology enrichment using the Saccharomyces Gene Database GO 
Termfinder (Fig.5A). The main functional categories comprised of vacuolar acidification 
and vacuolar transport, protein modifications, mitochondrial organization and translation. 
Interestingly, many mutants related to membrane and vesicular transport or trafficking 
systems were PDTC-sensitive (e.g. endosomal sorting complex required for transport 
(ESCRT); Golgi-associated retrograde protein complex (GARP), HOPS complex).  
Furthermore, mutants disrupting vacuolar trafficking including vacuolar protein sorting 
genes such as VPS3, VPS4, VPS8, VPS18, VPS33, VPS41, VPS45, as well as function 
and assembly of the V-ATPase such as VMA8, VMA22, VMA2, TFP1, VMA21, VMA6, 
PPA1 were PDTC-sensitive, suggesting that vacuolar biogenesis and maintenance is 
pivotal for cells responding to PDTC.  
The vacuole is the main storage and detoxification compartment in yeast. Thus, 
components involved in vacuolar biogenesis and trafficking are essential under various 
stress conditions. Remarkably, we found a significant overlap of PDTC-sensitive mutants 
(Fig.5B) and deletion strains sensitive to excess zinc, cadmium, oxidative stress and 
alkaline pH (Pagani et al., 2007, Outten et al., 2005, Serrano et al., 2004, Jin et al., 2008). 
For example, a functional V-ATPase is crucial for establishing a proton gradient across 
the membrane to ensure vacuolar import of ions, especially for zinc sequestration 
(MacDiarmid et al., 2002). Thus, PDTC tolerance requires several cellular mechanisms 
and processes to avoid a collapse of cellular ion homeostasis. 
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DISCUSSION 
 
In this study, we exploit yeast and a chemical-genetic approach combining transcriptional 
profiling and phenotypic screening techniques to identify possible cellular targets of the 
antiviral drug pyrrolidine dithiocarbamate (PDTC). The transcriptional profiling indicates 
that PDTC massively disturbs metal ion homeostasis, including a strong induction of the 
iron regulon, as well as regulation of zinc transport. The screening of the yeast gene 
deletion collection for mutants with increased PDTC susceptibility identifies numerous 
genes essential for the PDTC response, including those required for vacuolar functions 
and transport complexes. 
The transcriptional changes upon PDTC treatment involve more than 200 genes, 
including general stress response genes.  Strikingly, we detect a specific activation of the 
Aft1 transcription factor driving the iron regulon. Beside iron deprivation, the iron regulon 
is activated by various stress conditions, ranging from changes in ion concentrations such 
as excess zinc (Pagani et al., 2007) or cobalt (Stadler & Schweyen, 2002) to physiological 
changes induced by lactic or acetic acid (Kawahata et al., 2006), as well as glucose 
depletion occurring during the diauxic shift (Haurie et al., 2003). Moreover, drugs such as 
the fungicide mancozeb (Santos et al., 2009), chloroquine toxicity (Emerson et al., 2002), 
hydroxyurea (Dubacq et al., 2006) or the anticancer drug cisplatin (Kimura et al., 2007) 
mimic iron depletion and thus trigger activation of the iron regulon.  
Like PDTC, the fungicide mancozeb is a dithiocarbamate that complexes 
manganese and zinc and also activates the Aft1 transcription factor (Santos et al., 2009). 
Proteomic analysis suggests that mancozeb induces oxidative stress response genes, 
genes involved in translation and protein degradation (Santos et al., 2009). An important 
property of dithiocarbamates is their metal chelating activity, thereby forming lipophilic 
dithiocarbamate-metal complexes and facilitating metal entry into cells (Krenn et al., 
2005). Mag-fura-2 experiments show an immediate PDTC-caused influx of Zn2+ ions into 
yeast cells. Thus, by changing the delicate ion balance inside cells, excess ions alter 
enzyme activities and metabolic functions. Thus, PDTC and dithiocarbamates in general 
might mask significant amounts of intracellular iron or disturb the intracellular zinc / copper 
homeostasis to drive induction of the iron regulon.  
Maintenance of a proper metal ion homeostasis is of pivotal importance for yeast 
viability and metabolic functions. Cross-talk between responses to different ions has been 
proposed due to overlapping regulatory networks. For instance, iron and copper are tightly 
connected, since copper is the essential co-factor in the high-affinity iron permease 
complex Ftr1/Fet3 (Gross et al., 2000). Consequently, inhibition of copper uptake results 
in reduced iron uptake. Fet3 is a multicopper ferroxidase whose deletion renders cells 
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highly sensitive to transition metal stress, alkaline pH and causes impaired growth on 
ethanol and galactose/raffinose (Rutherford & Bird, 2004). Moreover, relationships 
between cobalt-iron (Stadler & Schweyen, 2002) and zinc-iron (Pagani et al., 2007, 
Santos et al., 2003) responses are known. Notably, the vacuolar transporter Cot1 
normally involved in zinc transport into the vacuole and cobalt accumulation, is induced 
under iron-limited conditions (Li & Kaplan, 1998). High excess of zinc disrupts iron 
homeostasis by altering the intracellular iron content and iron-dependent respiratory 
enzyme activities such as cytochrome c oxidase, and aconitase, connecting zinc, iron and 
iron/sulfur cluster (ISC) metabolism (Pagani et al., 2007, Santos et al., 2003). Studies of 
the yeast ionome, as well as the interplay of alkaline pH stress and ion metabolism 
confirm a tight and dynamic co-regulation at genomic (Eide et al., 2005, Serrano et al., 
2004, Serrano et al., 2002) and perhaps at proteomic and regulatory levels. 
We here show the impact of various metal ions in combination with PDTC on ion 
homeostasis (Fig.2C). For example, the aft1∆ strain is sensitive to nickel, calcium, 
manganese, cobalt, zinc as well as alkaline pH (Stadler & Schweyen, 2002, Serrano et al., 
2004). These growth phenotypes can be compensated by the supplementation of high 
iron to the growth media, thereby increasing cellular iron concentrations. In the case of 
glucose exhaustion, addition of iron fails to rescue the growth defect indicating two 
independent signals inducing the iron regulon (Haurie et al., 2003). In cells lacking the 
AFT1 gene, the copper-binding metallothionein Cup1 is highly induced upon PDTC 
treatment, which might explain the increased copper-tolerance compared to the wild type 
(data not shown). Consistent with the fact that PDTC acts as a zinc ionophore mediating 
zinc influx into HeLa cells (Krenn et al., 2005) as well as yeast cells (Fig. 4), it triggers 
changes in transcript levels of certain zinc transporters due to the intracellular ionic 
imbalance. 
By functionally screening the yeast gene deletion collection for PDTC-sensitive 
strains, we identify genes involved in vacuolar functions and transport complexes (Fig.5A) 
that are also essential under excess zinc conditions (Fig.5B) (Jin et al., 2008, Pagani et 
al., 2007). For example, a functional V-ATPase is required for establishing a proton 
gradient across the vacuolar membrane and for zinc storage. Indeed, mutants lacking a 
functional V-ATPase are both zinc- and PDTC-hypersensitive. Furthermore, the chemical-
genomic profile of yeast cells demonstrates that mutants involved in endosome transport, 
transcription, vacuolar degradation and function of the V-ATPase are sensitive to multiple 
stress conditions (Hillenmeyer et al., 2008).  
Taken together, and based on our data, we propose the ‘ionic imbalance’ model 
for the cellular response to PDTC exposure and the PDTC mechanism of action (Fig.6). 
Zinc excess as caused by PDTC (Fig.3A) triggers dynamic expression changes of zinc 
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transporter genes and activation of the iron regulon, whose main transcriptional activator 
Aft1 is required to counteract ion toxicity as well as alkaline pH stress (Serrano et al., 
2004, Stadler & Schweyen, 2002, Pagani et al., 2007), thus orchestrating the adaptive 
regulation of ion homeostasis pathways. This rapid response regulation prevents further 
zinc uptake, followed by subsequent activation of the Aft1 regulon. Viability assays 
investigating the supplementary effect of zinc and iron on PDTC treated cells point 
towards cross-regulatory networks, linking zinc and iron homeostasis (Fig.3D). Iron 
supplementation rescues the PDTC-induced growth defects in both wild type and aft1∆ 
cells. By contrast and as expected, additional zinc influx in combination with PDTC is 
highly toxic (Fig.3D). By investigating cumulative or additive effects of zinc plus iron in 
combination with PDTC treatment, the aft1∆ mutant survives whereas the wild type is 
hypersensitive. This suggests that Aft1 in wild type cells also controls a yet unidentified 
cellular function, which counteracts zinc detoxification at least in the presence of PDTC. 
Thus, we believe that PDTC-promotes zinc storage through zinc-binding proteins such as 
Sod1 (Fig.3B), as well as vacuolar detoxification, thereby disturbing intracellular metal ion 
balance causing cross-activation of the iron regulon (Fig.5).  
In higher eukaryotes, PDTC is a known inhibitor of NF-κB activation (Schreck et 
al., 1992), and the eukaryotic translation initiation factor eIF4G in rhinovirus-infected HeLa 
cells (Gaudernak et al., 2002). Moreover, PDTC prevents protein degradation by inhibiting 
a E3 ubiquitin ligase (Hayakawa et al., 2003) or the proteasome (Kim et al., 2004) in a 
zinc-dependent manner. Hence, it will be interesting for future studies to test whether 
PDTC can affect related yeast transcription factors such as Rim101, a functional 
homologue of NF-κB implicated in pH regulation, especially since several deletion strains 
defective in alkaline pH regulation are also PDTC-sensitive (Fig.4; Table 2, Supplemental 
Data).  
Taken together, this work demonstrates the importance of yeast as a model 
system for performing chemical genetics approaches at the genome-wide scale and its 
high potential for drug target identification. By combining transcriptional profiling datasets 
and genome-wide phenotypic screening, it is possible to identify complex and highly 
dynamic regulatory networks to disclose various biological processes involved in the 
response to a single drug. 
APPENDIX – Manuscript – Landstetter et al, OMICS, in print 
  115    
CONCLUSION 
 
In this study, we successfully exploit genome-wide screening tools and microarray 
profiling techniques in the eukaryotic model organism S. cerevisiae to identify genes, 
processes and signaling pathways involved in the response to the antiviral drug PDTC. 
The transcriptional changes upon PDTC-treatment involve more than 200 genes, 
including general stress response genes and other specific adaptations such as an 
intense cross-talk in metal ion homeostasis. The general stress response genes are 
involved in growth-related processes, RNA metabolism and repression of ribosomal 
protein genes. Interestingly, the specific response comprises of many genes involved in 
metal ion homeostasis, particularly genes of the iron regulon requiring Aft1-dependent 
activation and cellular remodeling as necessary during iron limitation. Furthermore, 
transcriptional regulation of cellular zinc transporters and fluorescent visualization of 
intracellular zinc accumulation hint a PDTC-induced zinc influx and vacuolar zinc 
sequestration.  
By systematically screening of the yeast gene deletion collection, we identify about 
140 genes that are essential for PDTC-tolerance. The main functional categories 
comprise vacuolar acidification and vacuolar transport, protein modifications, 
mitochondrial organization and translation. Many of these genes have previously been 
identified as non-transporter multidrug resistance genes, especially under excess zinc and 
alkaline pH stress conditions. By combining microarray datasets with phenotypic 
screening results, we suggest PDTC-induced increase in the intracellular zinc-content 
leading to vacuolar zinc storage accompanied by iron-limitation and full activation of the 
iron regulon.  
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Figure Legends 
Figure 1: PDTC inhibits growth of several yeast species 
A. The effect of PDTC on growth of various yeast species was examined by spot assays 
on solid medium. Logarithmically growing wild type strains were spotted in serial 
dilutions ranging from OD600 of 0.2 to 2x10-4 onto YPD and PDTC containing plates 
and grown at 30°C for 2 days. S. pombe (OD600 of 0.2) was spotted on YES medium 
containing a gradient from 0 to 50µM PDTC. 
B. Growth curves of the S. cerevisiae wild type strain BY4741 with increasing 
concentrations of PDTC. Cells were grown in rich medium supplemented with PDTC 
for 8 hours at 30°C. Growth was monitored by measuring OD600 every hour. Data are 
displayed as mean ± 1 SD of three independent growth experiments. Arrows indicate 
the time points at which samples were harvested for microarray analysis of 
unstressed cells and cells treated with 75µM PDTC. 
 
Figure 2: PDTC activates the Aft1-dependent iron regulon  
A. Induction of the iron regulon is Aft1-dependent. Northern blot analysis comparing 
PDTC-induced gene expression of the iron-responsive genes FIT2, FIT3 and the 
Aft1-independent gene GRE2 in wild type and aft1∆ cells. Cells were treated for 1, 3 
and 5h with PDTC. Untreated and PDTC treated cells were harvested, total RNA was 
isolated for Northern blot analysis. 
B. PDTC activates the FET3-promoter. Cells containing an integrated lacZ-FET3 
reporter construct were grown to the mid-log phase (OD600 ~ 0.6) in YPD and treated 
with 100µM PDTC for 3 hours. Cells were harvested and assayed for β-galactosidase 
activity. Data of a representative experiment are shown and the error bars represent ± 
1 SD of three replicates.  
C. PDTC-induced growth deficiency is rescued by iron supplementation. Wild type and 
aft1∆ cells were spotted in serial dilutions on rich media containing PDTC and/or 
different ions. Growth was monitored after 2 days incubation at 30°C. 
 
Figure 3: PDTC causes intracellular zinc overload 
A. Northern blot comparing the PDTC-induced changes of transcript levels of various 
zinc transporters whose cellular location is indicated in the scheme on the left. These 
alterations in gene expression indicate intracellular zinc accumulation and 
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subsequent vacuolar zinc sequestration. Cells were grown in rich medium to an OD600 
of ~0.5, 75µM PDTC was supplemented and cells were harvested at the indicated 
time points and prepared for Northern analysis. 
B. PDTC induces the transcript levels of the copper/zinc superoxide dismutase SOD1 
gene. Cells were treated with PDTC, harvested at the indicated time points and total 
RNA was prepared for Northern analysis. 
C. Deletion of the SOD1 gene renders cells zinc and PDTC-hypersensitive. Wild type 
and deletion mutants were spotted in serial dilutions (OD600 of 0.2 to 2x10-4) on YPD 
plates supplemented with 20µM PDTC, 4mM ZnSO4 and 2 mM FeCl3, respectively. 
Growth was monitored after a 2 day incubation at 30°C. 
D. Cell viability assays to investigate the nature of a probable cross-talk between iron 
and zinc homeostasis. Wild type and aft1∆ were grown in liquid rich medium for 24h 
in the presence of PDTC, ZnSO4 and FeCl3, respectively. Afterwards, cells were 
plated on YPD and colony forming units (CFU) were determined after a 2 day 
incubation at 30°C. Data are presented as percent CFU relative to the untreated wild 
type. Error bars represent ± 1 SD of three independent growth experiments; stars 
indicate significance of data valued by a Students t-test.  
 
Figure 4: PDTC induces immediate influx of zinc ions into yeast cells 
Cells were loaded with the mag-fura-2 dye and fluorescence was monitored in real-time 
after adding metal ions such as ZnSO4, CaCl2, CuSO4, MgCl2, PDTC and EDTA at the 
indicated time points. The excitation wavelength of mag-fura-2 is shifted by binding 
bivalent metal ions. Thus, change of the fluorescent ratio of F340/380nm following 
addition of zinc and PDTC, but not by calcium, magnesium or copper, show accumulation 
of intracellular labile zinc.  
 
Figure 5: Functional screening identifies processes mediating PDTC tolerance 
A. Functional categories of genes required for PDTC tolerance in yeast. The about 4800 
deletion strains were screened on YPD and PDTC-containing plates using a Singer 
RoToR HAD Robot. Growth was monitored after 2 days. Sensitive strains were 
verified by manual re-spotting and clustered into functional categories using the Gene 
Ontology termfinder. The number of genes per category and the percentages of each 
category to the dataset are indicated. All PDTC-sensitive genes are listed in 
supplementary data S2.  
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B. Venn diagrams showing the overlap of PDTC-sensitive genes and genes required 
during zinc and cadmium toxicity, as well as under alkaline pH conditions. Screening 
data for comparison were taken from published datasets (Jin et al., 2008, Serrano et 
al., 2004, Pagani et al., 2007).  
 
Figure 6: The ionic imbalance model 
We show that PDTC mediates intracellular zinc accumulation, leading to zinc 
detoxification by vacuolar sequestration, thereby causing a decrease in iron availability. 
Hence, the iron-dependent transcription factor Aft1 activates the iron regulon and 
stimulates cellular remodeling as under iron scarcity. Consequently, PDTC might link 
intracellular disturbance of iron and zinc homeostasis to other cellular processes, 
including vacuolar and vesicular transport or even pH regulation. 
 
Table 1: Functional categories of differentially expressed genes after PDTC stress 
Wild type yeast cells were grown to the logarithmic growth phase in rich medium, treated 
with PDTC for 1, 3 or 5 hours. RNA was extracted and labeled samples were used to 
probe yeast DNA microarrays. We carried out three independent comparisons of PDTC-
treated versus untreated cells considering changes more than two-fold as significant. The 
PDTC transcriptome comprises of a general and a specific stress response, all together 
involving more than 200 genes that were categorized by gene ontology enrichment. 
Overlapping processes were manually collapsed. All genes affected by PDTC treatment 
are listed in Supplementary Data S2, including data of all time points, fold-expression and 
p-values.  
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Table 1. Functional categories of genes regulated upon PDTC stress 
Categories Gene names N° of genes 
Iron regulon 
Aft1/Aft2 target 
genes 
FTH1, SIT1, FTR1, ARN1, ARN2, CTR2, FRE1, CCS1, FET3,  
ENB1, FIT1, FIT2, FIT3, YLR126C, ISU2, ISU1, FTR1 17 
Carboxylic acid 
metabolic process 
CYS3, GCV3, SHM1, CHA1, SFA1, GLT1, GCV1, ARO3, 
HOM3, MET6, LPD1, ARO9, POT1, ELO1, FBA1, FAS1, 
ILV5, ILV2, GCV2, LEU4,  LYS9, LEU9, HIS3, GDH1, CAR1, 
GLN1, SHM2, URA1, GTT1, URA4 
30 
Purine 
biosynthetic 
process 
ADE1, ADE8, ADE5,7, ADE13, ADE17, ADE3, ADE12 7 
Stress response to 
drug / toxin 
AAD3, RPN4, UBC5, YCF1,  SNF1,  AAD6, AAD16, 
YML131W,  DDR48, HOR7, LAP3, GRE2, TIR2, OYE3, 
HSP31, SFP1, OYE2 
17 
Response to 
oxidative stress 
YDL124W, CTA1, TRR1, YPR1, GRX2, TRX2, STB5, SOD1, 
CCP1, TRX1, AHP1, ZWF1, ATX1, GLR1,  PEP4 15 
Respiration and 
citric acid cycle 
COX6, COX5A, COX9, COX13, IDH1, ACO1, RIB3, POR1, 
QCR7 9 
Transport 
STP22, TRS23, INH1, VHT1, TOM6, HNM1, MUP1, TPO1, 
DIC1, SFH5, HXT10, HXT4, HXT5, HXT8, GAL2, HXT11, 
HXT12 
18 
Heme and 
ergosterol 
biosynthesis 
ERG3, ERG1, ERG27, ERG11, HEM13, YHB1, YCP4 7 
Telomere 
maintenance YGL039W, NMD2, CST6, HCR1, LST7, SWD1, PNC1 7 
Transcription / 
translation 
MRP8, EFB1, GCD2, RLI1, GAT1, ERB1, UTP23, SSZ1, 
RLP7, TUF1 10 
DNA replication / 
repair RNR2, RNR4, DON1, WTM1, YPL033C, NNF1, RFA2, SIM1 8 
Oxidoreductase 
activity ADH7, YDR541C, DLD3, YGL157W, ADH6, YNL134C 6 
Other 
PHO5, PHO11, PHO86, IRC7, IZH1, FRM2, MFA1, EMI2, 
AGA2, KOG1, BAR1, BNR1, MSG5, LAP4, AIM46, RIB4, 
SLA1, EHD3, FLO9, NDE1, SNC2, PAC11, TEC1, PEX5, 
UGP1, RMD6, AIM18, PMI40, SCW4, CWP1, SRP40, EMI1, 
VHS1, YRO2, PRE8, MRH1, APT2, TIP1, LRG1, CNS1, 
WWM1, RPN6, DPH5, FRQ1, FMP43 
45 
Unknown 
YAL065C, YMR173W-A, YCR102C, YJL217W, YER156C, 
YGR146C, YDR476C, YOR285W, YKL088W, YDR154C, 
YKL030W, YPL067C, YKL066W, YLL044W, YDR271C, 
YBR053C, YJL068C, YFR024C, YHR213W, YAR073W, 
YKL171W, YEL033W, YDR119W, YLR460C, YNL208W, 
YCR074C 
26 
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Supplementary Table 1 - Yeast strains used in this study 
Name Genotype Reference 
BY4741 MATa his3∆1; leu2∆0; met15∆0; 
ura3∆0 
(Brachmann et al., 
1998) 
BY4742 MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 (Brachmann et al., 
1998) 
EUROSCARF 
yeast deletion 
collection 
 http://web.uni-
frankfurt.de/fb15/mikro/
euroscarf/index.html 
DY1457 MATα, ura3-52, leu2-3, trp2-1, his3-11, 
can1-100(oc), ade6 
(Chen et al., 2004) 
OCY355  MATα, ura3-52, leu2-3, trp2-1, his3-11, 
can1-100(oc), ade2, ho::FET3LacZ  
(Kumanovics et al., 
2008) 
ATCC2001  C. glabrata wild type strain available at 
www.atcc.org 
  
SC5314  C. albicans wild type strain    
K11217 S. pombe wild type strain Kindly provided by K. 
Nasmyth 
YRE107 YPH499 MATa, leu2∆1, ura3∆52, 
his3∆200, ade2∆10 lys2∆801a 
pdr5∆::TRP1 pdr12∆::URA3 
Kindly provided by R. 
Egner 
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Supplementary File S2  
Microarray Data – Differentially expressed genes at 1, 3 and 5h PDTC exposure (cut-off values of 0.001 for the adjusted p-value and 
a 2-fold expression change) 
Sc ORF Gene 1h-
fold 
3h-
fold 
5h-
fold 
min p-val Biological Process Function Subcellular Localization 
YOR004W UTP23 -1,23 1,25 2,07 7,51133E-06 35S primary transcript processing* molecular function unknown mitochondrion* 
YIL159W BNR1 -1,27 -1,45 -2,09 4,65257E-10 actin filament organization* cytoskeletal protein binding contractile ring (sensu 
Saccharomyces) 
YGL191W COX13 -1,09 -1,45 -2,06 7,11238E-07 aerobic respiration enzyme regulator activity* respiratory chain complex IV (sensu 
Eukaryota) 
YDR529C QCR7 -2,14 -3,10 -3,79 3,00235E-09 aerobic respiration* ubiquinol-cytochrome-c reductase activity respiratory chain complex III (sensu 
Eukaryota) 
YDR487C RIB3 2,24 1,52 1,50 3,02885E-06 aerobic respiration* 3,4-dihydroxy-2-butanone-4-phosphate synthase 
activity 
cytosol* 
YNL055C POR1 2,24 1,64 -1,63 9,83167E-11 aerobic respiration* voltage-gated ion-selective channel activity mitochondrial outer membrane* 
YGL032C AGA2 2,43 -1,99 -3,16 2,37633E-06 agglutination during conjugation 
with cellular fusion 
cell adhesion molecule binding cell wall (sensu Fungi) 
YCR105W ADH7 3,49 2,24 1,41 6,46982E-05 alcohol metabolism alcohol dehydrogenase (NADP+) activity soluble fraction 
YFL057C AAD16 8,88 2,60 2,02 1,02598E-11 aldehyde metabolism aryl-alcohol dehydrogenase activity cellular component unknown 
YFL056C AAD6 5,85 2,00 1,63 2,25567E-08 aldehyde metabolism aryl-alcohol dehydrogenase activity cellular component unknown 
YCR107W AAD3 5,56 2,19 2,05 3,63895E-08 aldehyde metabolism aryl-alcohol dehydrogenase activity cellular component unknown 
YMR318C ADH6 5,69 2,32 1,76 4,3974E-08 aldehyde metabolism* alcohol dehydrogenase (NADP+) activity soluble fraction 
YDR368W YPR1 4,53 1,86 -1,91 4,37888E-14 arabinose catabolism* oxidoreductase activity* cytoplasm* 
YPL111W CAR1 2,35 1,66 -1,03 8,35886E-08 arginine catabolism to ornithine zinc ion binding* Cytosol 
YDR035W ARO3 -1,63 -2,05 -1,95 1,02254E-06 aromatic amino acid family 
biosynthesis 
3-deoxy-7-phosphoheptulonate synthase activity cytoplasm* 
YHR137W ARO9 -1,40 -1,96 -2,05 5,50495E-07 aromatic amino acid family 
metabolism 
aromatic-amino-acid transaminase activity cytoplasm* 
YDL181W INH1 -1,05 -1,59 -3,29 4,16164E-11 ATP synthesis coupled proton 
transport 
enzyme inhibitor activity proton-transporting ATP synthase 
complex (sensu Eukaryota) 
YDR533C HSP31 58,65 9,02 4,55 1,65637E-15 biological process unknown unfolded protein binding* soluble fraction 
YNL134C  52,69 7,76 6,18 3,00983E-11 biological process unknown alcohol dehydrogenase (NADP+) activity cytoplasm* 
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YLR460C  31,39 10,03 5,12 3,10104E-13 biological process unknown molecular function unknown cellular component unknown 
YAL065C  8,67 21,18 16,51 1,50726E-10 biological process unknown molecular function unknown cellular component unknown 
YML131W  11,65 3,46 2,18 3,38101E-11 biological process unknown molecular function unknown Cytoplasm 
YPL171C OYE3 9,52 4,00 3,01 9,83167E-11 biological process unknown NADPH dehydrogenase activity cellular component unknown 
YGL157W  7,83 3,41 3,11 9,63025E-15 biological process unknown oxidoreductase activity* cytoplasm* 
YNL208W  5,21 2,29 -1,23 3,38101E-11 biological process unknown molecular function unknown Mitochondrion 
YJL217W  -5,13 -1,70 -2,67 3,50744E-10 biological process unknown molecular function unknown Cytoplasm 
YER156C  -5,00 -4,52 -3,30 2,08038E-08 biological process unknown molecular function unknown cytoplasm* 
YGR146C  2,39 3,18 4,81 4,62474E-09 biological process unknown molecular function unknown cellular component unknown 
YDR541C  4,76 2,01 1,57 9,83167E-11 biological process unknown dihydrokaempferol 4-reductase activity cellular component unknown 
YDR476C  3,96 4,32 4,65 1,96296E-10 biological process unknown molecular function unknown endoplasmic reticulum 
YHR199C AIM46 4,58 3,81 3,57 1,10258E-09 biological process unknown molecular function unknown Mitochondrion 
YOR285W  4,32 2,47 -1,94 1,48091E-12 biological process unknown molecular function unknown mitochondrion* 
YJL200C ACO2 -4,28 -2,33 -2,11 9,46215E-11 biological process unknown aconitate hydratase activity Mitochondrion 
YHR179W OYE2 4,23 2,98 1,81 3,9155E-07 biological process unknown NADPH dehydrogenase activity cytoplasm* 
YCR004C YCP4 3,05 1,31 -1,16 2,25323E-10 biological process unknown electron carrier activity cytoplasm* 
YEL072W RMD6 1,88 1,78 2,82 8,33849E-10 biological process unknown molecular function unknown cellular component unknown 
YHR198C AIM18 2,74 2,37 1,78 1,12538E-06 biological process unknown molecular function unknown Mitochondrion 
YGR243W FMP43 2,48 1,79 1,38 1,51395E-10 biological process unknown molecular function unknown Mitochondrion 
YBR054W YRO2 -1,84 -2,16 -2,37 4,95717E-08 biological process unknown molecular function unknown mitochondrion* 
YPL067C  -1,35 -1,92 -2,24 3,57568E-06 biological process unknown molecular function unknown Cytoplasm 
YDR033W MRH1 -1,54 -1,77 -2,18 6,14167E-07 biological process unknown molecular function unknown mitochondrion* 
YBR053C  -1,25 -1,45 -2,15 1,97731E-08 biological process unknown molecular function unknown cellular component unknown 
YDR441C APT2 1,31 1,15 2,13 0,000376073 biological process unknown molecular function unknown* Cytoplasm 
YHR213W  -1,28 -1,55 -2,09 0,000178934 biological process unknown molecular function unknown cellular component unknown 
YDR119W  1,35 -1,20 -2,03 7,61006E-07 biological process unknown molecular function unknown vacuolar membrane (sensu Fungi) 
YFL010C WWM1 2,02 1,28 1,02 1,32837E-09 biological process unknown molecular function unknown cytoplasm* 
YIL170W HXT12 -1,04 1,18 -2,05 0,00023407 biological process unknown* molecular function unknown* cellular component unknown 
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YGR065C VHT1 2,92 2,02 2,96 6,71791E-06 biotin transport biotin transporter activity plasma membrane 
YMR108W ILV2 -2,11 -2,22 -1,60 0,000302065 branched chain family amino acid 
biosynthesis 
acetolactate synthase activity* mitochondrion* 
YKL096W CWP1 2,21 -1,65 -2,66 1,90103E-08 cell wall organization and 
biogenesis 
structural constituent of cell wall cell wall (sensu Fungi) 
YBR067C TIP1 1,48 2,12 1,95 0,000216321 cell wall organization and 
biogenesis 
structural constituent of cell wall* cell wall (sensu Fungi) 
YBL007C SLA1 3,98 5,29 4,89 1,31656E-06 cell wall organization and 
biogenesis* 
protein binding, bridging* actin cortical patch 
YGL077C HNM1 -2,15 -1,84 -2,03 4,44125E-08 choline transport choline transporter activity plasma membrane 
YGL037C PNC1 2,54 -1,03 -1,75 3,42139E-08 chromatin silencing at telomere* nicotinamidase activity cytoplasm* 
YJR112W NNF1 2,09 -1,05 1,45 0,00037014 chromosome segregation molecular function unknown kinetochore* 
YMR145C NDE1 -1,34 -1,90 -2,17 0,000122532 chronological cell aging* NADH dehydrogenase activity Mitochondrion 
YGR279C SCW4 1,73 2,67 2,36 5,30319E-10 conjugation with cellular fusion glucosidase activity cell wall (sensu Fungi) 
YFR055W IRC7 -3,83 -1,69 -1,80 2,96119E-09 copper ion homeostasis* cystathionine beta-lyase activity cellular component unknown 
YMR120C ADE17 -1,99 -3,36 -8,11 2,39643E-10 'de novo' IMP biosynthesis* IMP cyclohydrolase activity* Cytosol 
YLR359W ADE13 -1,71 -2,00 -3,26 1,22968E-08 'de novo' IMP biosynthesis* adenylosuccinate lyase activity cellular component unknown 
YGL234W ADE5,7 -1,78 -1,87 -2,39 0,000137037 'de novo' IMP biosynthesis* phosphoribosylamine-glycine ligase activity* Cytoplasm 
YAR015W ADE1 -1,41 -1,57 -2,39 3,93387E-09 'de novo' IMP biosynthesis* phosphoribosylaminoimidazolesuccinocarboxami
de synthase activity 
cytoplasm* 
YDR408C ADE8 -1,51 -1,74 -2,39 1,04042E-08 'de novo' IMP biosynthesis* phosphoribosylglycinamide formyltransferase 
activity 
cytoplasm* 
YKL216W URA1 -4,22 -2,20 -2,37 1,99817E-11 'de novo' pyrimidine base 
biosynthesis 
dihydroorotate dehydrogenase activity cytoplasm* 
YLR420W URA4 -2,06 -1,48 -1,83 3,12986E-08 'de novo' pyrimidine base 
biosynthesis* 
dihydroorotase activity cytoplasm* 
YLR348C DIC1 -1,51 -2,18 -1,65 1,6088E-06 dicarboxylic acid transport dicarboxylic acid transporter activity mitochondrial envelope 
YNL312W RFA2 2,03 1,11 1,10 3,9155E-07 DNA recombination* DNA binding chromosome, telomeric region* 
YMR173W DDR48 14,25 3,38 1,28 6,08658E-15 DNA repair ATPase activity* Cytoplasm 
YGR180C RNR4 -3,09 -3,51 -2,60 1,13232E-07 DNA replication ribonucleoside-diphosphate reductase activity cytoplasm* 
YJL026W RNR2 -2,11 -2,68 -2,73 2,61035E-07 DNA replication ribonucleoside-diphosphate reductase activity cytoplasm* 
YLR056W ERG3 1,32 3,85 3,10 3,29195E-09 endocytosis* C-5 sterol desaturase activity endoplasmic reticulum 
YDR036C EHD3 -2,70 -3,37 -1,66 0,000585689 endocytosis* 3-hydroxyisobutyryl-CoA hydrolase activity Mitochondrion 
YBR207W FTH1 2,12 2,54 2,39 4,10896E-08 endocytosis* iron ion transporter activity vacuolar membrane (sensu Fungi) 
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YDR059C UBC5 2,20 1,43 1,19 1,17047E-08 endocytosis* ubiquitin conjugating enzyme activity proteasome complex (sensu 
Eukaryota) 
YDR246W TRS23 -1,30 -1,11 -3,62 1,76906E-07 ER to Golgi vesicle-mediated 
transport 
molecular function unknown TRAPP complex 
YGR209C TRX2 5,46 2,15 -1,09 4,04376E-16 ER to Golgi vesicle-mediated 
transport* 
thiol-disulfide exchange intermediate activity cytosol* 
YLR043C TRX1 1,91 1,51 -2,12 3,54014E-05 ER to Golgi vesicle-mediated 
transport* 
thiol-disulfide exchange intermediate activity cytosol* 
YHR007C ERG11 -4,43 -2,37 -2,01 3,06725E-12 ergosterol biosynthesis sterol 14-demethylase activity endoplasmic reticulum 
YGR175C ERG1 -3,59 -2,04 -2,10 2,05393E-10 ergosterol biosynthesis squalene monooxygenase activity* endoplasmic reticulum* 
YLR100W ERG27 1,85 2,51 2,04 2,67519E-06 ergosterol biosynthesis 3-keto sterol reductase activity endoplasmic reticulum* 
YIL160C POT1 2,86 2,95 2,64 0,000300542 fatty acid beta-oxidation acetyl-CoA C-acyltransferase activity peroxisomal matrix 
YKL182W FAS1 -2,04 -1,23 -1,47 3,40608E-05 fatty acid biosynthesis [acyl-carrier protein] S-malonyltransferase 
activity* 
mitochondrion* 
YJL196C ELO1 -1,31 -1,97 -2,38 5,79968E-08 fatty acid elongation, unsaturated 
fatty acid 
fatty acid elongase activity Membrane 
YOL158C ENB1 5,59 3,36 5,13 7,53054E-06 ferric-enterobactin transport ferric-enterobactin transporter activity integral to membrane* 
YAL063C FLO9 3,33 3,18 1,59 1,74816E-06 flocculation (sensu 
Saccharomyces) 
mannose binding cell wall (sensu Fungi) 
YDL168W SFA1 3,31 1,94 1,80 1,01867E-05 formaldehyde catabolism alcohol dehydrogenase activity* cytoplasm* 
YJL068C  2,15 1,07 -1,81 1,48802E-07 formaldehyde catabolism S-formylglutathione hydrolase activity Cytosol 
YLR081W GAL2 -1,33 1,01 -2,75 0,000197301 galactose metabolism* glucose transporter activity* plasma membrane 
YDL171C GLT1 -3,45 -2,76 -2,12 1,09675E-09 glutamate biosynthesis glutamate synthase (NADH) activity mitochondrion* 
YOR375C GDH1 1,22 -1,82 -2,74 0,000169205 glutamate biosynthesis glutamate dehydrogenase (NADP+) activity cytoplasm* 
YIR038C GTT1 2,77 1,29 -1,48 1,67415E-09 glutathione metabolism glutathione transferase activity mitochondrion* 
YFL018C LPD1 1,01 -1,60 -2,62 3,28322E-08 glycine catabolism* glycine dehydrogenase (decarboxylating) activity* mitochondrial nucleoid* 
YKL060C FBA1 -1,39 -1,33 -2,23 3,00235E-09 glycolysis* fructose-bisphosphate aldolase activity Cytoplasm 
YDR044W HEM13 -7,24 -4,30 -3,54 2,6884E-08 heme biosynthesis coproporphyrinogen oxidase activity mitochondrial inner membrane 
YHR092C HXT4 -1,50 -1,13 -2,74 0,000238609 hexose transport glucose transporter activity* plasma membrane 
YOL156W HXT11 -1,76 -1,50 -2,40 0,00051152 hexose transport glucose transporter activity* plasma membrane 
YFL011W HXT10 -1,88 -1,03 -2,29 0,000198859 hexose transport glucose transporter activity* mitochondrion* 
YJL214W HXT8 -1,24 1,02 -2,22 0,000433264 hexose transport glucose transporter activity* plasma membrane 
YHR096C HXT5 -1,54 -1,03 -2,12 0,000745868 hexose transport glucose transporter activity* plasma membrane 
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YER145C FTR1 5,14 6,28 6,37 7,40753E-07 high affinity iron ion transport iron ion transporter activity plasma membrane 
YMR058W FET3 4,03 3,32 3,41 3,24405E-06 high affinity iron ion transport* ferroxidase activity plasma membrane 
YOR202W HIS3 -1,30 -1,87 -2,73 3,29477E-07 histidine biosynthesis imidazoleglycerol-phosphate dehydratase activity Intracellular 
YMR038C CCS1 4,08 2,76 2,76 2,21309E-10 intracellular copper ion transport superoxide dismutase copper chaperone activity cytosol* 
YHR175W CTR2 2,30 2,41 2,44 5,4829E-09 intracellular copper ion transport* copper uptake transporter activity* vacuolar membrane (sensu Fungi) 
YHL047C ARN2 7,34 9,83 7,71 2,30174E-07 iron ion homeostasis* siderophore-iron transporter activity plasma membrane* 
YOR226C ISU2 3,07 2,88 3,67 1,98724E-10 iron ion homeostasis* molecular function unknown mitochondrial matrix 
YPL135W ISU1 1,47 2,26 2,12 1,61566E-06 iron ion homeostasis* protein binding mitochondrion* 
YEL065W SIT1 1,51 1,97 2,13 3,20822E-05 iron ion homeostasis* siderophore-iron (ferrioxamine) uptake transporter 
activity 
endosome* 
YLR126C  2,05 2,00 1,31 3,86266E-07 iron ion homeostasis* molecular function unknown Cytoplasm 
YLR214W FRE1 1,41 2,71 1,83 8,13349E-05 iron ion transport* ferric-chelate reductase activity plasma membrane 
YEL071W DLD3 1,35 1,61 2,76 5,72791E-09 lactate metabolism D-lactate dehydrogenase (cytochrome) activity cytoplasm* 
YOR108W LEU9 -2,36 -2,85 -2,18 6,14953E-06 leucine biosynthesis 2-isopropylmalate synthase activity Mitochondrion 
YNL104C LEU4 -2,12 -2,38 -1,89 5,05694E-06 leucine biosynthesis 2-isopropylmalate synthase activity cytoplasm* 
YDR492W IZH1 -2,17 -1,10 -1,05 1,04583E-08 lipid metabolism* metal ion binding endoplasmic reticulum* 
YNR050C LYS9 -1,30 -1,31 -2,15 4,86684E-05 lysine biosynthesis via aminoadipic 
acid 
saccharopine dehydrogenase (NADP+, L-
glutamate-forming) activity 
Cytoplasm 
YDR273W DON1 -3,48 -4,27 -7,39 1,00307E-07 meiosis* molecular function unknown spindle* 
YPL033C  -1,18 -1,02 -2,30 3,10073E-07 meiosis* molecular function unknown cellular component unknown 
YDL124W  13,88 5,70 3,25 1,5632E-12 Metabolism alpha-keto amide reductase activity* cytoplasm* 
YER091C MET6 -1,52 -2,17 -1,76 4,87252E-07 methionine biosynthesis 5-methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase activity 
Cytoplasm 
YER052C HOM3 2,04 1,62 1,63 6,85735E-08 methionine metabolism* aspartate kinase activity Cytoplasm 
YIL123W SIM1 2,98 2,83 2,61 6,77738E-07 microtubule cytoskeleton 
organization and biogenesis 
molecular function unknown cell wall (sensu Fungi) 
YHR051W COX6 -2,95 -4,28 -6,44 6,78731E-09 mitochondrial electron transport, 
cytochrome c to oxygen 
cytochrome-c oxidase activity respiratory chain complex IV (sensu 
Eukaryota) 
YNL052W COX5A -1,55 -2,52 -4,14 2,3686E-09 mitochondrial electron transport, 
cytochrome c to oxygen 
cytochrome-c oxidase activity respiratory chain complex IV (sensu 
Eukaryota) 
YDL067C COX9 -1,61 -1,76 -2,46 3,89744E-07 mitochondrial electron transport, 
cytochrome c to oxygen 
cytochrome-c oxidase activity respiratory chain complex IV (sensu 
Eukaryota) 
YLR304C ACO1 -5,91 -3,09 -2,21 7,13678E-11 mitochondrial genome 
maintenance* 
aconitate hydratase activity cytosol* 
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YLR355C ILV5 -2,50 -2,91 -1,71 6,64534E-11 mitochondrial genome 
maintenance* 
ketol-acid reductoisomerase activity mitochondrion* 
YPR035W GLN1 2,76 1,64 -1,40 2,22861E-09 nitrogen compound metabolism* glutamate-ammonia ligase activity Cytoplasm 
YDR488C PAC11 2,00 2,88 2,46 5,3931E-05 nuclear migration, microtubule-
mediated* 
microtubule motor activity* cytoplasmic microtubule* 
YKR092C SRP40 2,02 2,57 2,39 8,26061E-07 nucleocytoplasmic transport unfolded protein binding Nucleolus 
YLR058C SHM2 -2,13 -2,75 -5,60 1,98682E-09 one-carbon compound metabolism glycine hydroxymethyltransferase activity Cytoplasm 
YBR263W SHM1 -1,23 -1,50 -2,02 6,36091E-07 one-carbon compound metabolism glycine hydroxymethyltransferase activity Mitochondrion 
YMR189W GCV2 -1,05 -1,94 -4,75 6,81319E-09 one-carbon compound metabolism* glycine dehydrogenase (decarboxylating) activity mitochondrion* 
YDR019C GCV1 -1,02 -2,05 -4,23 4,89185E-11 one-carbon compound metabolism* glycine dehydrogenase (decarboxylating) activity mitochondrion* 
YDR256C CTA1 -1,07 1,33 2,44 2,80899E-08 oxygen and reactive oxygen 
species metabolism 
catalase activity mitochondrion* 
YNL241C ZWF1 2,01 1,54 1,77 0,000213503 pentose-phosphate shunt, oxidative 
branch* 
glucose-6-phosphate 1-dehydrogenase activity Cytoplasm 
YLR172C DPH5 1,09 1,42 2,01 7,8644E-06 peptidyl-diphthamide biosynthesis 
from peptidyl-histidine 
diphthine synthase activity Cytoplasm 
YDR244W PEX5 1,88 2,83 2,45 3,71098E-10 peroxisome organization and 
biogenesis* 
peroxisome targeting sequence binding* cytosol* 
YDR461W MFA1 2,35 1,26 -1,15 1,85914E-06 pheromone-dependent signal 
transduction during conjugation 
with cellular fusion 
mating pheromone activity soluble fraction* 
YAR071W PHO11 2,23 1,98 1,34 1,36173E-07 phosphate metabolism acid phosphatase activity extracellular region 
YBR093C PHO5 2,93 1,87 1,68 6,90419E-09 phosphate metabolism* acid phosphatase activity* cell wall (sensu Fungi)* 
YJL145W SFH5 1,38 1,40 2,11 4,28712E-07 phospholipid transport phosphatidylinositol transporter activity cytosol* 
YLL028W TPO1 2,42 1,71 1,89 0,000486673 polyamine transport spermine transporter activity* plasma membrane* 
YNL053W MSG5 -1,33 -1,80 -2,00 8,48573E-06 protein amino acid 
dephosphorylation* 
prenylated protein tyrosine phosphatase activity Cytoplasm 
YKL035W UGP1 -1,19 -2,77 -2,82 0,000355231 protein amino acid glycosylation* UTP:glucose-1-phosphate uridylyltransferase 
activity 
Cytoplasm 
YER003C PMI40 -1,65 -2,70 -2,04 3,602E-10 protein amino acid glycosylation* mannose-6-phosphate isomerase activity cytoplasm* 
YDR477W SNF1 4,29 8,29 11,15 9,97601E-13 protein amino acid phosphorylation* AMP-activated protein kinase activity cytoplasm* 
YDR247W VHS1 -1,24 -1,08 -2,49 2,27783E-05 protein amino acid phosphorylation* protein kinase activity* Cytoplasm 
YHR064C SSZ1 -1,05 1,03 -2,07 7,57592E-06 protein biosynthesis* unfolded protein binding Cytoplasm 
YIL015W BAR1 -1,03 -2,16 -2,51 5,49872E-08 protein catabolism aspartic-type endopeptidase activity periplasmic space (sensu Fungi) 
YBR155W CNS1 1,01 1,34 2,09 5,79968E-08 protein folding unfolded protein binding Cytoplasm 
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YJL117W PHO86 1,70 1,86 2,10 2,30085E-07 protein folding* molecular function unknown endoplasmic reticulum 
YOR045W TOM6 -1,09 -1,21 -2,26 2,15172E-05 protein import into mitochondrial 
matrix 
protein transporter activity mitochondrial outer membrane 
translocase complex 
YKL171W  1,11 2,06 1,40 2,94535E-05 Proteolysis protein kinase activity Cytoplasm 
YBR083W TEC1 1,11 2,84 1,47 0,000835527 pseudohyphal growth* RNA polymerase II transcription factor activity  Nucleus 
YGR204W ADE3 1,04 -1,53 -2,23 0,000409594 purine base biosynthesis* formate-tetrahydrofolate ligase activity* cytoplasm* 
YHR186C KOG1 2,52 1,51 1,39 8,46451E-09 regulation of cell growth* molecular function unknown mitochondrion* 
YDR353W TRR1 1,90 2,21 1,15 4,06151E-05 regulation of cell redox 
homeostasis 
thioredoxin-disulfide reductase activity Cytoplasm 
YLR109W AHP1 6,15 2,24 1,10 6,87333E-16 regulation of cell redox 
homeostasis* 
thioredoxin peroxidase activity Cytoplasm 
YOR230W WTM1 -3,59 -4,86 -4,08 6,87687E-09 regulation of meiosis transcription corepressor activity Nucleus 
YDR373W FRQ1 2,01 1,54 1,28 6,02415E-08 regulation of signal transduction enzyme activator activity* Membrane 
YNL239W LAP3 2,00 1,43 1,09 1,98502E-07 response to antibiotic transcription regulator activity* cytoplasm* 
YCR102C  20,64 8,68 4,22 1,69046E-12 response to copper ion molecular function unknown cellular component unknown 
YDR135C YCF1 3,29 2,18 2,02 1,08645E-08 response to metal ion* bilirubin transporter activity* vacuolar membrane 
YKR066C CCP1 -2,28 -1,93 -1,93 4,80904E-05 response to oxidative stress cytochrome-c peroxidase activity mitochondrion* 
YPL091W GLR1 2,03 1,60 1,29 3,37519E-06 response to oxidative stress glutathione-disulfide reductase activity cytoplasm* 
YDR513W GRX2 3,30 1,30 -1,23 6,70908E-08 response to oxidative stress* thiol-disulfide exchange intermediate activity* mitochondrion* 
YNL259C ATX1 2,80 3,24 1,99 4,85992E-10 response to oxidative stress* copper chaperone activity Cytosol 
YKL088W  2,34 3,36 2,64 1,15207E-08 response to salt stress* purine nucleotide binding* Cytoplasm 
YOL151W GRE2 46,46 10,06 4,92 5,33853E-13 response to stress oxidoreductase activity* cytoplasm* 
YMR251W-A HOR7 1,22 -2,40 -5,14 2,3686E-09 response to stress molecular function unknown endoplasmic reticulum* 
YOR010C TIR2 1,77 4,62 3,93 1,15207E-08 response to stress molecular function unknown cell wall (sensu Fungi) 
YGR234W YHB1 4,34 4,55 4,33 4,24914E-09 response to stress nitric oxide reductase activity cytoplasm* 
YOL143C RIB4 -2,63 -2,19 -3,98 2,29314E-11 riboflavin biosynthesis 6,7-dimethyl-8-ribityllumazine synthase activity cytoplasm* 
YNL002C RLP7 -1,18 1,51 2,05 3,1909E-08 ribosomal large subunit biogenesis* rRNA binding Nucleolus 
YMR049C ERB1 -1,12 1,24 2,50 3,65947E-07 rRNA processing molecular function unknown nucleus* 
YDR534C FIT1 30,84 64,14 78,89 4,14174E-11 siderophore transport molecular function unknown cell wall (sensu Fungi) 
YOR382W FIT2 46,09 45,13 30,29 9,87273E-12 siderophore transport molecular function unknown cell wall (sensu Fungi) 
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YOR383C FIT3 18,58 27,42 23,98 1,1794E-08 siderophore transport molecular function unknown cell wall (sensu Fungi) 
YHL040C ARN1 19,59 12,84 12,26 1,16314E-08 siderophore-iron transport siderophore-iron transporter activity endosome* 
YDL240W LRG1 -2,12 -1,57 1,12 7,17063E-05 small GTPase mediated signal 
transduction* 
Rho GTPase activator activity cytoplasm* 
YDR512C EMI1 2,51 1,20 -1,14 1,98502E-07 sporulation (sensu Fungi) molecular function unknown cellular component unknown 
YDR516C EMI2 2,40 1,18 -2,16 5,82485E-05 sporulation (sensu Fungi) molecular function unknown Cytoplasm 
YPL154C PEP4 2,29 1,41 -1,04 5,70433E-06 sporulation* endopeptidase activity* mitochondrion* 
YAL012W CYS3 2,17 1,59 2,03 0,00019831 sulfur amino acid metabolism* cystathionine gamma-lyase activity Cytoplasm 
YGR055W MUP1 2,46 1,73 1,73 0,000590636 sulfur amino acid transport L-methionine porter activity integral to plasma membrane 
YGL039W  8,88 5,58 4,62 5,33853E-13 telomere maintenance oxidoreductase activity* Cytoplasm 
YHR077C NMD2 3,54 4,19 3,15 1,11356E-09 telomere maintenance* protein binding cytoplasm* 
YCL008C STP22 3,95 1,81 -1,06 5,03273E-15 telomere maintenance* protein binding endosome* 
YIL036W CST6 2,14 3,65 3,67 5,85428E-08 telomere maintenance* specific RNA polymerase II transcription factor 
activity 
Nucleus 
YLR192C HCR1 1,66 1,87 3,31 4,16164E-11 telomere maintenance* translation initiation factor activity* eukaryotic translation initiation factor 3 
complex 
YGR057C LST7 2,89 2,59 3,31 1,05549E-06 telomere maintenance* protein transporter activity vesicle coat 
YAR003W SWD1 1,63 2,60 3,03 2,72762E-08 telomere maintenance* histone lysine N-methyltransferase activity (H3-K4 
specific) 
COMPASS complex 
YAL044C GCV3 -1,11 -1,58 -2,63 1,77651E-10 telomere maintenance* glycine dehydrogenase (decarboxylating) activity mitochondrion* 
YDL020C RPN4 2,44 1,95 2,34 2,93678E-10 telomere maintenance* transcriptional activator activity proteasome regulatory particle (sensu 
Eukaryota)* 
YNL220W ADE12 -1,72 -2,19 -2,14 0,000569341 telomere maintenance* adenylosuccinate synthase activity Cytoplasm 
YOR327C SNC2 2,01 1,52 1,52 2,04121E-05 telomere maintenance* v-SNARE activity transport vesicle 
YCL064C CHA1 1,09 1,54 5,49 4,16164E-11 threonine catabolism* L-serine ammonia-lyase activity* mitochondrion* 
YLR403W SFP1 3,35 6,10 8,02 2,66552E-08 transcription from RNA polymerase 
III promoter* 
transcription factor activity cytoplasm* 
YFL021W GAT1 -1,56 -2,53 -1,17 0,000323374 transcription initiation from RNA 
polymerase II promoter* 
specific RNA polymerase II transcription factor 
activity* 
nucleus* 
YHR178W STB5 6,03 3,72 2,72 5,21475E-11 transcription* transcription factor activity Nucleus 
YKL142W MRP8 3,16 2,23 2,16 1,07556E-09 Translation structural constituent of ribosome mitochondrial ribosome 
YAL003W EFB1 1,26 2,02 3,09 1,88987E-06 translational elongation translation elongation factor activity ribosome* 
YOR187W TUF1 1,09 -1,36 -2,02 3,00413E-05 translational elongation GTPase activity* mitochondrial matrix 
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YGR083C GCD2 1,33 2,23 3,05 9,17858E-06 translational initiation translation initiation factor activity* ribosome* 
YDR091C RLI1 -2,68 -2,09 -1,62 1,88162E-08 translational initiation* ATPase activity* cytoplasm* 
YNL037C IDH1 1,06 1,72 2,10 3,42894E-05 tricarboxylic acid cycle* isocitrate dehydrogenase (NAD+) activity mitochondrial matrix* 
YML092C PRE8 2,31 1,29 1,36 1,32333E-07 ubiquitin-dependent protein 
catabolism 
endopeptidase activity proteasome core complex, alpha-
subunit complex (sensu Eukaryota) 
YDL097C RPN6 1,53 1,38 2,01 9,54166E-10 ubiquitin-dependent protein 
catabolism 
structural molecule activity proteasome regulatory particle, lid 
subcomplex (sensu Eukaryota) 
YKL103C LAP4 4,75 3,19 1,89 1,50992E-09 vacuolar protein catabolism aminopeptidase I activity vacuole (sensu Fungi) 
YJR104C SOD1 4,09 1,78 1,67 9,60563E-13 zinc ion homeostasis* copper, zinc superoxide dismutase activity cytosol* 
YMR173W-A  20,86 3,40 1,51 1,07204E-16    
YCLX08C FRM2 14,24 5,45 3,47 2,10682E-08    
YCR074C  2,53 4,21 3,41 6,87687E-09    
YDR154C  2,69 1,18 1,03 4,52369E-08    
YKL030W  -2,67 -1,95 -1,78 2,49685E-09    
YKL066W  2,21 1,23 -1,53 1,00734E-08    
YLL044W  -2,19 -1,67 -1,57 2,14521E-06    
YDR271C  1,64 2,18 1,68 3,88956E-06    
YFR024C  2,12 2,08 1,47 4,42415E-05    
YAR073W  -1,25 -1,27 -2,07 0,000108108    
   140    
List of PDTC-sensitive genes 
 
  
  
 
PDTC-sensitive genes 
 
  
  
 
Sc ORF Gene Biological Process 
  Transport     
1 YAL002W VPS8 late endosome to vacuole transport 
2 YJR102C VPS25 telomere maintenance 
3 YMR231W PEP5 vacuole fusion, non-autophagic 
4 YNL246W VPS75 telomere maintenance 
5 YOR036W PEP12 Golgi to vacuole transport 
6 YOR106W VAM3 vesicle fusion 
7 YKL041W VPS24 late endosome to vacuole transport 
8 YLR148W PEP3 telomere maintenance 
9 YBR097W VPS15 telomere maintenance 
10 YDL077C VAM6 telomere maintenance 
11 YDL226C GCS1 ER to Golgi vesicle-mediated transport 
12 YDR080W VPS41 vacuole fusion, non-autophagic 
13 YDR129C SAC6 Endocytosis 
14 YDR264C AKR1 Endocytosis 
15 YDR323C PEP7 vesicle fusion 
16 YDR484W VPS52 Golgi to vacuole transport 
17 YDR485C VPS72 protein targeting to vacuole 
18 YDR495C VPS3 telomere maintenance 
19 YGL095C VPS45 protein complex assembly 
20 YGL124C MON1 protein targeting to vacuole 
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21 YGL212W VAM7 telomere maintenance 
22 YMR319C FET4 intracellular copper ion transport 
23 YLR396C VPS33 vacuole fusion, non-autophagic 
    
  vacuolar acidification   
1 YEL051W VMA8 vacuolar acidification 
2 YHR060W VMA22 protein complex assembly 
3 YBR127C VMA2 vacuolar acidification 
4 YDL185W TFP1 vacuolar acidification 
5 YGR020C VMA7 vacuolar acidification 
6 YGR105W VMA21 protein complex assembly 
7 YHR026W PPA1 vacuolar acidification 
8 YLR447C VMA6 vacuolar acidification 
9 YPR036W VMA13 vacuolar acidification 
10 YBR171W SEC66 filamentous growth 
11 YKL119C VPH2 protein complex assembly 
    
  mitochondrium related 
1 YMR286W MRPL33 Translation 
2 YPR100W MRPL51 Translation 
3 YBR122C MRPL36 Translation 
4 YCR003W MRPL32 Translation 
5 YDR237W MRPL7 Translation 
6 YGR076C MRPL25 Translation 
7 YKR085C MRPL20 Translation 
8 YGR171C MSM1 methionyl-tRNA aminoacylation 
9 YML001W YPT7 telomere maintenance 
10 YDR069C DOA4 telomere maintenance 
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11 YDR175C RSM24 Translation 
12 YHR168W MTG2 protein biosynthesis 
13 YKL155C RSM22 Translation 
14 YLR369W SSQ1 DNA-dependent DNA replication 
15 YBR179C FZO1 mitochondrion organization and biogenesis 
16 YER154W OXA1 protein import into mitochondrial inner membrane 
17 YMR072W ABF2 mitochondrial genome maintenance 
18 YPR024W YME1 mitochondrion organization and biogenesis 
19 YMR098C ATP25 
mitochondrial proton-transporting ATP synthase complex 
assembly 
20 YJL180C ATP12 protein complex assembly 
21 YDR405W MRP20 Translation 
22 YKL194C MST1 threonyl-tRNA aminoacylation 
23 YMR097C MTG1 protein biosynthesis 
    
  chromatin / telomere / transcription / translation 
1 YAR002W NUP60 telomere maintenance 
2 YJL140W RPB4 telomere maintenance 
3 YJL176C SWI3 chromatin remodeling 
4 YLR025W SNF7 telomere maintenance 
5 YNL229C URE2 telomere maintenance 
6 YNL236W SIN4 transcription from RNA polymerase II promoter 
7 YPL129W TAF14 chromatin remodeling 
8 YPL161C BEM4 telomere maintenance 
9 YBL058W SHP1 telomere maintenance 
10 YBL093C ROX3 transcription from RNA polymerase II promoter 
11 YBR231C SWC5 chromatin remodeling 
12 YCL008C STP22 telomere maintenance 
13 YDL006W PTC1 telomere maintenance 
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14 YDL160C DHH1 deadenylylation-dependent decapping 
15 YDR138W HPR1 telomere maintenance 
16 YDR364C CDC40 nuclear mRNA splicing, via spliceosome 
17 YGR006W PRP18 nuclear mRNA splicing, via spliceosome 
18 YGR252W GCN5 histone acetylation 
19 YLR357W RSC2 telomere maintenance 
20 YLR399C BDF1 DNA repair 
21 YMR091C NPL6 telomere maintenance 
22 YNL107W YAF9 chromatin remodeling 
23 YPR163C TIF3 translational initiation 
24 YGL071W AFT1 high-affinity iron transport 
25 YGL220W FRA2 
negative regulation of transcription from RNA polymerase II 
promoter in response to iron 
    
  Other     
1 YAL009W SPO7 sporulation (sensu Fungi) 
2 YML028W TSA1 response to oxidative stress 
3 YMR032W HOF1 Cytokinesis 
4 YMR205C PFK2 Glycolysis 
5 YMR293C   aerobic respiration 
6 YOR205C FMP38 biological process unknown 
7 YBL022C PIM1 Proteolysis 
8 YDR098C GRX3 response to oxidative stress 
9 YDR126W SWF1 spore wall assembly (sensu Fungi) 
10 YDR207C UME6 sporulation (sensu Fungi) 
11 YDR245W MNN10 actin filament organization 
12 YAL016W TPD3 protein biosynthesis 
13 YAL047C SPC72 mitotic sister chromatid segregation 
14 YER155C BEM2 cell wall organization and biogenesis 
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15 YFL014W HSP12 response to oxidative stress 
16 YJR104C SOD1 zinc ion homeostasis 
17 YJR122W CAF17 biological process unknown 
18 YLR260W LCB5 response to heat 
19 YLR370C ARC18 actin filament organization 
20 YPR160W GPH1 glycogen catabolism 
21 YPL148C PPT2 protein-cofactor linkage 
22 YLR056W ERG3 Endocytosis 
23 YLR079W SIC1 G1/S transition of mitotic cell cycle 
24 YCR009C RVS161 Endocytosis 
    
  protein modification   
1 YNL080C EOS1 Protein involved in N-glycosylation; response to oxidative stress 
2 YML112W CTK3 protein amino acid phosphorylation 
3 YGR262C BUD32 protein amino acid phosphorylation 
4 YGR092W DBF2 protein amino acid phosphorylation 
5 YDR507C GIN4 protein amino acid phosphorylation 
6 YDR523C SPS1 protein amino acid phosphorylation 
7 YGL017W ATE1 protein modification 
8 YDL232W OST4 protein amino acid N-linked glycosylation 
9 YJL095W BCK1 protein amino acid phosphorylation 
10 YDL090C RAM1 protein amino acid farnesylation 
    
  Rim101 pathway   
1 YHL027W RIM101 neg. regulation of transcription; response to pH; meiosis 
2 YMR154C RIM13 protein processing 
3 YMR063W RIM9 ascospore formation 
4 YKL002W DID4 late endosome to vacuole transport 
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5 YPR173C VPS4 intralumenal vesicle formation 
6 YGL045W RIM8 protein processing; meiosis 
    
  unknown     
1 YML013C-A   Dubious open reading frame  
2 YPR109W   
Predicted membrane protein; dipoid deletion strain has high 
budding index 
3 YMR073C   response to drug 
4 YOL087C   Putative protein of unknown function 
5 YDR532C KRE28 Protein of unknown function; forms a complex with Spc105p 
6 YDR433W   
Dubious open reading frame unlikely to encode a functional 
protein 
7 YCL007C CWH36 Dubious ORF unlikely to encode a protein;  
8 YDL183C   biological process unknown 
9 YBL012C   Dubious open reading frame 
10 YNL171C   Dubious open reading frame 
11 YNL198C   Dubious open reading frame 
12 YNL296W   Dubious open reading frame 
13 YDL167C NRP1 biological process unknown 
    
  Excluded     
1 YLR338W OPI9 Dubious open reading frame 
2 YLR358C   Dubious open reading frame 
3 YPR099C   Dubious open reading frame  
4 YKL118W   Dubious open reading frame 
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N° Genes / 
Category 
Functional 
Categories Gene Names 
 
24 Transport 
VPS8, VPS25, PEP5, VPS75, PEP12, VAM3, VPS24, PEP3, 
VPS15, VAM6, GCS1, VPS41, SAC6, AKR1, PEP7, VPS52, 
VPS72, VPS3, VPS45, MON1, VAM7, FET4, VPS33, STP22 
 
11 
vacuolar 
acidification 
VMA8, VMA22, VMA2, TFP1, VMA7, VMA21, PPA1, VMA6, 
VMA13, SEC66, VPH2 
 
23 
mitochondria 
organization / 
maintainance 
MRPL33, MRPL51, MRPL36, MRPL32, MRPL7, MRPL25, 
MRPL20, MSM1, YPT7, DOA4, RSM24, MTG2, RSM22, SSQ1, 
FZO1, OXA1, ABF2, YME1, ATP25, ATP12, MRP20, MST1, 
MTG1 
 
24 
chromatin / 
telomere / 
transcription / 
translation 
NUP60, RPB4, SWI3, SNF7, URE2, SIN4, TAF14, BEM4, SHP1, 
ROX3, SWC5, PTC1, DHH1, HPR1, CDC40, PRP18, GCN5, 
RSC2, BDF1, NPL6, YAF9, TIF3, AFT1, FRA2 
 
10 
protein 
modification 
EOS1, CTK3, BUD32, DBF2, GIN4, SPS1, ATE1, OST4, BCK1, 
RAM1 
 
6 Rim101 pathway RIM101, RIM13, RIM9, DID4, VPS4, RIM8 
 
24 Other 
SPO7, TSA1, HOF1, PFK2, YMR293C, FMP38, PIM1, GRX3, 
SWF1, UME6, MNN10, TPD3, SPC72, BEM2, HSP12, SOD1, 
CAF17, LCB5, ARC18, GPH1, PPT2, ERG3, SIC1, RVS161 
 
13 Unknown 
YML013C-A, YPR109W, YMR073C, YOL087C, KRE28, 
YDR433W, CWH36, YDL183C, YBL012C, YNL171C, YNL198C, 
YNL296W, NRP1,  
 
4 Excluded OPI9, YLR358C, YPR099C, YKL118W 
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YEASTRACT - Differentially expressed genes were grouped according to their transcription factors or potential regulators 
Transcription 
Factor 
% Sc Gene Name 
Yap1 60.3 EFB1, CYS3, ADE1, PHO11, IMD1, SLA1, YBR053C, YRO2, TIP1, PHO5, CNS1, FTH1, SHM1, YCL026C-A, YCP4, YCR102c, ADH7, AAD3, RPN4, RPN6, YDL124w, 
SFA1, GLT1, GCV1, MRH1, ARO3, EHD3, VBA4, YCF1, YDR154c, CTA1, DON1, TRR1, YPR1, FRQ1, ADE8, RIB3, GRX2, EMI2, HSP31, FIT1, DLD3, RMD6, PMI40, 
MET6, YER156c, GAT1, AAD6, AAD16, IRC7, PNC1, HNM1, MUP1, VHT1, YGR146c, ERG1, RNR4, ADE3, TRX2, YHB1, ARN1, ERG11, COX6, HXT4, HXT5, ARO9, 
CTR2, STB5, OYE2, KOG1, FMP22, FMP34, SIM1, HXT12, GTT1, RNR2, SOD1, YKL030w, FBA1, YKL066w, CWP1, LAP4, MRP8, FAS1, URA1, CCP1, SRP40, TPO1, 
TRX1, ERG3, SHM2, AHP1, DPH5, FRE1, ACO1, ILV5, SFP1, URA4, YLR460c, PRE8, YML131w, CCS1, ERB1, FET3, ADE17, DDR48, YMR173w-a, GCV2, HOR7, ADH6, 
LEU4, YNL134c, YNL208w, ADE12, LAP3, ZWF1, RFA2, RIB4, GRE2, HXT11, LEU9, ISU2, WTM1, YOR285w, GDH1, FIT3, YPL067c, GLR1, CAR1, PEP4, OYE3, GLN1 
Sfp1 47.0 EFB1, GCV3, FLO9, IMD1, SLA1, YBR053c, CNS1, STP22, YCL026c-a, YCR102c, RPN4, RPN6, LRG1, GCV1, MRH1, HEM13, RLI1, VBA4, YCF1, YDR154c, TRS23, 
TRR1, YPR1, FRQ1, MFA1, PAC11, IZH1, HSP31, FIT1, SIT1, DLD3, PMI40, HOM3, FTR1, YER156c, HXT10, AAD16, AGA2, YGL039w, YGL157w, VHT1, YGR146c, 
ERG1, ADE3, YHB1, ARN1, ERG11, SSZ1, HXT4, CTR2, STB5, OYE2, YHR213w, BAR1, POT1, HXT12, RNR2, YJL068c, ELO1, NNF1, CWP1, FAS1, URA1, SRP40, 
ERG3, SHM2, GAL2, ERG27, AHP1, HCR1, ACO1, ILV5, SFP1, YLR460c, YML131w, ERB1, FET3, ILV2, ADE17, YMR173w-a, GCV2, HOR7, ADH6, RLP7, MSG5, LEU4, 
YNL134c, LAP3, ZWF1, RFA2, LYS9, RIB4, GRE2, ENB1, UTP23, LEU9, HIS3, ISU2, FIT2, YPL067c, CAR1, OYE3, GLN1 
Msn2 34.2 EFB1, PHO11, SLA1, YBR053c, PHO5, RPN4, YDL124w, MRH1, YDR154c, CTA1, TRR1, APT2, EMI1, GRX2, EMI2, HSP31, MET6, FTR1, GAT1, AAD16, PNC1, HNM1, 
YGL157w, ADE5,7, MUP1, LST7, VHT1, ERG1, TRX2, YHB1, HXT4, HXT5, ARO9, CTR2, SIM1, POT1, GTT1, ACO2, REE1, SOD1, UGP1, FBA1, CWP1, LAP4, MRP8, 
CCP1, ERG3, AHP1, YLR126c, FRE1, ILV5, YML131w, ERB1, FET3, DDR48, YMR173w-a, HOR7, RLP7, IDH1, COX5a, YNL134c, LAP3, ATX1, RIB4, GRE2, UTP23, 
LEU9, HIS3, ISU2, WTM1, YOR285w, GDH1, FIT2, PEP4, OYE3 
Ste12 34.2 EFB1, FLO9, ADE1, PHO11, YBR053c, YRO2, TIP1, TEC1, YCL026c-a, CHA1, YCR102c, SFA1, GLT1, LRG1, EHD3, HEM13, RLI1, APT2, MFA1, HSP31, RMD6, MET6, 
FTR1, LPD1, GAT1, IRC7, AGA2, PNC1, YGL039w, YGR146c, RNR4, YHB1, FMP43, SCW4, ARN1, ERG11, HXT4, HXT5, ARO9, OYE2, BAR1, CST6, SIM1, BNR1, POT1, 
HXT12, GTT1, SFH5, ELO1, ACO2, HXT8, CWP1, LAP4, TPO1, TRX1, GAL2, AHP1, ACO1, DIC1, URA4, YLR460c, CCS1, ERB1, ILV2, NDE1, DDR48, HOR7, MSG5, 
POR1, YNL208w, LYS9, TIR2, SNC2, GDH1, ISU1 
Sok2 30.1 EFB1, FLO9, YBR053c, YRO2, TIP1, TEC1, CHA1, AAD3, YDL124w, SFA1, HEM13, APT2, IZH1, EMI2, HSP31, SIT1, DLD3, FTR1, AAD16, IRC7, AGA2, PNC1, YGL157w, 
YGR146c, RNR4, YHB1, SCW4, ERG11, HXT4, HXT5, OYE2, SIM1, HXT12, GTT1, RNR2, HXT8, CWP1, LAP4, FAS1, SRP40, TPO1, ERG3, SHM2, ACO1, ILV5, 
YLR460c, YML131w, NDE1, DDR48, HOR7, LEU4, ZWF1, LYS9, GRE2, HXT11, ENB1, TIR2, TUF1, WTM1, SNC2, GDH1, FIT3, YPL067c, ISU1, PEP4, OYE3 
Met4 28.8 CYS3, GCV3, FLO9, IMD1, YBR053c, YRO2, SHM1, YCP4, AAD3, RPN4, INH1, GCV1, HEM13, UBC5, YCF1, YDR154c, YDR476c, RIB3, GRX2, QCR7, HSP31, SIT1, 
DLD3, MET6, HXT10, GAT1, AAD6, AAD16, YFR024c-a, PNC1, ADE5,7, MUP1, LST7, VHT1, ADE3, ARO9, BNR1, RNR2, PHO86, ACO2, REE1, SOD1, UGP1, MRP8, 
URA1, CCP1, TRX1, SHM2, SFP1, PRE8, YML131w, ERB1, NDE1, GCV2, MSG5, YNL208w, ADE12, LAP3, LYS9, HXT11, WTM1, FIT2, OYE3 
Rpn4 28.8 GCV3, IMD1, YBR053c, YRO2, TIP1, PHO5, STP22, YCL026c-a, CHA1, YCP4, YCR102c, RPN4, RPN6, GCV1, MRH1, TRR1, FRQ1, FIT1, MTC7, DLD3, PMI40, HOM3, 
MET6, AAD6, AAD16, PNC1, YGL039w, TRX2, YHB1, FMP43, SCW4, ARN1, ARN2, HXT4, HXT5, ARO9, GTT1, UGP1, CWP1, LAP4, FAS1, URA1, ERG3, FRE1, DIC1, 
YLR460c, PRE8, YML131w, FET3, ILV2, ADE17, NDE1, GCV2, HOR7, IDH1, POR1, ENB1, TIR2, YOR285w, FIT2, FIT3, PEP4, GLN1 
Pdr1 27.9 EFB1, YAL065c, PHO11, YBR053c, YRO2, TEC1, PHO5, YCL026c-a, ADH7, RPN4, YDL124w, TRR1, YPR1, IZH1, EMI2, HSP31, FIT1, SIT1, DLD3, HOM3, FTR1, AAD16, 
PNC1, YGL039w, YGL157w, YGR146c, FMP43, SCW4, HXT4, OYE2, HXT12, GTT1, YKL030w, UGP1, CWP1, FAS1, URA1, TPO1, ERG27, AHP1, ACO1, DIC1, ILV5, 
YML131w, FET3, NDE1, HOR7, ADH6, YNL134c, ZWF1, ATX1, LYS9, GRE2, HXT11, ENB1, HIS3, SNC2, FIT2, ISU1, PEP4, GLN1 
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Aft1 25.6 FLO9, YRO2, FTH1, YCP4, ADH7, AAD3, RPN4, YDL124w, YDR154c, YDR271c, HSP31, FIT1, YDR541c, SIT1, FTR1, YER156c, PNC1, COX13, VHT1, YGR146c, YHB1, 
FMP43, ARN1, ARN2, HXT4, HXT5, FMP22, GTT1, ELO1, SOD1, UGP1, LAP4, TPO1, ERG3, GAL2, AHP1, HCR1, FRE1, YML131w, FET3, NDE1, DDR48, GCV2, HOR7, 
IDH1, ZWF1, ATX1, HXT11, ENB1, TUF1, ISU2, FIT2, FIT3, ISU1, PEP4, OYE3 
Gcn4 24.7 CYS3, GCV3, ADE1, PHO11, YRO2, PHO5, YCL026c-a, CHA1, COX9, GLT1, GCV1, ARO3, PEX5, ADE8, RIB3, EMI1, GRX2, HOM3, LPD1, GAT1, IRC7, PNC1, ADE5,7, 
VHT1, ADE3, YHB1, HXT5, ARO9, FMP34, ACO2, SOD1, NNF1, FBA1, CWP1, LAP4, ILV5, ADE13, ILV2, ADE17, DDR48, GCV2, IDH1, LEU4, ADE12, LAP3, ZWF1, LYS9, 
LEU9, HIS3, WTM1, GDH1, CAR1, ISU1, GLN1 
Pdr3 24.2 EFB1, YAL065c, PHO11, SLA1, YRO2, PHO5, YCL026c-a, YCR102c, RPN4, YDL124w, MRH1, TRR1, IZH1, EMI2, HSP31, DLD3, HOM3, FTR1, AAD6, AAD16, PNC1, 
YGL039w, YGL157w, TRX2, YHB1, FMP43, SSZ1, HXT4, UGP1, LAP4, URA1, SRP40, TPO1, ERG27, DPH5, ACO1, YLR460c, ERB1, HOR7, YNL134c, GRE2, HXT11, 
ENB1, UTP23, TIR2, HIS3, ISU2, SNC2, FIT2, CAR1, ISU1, PEP4, OYE3 
Cin5 20.5 GCV3, FLO9, ADE1, YBR053c, YRO2, YCR102c, SFA1, GLT1, MRH1, APT2, HSP31, RNR4, TRX2, ARN1, COX6, STB5, OYE2, SIM1, HXT12, GTT1, LAP4, MRP8, FAS1, 
CCP1, SHM2, GAL2, AHP1, YLR126c, FRE1, ACO1, ADE13, YLR460c, YML131w, CCS1, ADE17, DDR48, YMR173w-a, GCV2, ZWF1, GRE2, HXT11, WTM1, YOR285w, 
FIT2, GLN1 
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